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Abstract 
The negative energy balance (NEB) experienced by dairy cows due to pregnancy has been 
reported to decrease a cow’s milk production levels however pregnancy is required as part of 
an annual milk production cycle. Manipulation of the stem cells in the bovine mammary 
gland may have the potential to increase the duration of lactation at economically viable 
levels. The hypothesis being that maintenance of mammary epithelial cell populations by 
mammary stem cell division may enhance lactational persistence. This could remove the need 
for a concurrent pregnancy and therefore the impact of NEB. Mammary epithelial cells 
synthesise milk in the bovine mammary gland. These cells are generated as the mammary 
gland develops during puberty in the cow. The number of milk producing epithelial cells is 
derived from the division of mammary stem cells. The ratio of mammary stem/progenitor cell 
proliferation to apoptosis contributes to the maintenance of the tissue integrity of the 
mammary gland and allows milk production to continue during lactation (Capuco et al., 
2001). Evidence from isolated putative bovine, murine and human mammary stem cells has 
shown self-renewal capacity and the ability to proliferate to form large numbers of progenitor 
cells. Using putative murine mammary stem cells, a semi-functional mammary gland has been 
generated from a single cell (Shackleton et al., 2006). The proliferation of mammary stem 
cells in the bovine mammary gland may also influence milk production (Capuco et al., 2009). 
While populations of mammary stem cells have been identified and characterized in various 
species, little is known about this cell population in the bovine mammary gland (Tiede and 
Kang, 2011). It has been proposed through investigations in mice that putative mammary 
stem and progenitor cells exhibit different immunophenotypes (Visvader and Stingl, 2014) 
with the potential populations of putative mammary progenitor cells (Lin-
/CD24+/CD29+/CD61+) and putative mammary stem cells (Lin-/CD24+/CD29+/CD49f+). In 
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this thesis, these cell surface marker combinations were used to isolate bovine mammary 
epithelial cell populations to assess the utility of these markers for enriching populations of 
putative bovine mammary stem and progenitor cells. 
 
Antibodies were used to investigate bovine tissue sections from Holstein Friesian cows for the 
presence of possible stem cell surface markers that have been used in human and mouse 
mammary stem cell investigations (CD24, CD29, CD49f and CD61). Cryosections and 
paraffin embedded tissue sections were used for the investigation of the location of cells 
exhibiting the cell surface markers CD29 and CD49f in cryosectioned tissues and CD24 and 
CD61 for paraffin embedded tissues. All samples were imaged at five random locations using 
an Olympus FV1000 with a 60X oil objective for fluorescent imaging or an Olympus BX51 
Microscope. Using the Imaris® (Bitplane) and MetaMorph® image analysis software, it was 
possible to determine the number of nuclei in each field of view and the relative co-
localisation of CD29 and CD49f antibody fluorescence for each cell. Based on initial 
observations, the co- localisation between CD29 and CD49f seemed to occur on cells that 
inhabit a region adjacent to terminally differentiated cells on the interior surface of the alveoli. 
The position of these cells suggests a direct role in the cytodynamics of the mammary gland 
necessary to maintain milk producing cell populations that line the alveoli. This study 
investigated the use of stem and progenitor cell markers in bovine tissues that have been used 
previously in other species. Histological investigations using fluorescence microscopy 
revealed that CD29 was primarily located in the stromal area of the mammary tissue with 
CD49f located in the stromal and basal region surrounding the alveoli. This finding indicates 
that CD29 and CD49f potentially provide tissue stabilization through cell-to-cell interactions. 
Low levels of CD24 and CD61 were observed throughout the stroma of the mammary tissue 
however this result may be due to the method of visualization (colourimetric histology).  
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To further understand the tissue cytodynamics, a TUNEL apoptosis assay was performed on 
all samples in addition to the application of an antibody to the Ki-67 nuclear proliferation 
antigen (an indirect measure of proliferation). These showed an inverse relationship across a 
lactation with Ki-67 positive cells more abundant in late pregnancy and peak lactation and 
less abundant in involution; conversely cells exhibiting apoptosis observed in lowest 
abundance in late pregnancy and highest abundance in involution. The ratio of proliferation 
vs. apoptotic antigens at the three stages of lactation indicates that cell turnover increased as 
the lactation progressed. 
 
Mammary tissue biopsies from three Holstein Friesian cows sampled at 6-20 days prior to 
parturition were macerated, digested and isolated through a Percoll-Ficoll gradient. The cells 
isolated from the density layers (1.03/1.04 density layers) containing bovine mammary 
epithelial cells (BMEC) were removed and cultured. At passage 4 or  5 the cells were 
detached, put into solution and depleted of Lin+ (non-epithelial cells positive for antibodies: 
CD45, CD31, TER119, BP-1) through the use of magnetic bead separation. The remaining 
cells were treated with a cocktail of antibodies (CD24, CD29 and either CD49f or CD61) for 
the putative bovine mammary stem or progenitor cell populations and isolated by 
fluorescence activated cell sorting (FACS). Once isolated, the cell populations were tested 
functionally using proliferation (manual cell count) and mammosphere formation (number 
and area measurement by image analysis) assays. FACS analysis revealed 12.67 % (± 6.67 %) 
(from n=3 animals) of cells identified as putative stem cells (Lin-/CD24+/CD29+/CD49f+ 
phenotype) and 15.33% (± 4.16 %) (from n=3 animals) as putative progenitor cells (Lin-
/CD24+/CD29+/CD61+ phenotype). When cultured in vitro, the proliferation rate of the 
sorted putative stem/progenitor populations showed a significantly higher mean proliferation 
rate at 133 % (± 18 %) and 130 % (± 8 %), respectively, compared to the processed unsorted 
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control cells. When the same populations were isolated and investigated with Matrigel culture 
there were fewer observed mammospheres formed by both sorted populations, with 75.9 % (± 
1.02 %) and 80.6 % (± 9.57 %) for putative stem and progenitor cell populations, 
respectively, compared to unsorted control cells. There was very little difference in the size of 
the mammospheres seen in both the putative stem and progenitor cell population compared to 
the unsorted control cells. These observations suggest that the immunophenotypes observed in 
mice for enrichment of mammary stem and progenitor populations may have similar 
characteristics and utility in bovine mammary cell populations. Isolation of these ce ll 
populations may be useful in future experiments investigating mammary cytodynamics in the 
lactation cycles of dairy cows. 
 
The putative bovine mammary stem and progenitor cells populations were subjected to full 
transcriptomic analysis (RNA-seq). The RNA-seq results for the putative stem cell population 
showed differentially expressed genes for the production of extracellular matrix proteins 
(ECM) (Versican), internal structural proteins (Keratin 14 and alpha 2 Actin), receptors 
(Gamma-aminobutyric acid B receptor, 1) and growth modulation factors (Insulin- like growth 
factor binding protein 2 and platelet-derived growth factor, beta polypeptide). The putative 
progenitor cell population was also found to differentially express a number of genes for 
ECM proteins (Chondroitin Polymerizing Factor 2), metabolic and signaling pathway proteins 
(cytochrome P450, family 24, subfamily A, polypeptide 1, cytochrome P450, family 26, 
subfamily B, polypeptide 1, S100 calcium binding protein A8) and membrane transporters 
(aquaporin 3). 
 
The search for putative bovine mammary stem cells was extended to cell populations found in 
milk samples. A suite of stem and progenitor cell antibodies, including those to the markers 
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already validated in the earlier work, were tested on the cell population of bovine milk 
samples (CD24, CD29, CD34, CD44, CD49f, CD61, Sca-1, Ki67 and Nestin). The average 
level of milk cells positive for the markers CD29, CD44 and Nestin was found to be 
approximately 9 %, 30 % and 25 %, respectively in 10 milk samples. Of the cells isolated 
from milk an average of 48.71 % were assayed as viable and 39.26 % non-viable. The other 
markers used were also found, but at much lower levels. These markers were correlated with 
the lactation day of cow at sampling to understand any temporal influences on marker 
expression within a lactation cycle. The Ki67 and CD44 markers demonstrated a trend 
upwards and increase with greater number of days in lactation. All other markers were shown 
to decline with increasing days in lactation. Similar to the work conducted with side 
populations of mammary epithelial cells, the isolation and further characterization of these 
cell populations may be useful in future experiments investigating the mammary 
cytodynamics during lactation of dairy cows. 
 
Increased understanding of the cytodynamics relative to stem and progenitor cell populations 
in the bovine mammary gland could potentially reveal ways to increase or maintain milk yield 
across lactation whilst maintaining cow fertility, reduce the need for concurrent pregnancies 
and reduce the NEB cows may experience from the current cycle of pregnancy and high 
milking activities. Stem and progenitor cell markers have been identified in the mammary 
tissue and milk of cows. This is the first step towards further understanding of these 
cytodynamics. The methods developed in this thesis have provided an initial step that may 
assist in understanding the cytodynamics of the mammary gland that may influence milk 
production. Ultimately this increased understanding can potentially result in increased or 
maintenance of milk production.  
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Chapter 1  
Literature Review 
1.1 Introduction - The Australian dairy industry     
The dairy industry is Australia’s fourth largest rural industry with the farm, manufacturing 
and export components producing approximately $13 billion (AUD) annually (Dairy 
Australia, 2015). Despite the falling numbers of dairy cows Australia wide, production levels 
continue to increase (Dairy Australia, 2013) due to improved feeding, breeding and animal 
management practices. The higher demand on cows for increased milk production can lead to 
the cow experiencing a negative energy balance (NEB) compounded by pregnancy during 
lactation cycles. In order for a cow to produce milk in an annual milk production cycle, there 
is a requirement for pregnancy and parturition. Negative energy balance can create difficulties 
for cows to become pregnant and disrupt the production of milk. Subsequently, this can have 
a significant impact on the dairy industry as milk production and reproductive efficiency may 
be reduced leading to major financial losses for dairy farmers.  
 
An improved understanding of the cellular mechanisms involved in lactation could alleviate 
issues associated with reduced milk production in late lactation by identifying key cellular 
components and processes. This may also allow more control or potentially reduce the need 
for insemination and establishment of a pregnancy increasing the annual lactation cycle by 
enhancing persistence of lactation. One approach to managing the persistency of lactation is 
to control the cell turnover of the bovine mammary gland (i.e. the ratio of proliferation vs. 
apoptosis) as the cell turnover determines lactation levels (Capuco, 2007). Increased 
understanding about how the bovine mammary gland behaves during lactation on a cellular 
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level may lead to economically viable levels of lactation without the need for concurrent 
pregnancies and subsequent reduced milk production in late lactation. 
 
A dairy cows productive ability can be impacted due to the negative energy balance (NEB) 
that occurs when a cow maintains a pregnancy and is committed to commercially viable 
levels of milk production. Manipulation of the stem cells in the bovine mammary gland may 
have the potential to increase the duration of lactation at economically viable levels  and 
minimise the need for a concurrent pregnancy. Mammary epithelial cells are responsible for 
the synthesis of milk in the bovine mammary gland. The division of mammary stem cells as 
the mammary gland develops results in larger numbers of milk producing cells and an 
increase of milk producing epithelial cells relative to cellular apoptosis during pregnancy and 
lactation. It is the ratio of mammary stem/progenitor cell proliferation to apoptosis of 
mammary epithelial cells that maintains the tissue integrity of the mammary gland and allows 
milk production to continue during lactation (Herve et al., 2016). Stem cells isolated from 
bovine, murine and human mammary glands have shown self-renewal capacity, the ability to 
proliferate to form large numbers of progenitor cells and, in mice models, a single cell has 
been shown to generate a semi-functional mammary gland (functional alveolar subunits 
without a complete excretory network) (Shackleton et al., 2006). While populations of 
mammary stem cells have been identified and characterized in various species, little is known 
about this cell population in the bovine mammary gland (Tiede and Kang, 2011). Different 
immunophenotypes used in mice have outlined the potential populations of putative 
mammary progenitor cells (Lin- /CD24+/CD29+/CD61+) and putative mammary stem cells 
(Lin-/CD24+/CD29+/CD49f+) (Visvader and Stingl, 2014). These cell surface marker 
combinations were used to isolate cells from culture bovine mammary epithelial cells to 
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assess the utility of these markers for enriching populations of putative mammary stem and 
progenitor cells in this species.  
 
The work in this thesis involved the validation of a suite of antibodies (CD24, CD29, CD49f 
and CD61) in histology sections of bovine mammary gland tissue from three stages of 
lactation (late pregnancy, peak lactation and involution). Initially, the bovine mammary gland 
tissue samples were characterised for apoptosis and a marker of proliferation (Ki-67). 
Following this a mixture of fluorescent and colourimetric analysis was used to investigate the 
presence of CD24, CD29, CD49f and CD61 in tissues from the three stages of lactation 
studied. The project moved into cell sorting techniques to isolate putative bovine mammary 
stem (Lin- /CD24+/CD29+/CD49f+) and progenitor (Lin-/CD24+/CD29+/CD61+) cell 
populations. These populations of cells were studied with functional assays (proliferation and 
mammosphere formation potential) in addition to full transcriptome analysis with RNA 
sequencing (RNA-seq). Further work involved the investigation of the cell population of 
bovine milk samples to search for a more readily accessible source of mammary gland stem 
cells.  
 
1.2 Milk production challenges        
The physiological challenges of modern milk production systems may not impact on only the 
animal’s energy status, but also the animals ability to maintain homeostasis, a high milk yield 
and fertility (Pryce et al., 2004). The annual cycle of pregnancy and lactation results in a large 
metabolic burden on the cow and importantly, reproductive performance can be impacted 
during high milk yield (Nebel and McGilliard, 1993). In addition, pregnancy establishment 
prior to/during peak lactation is problematic due to the high metabolic demands of milk 
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production (Gröhn and Rajala-Schultz, 2000). Maintaining lactation at a productive level for 
longer than the typical 305 day lactation period may alleviate these issues by negating the 
need to establish a pregnancy during the peak lactation period and thus during this large 
energetic demand.  
 
Lactation levels are determined by the balance between the proliferation of milk-producing 
cells and the signals that initiate cell turnover (apoptosis) in the mammary gland. By 
controlling the balance of proliferation vs. apoptosis of mammary epithelial cells (milk 
secretary cells) within the bovine mammary gland, the overall milk yield can be increased or 
maintained if more secretory cells continue to produce milk. In the short term, this has the 
benefit of an increased yield. In the longer term, it leads to more control over milk-production 
for the farmer/producer by reducing the need for the cow to become pregnant during peak 
lactation. This may also alleviate some fertility issues resulting from NEB at this stage of 
lactation (peak lactation).  
 
1.3 Bovine lactation and challenges from various production systems  
The Australian dairy industry produced over 9.7 billion litres of milk in the 2014/15 (Dairy 
Australia, 2015) and accounts for a farm gate value of approximately $4.7 billion. This 
reportedly makes dairy the fourth largest agricultural export industry in Australia (Dairy 
Australia, 2011, Dairy Australia, 2015). Australian milk producers export 34 % of milk 
production (Dairy Australia, 2015) with the top markets being China, Japan and Singapore  
(Dairy Australia, 2015). The total number of dairy cows has declined by 1.5 % annually since 
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2000 (2,171,000 vs. 1,740,000) however production has only declined annually by 0.7 % for 
the same time period (Dairy Australia, 2015).  
 
A variety of production systems are utilised in Australia including pasture, feedlot and 
combination systems. These systems can also be organised around seasonal, non-seasonal and 
batch calving strategies. The farm and herd size varies considerably; the average dairy fa rm is 
reported to consist of 284 cows with the average cow producing 5,730 litres per year (Dairy 
Australia, 2015). Dairy systems that utilise pasture are most predominant in New Zealand, 
Australia and Western Europe (Macdonald et al., 2008). When coupled with seasonal or split 
calving, feeding costs are reduced through efficient pasture utilisation (Pedernera et al., 2008). 
According to Dobson et al. (2007), forage based systems have a theoretical maximum output 
of approximately 6000 litres per lactation (305 days). Australian dairy farms often supplement 
pasture with conserved fodder, such as maize silage or hay; and at milking, the diet is further 
supplemented with feed concentrates (García et al., 2007). 
 
Increasing the milk yield of dairy cows is a response to rising costs of production and the 
need to keep the Australian dairy industry competitive in an increasingly commoditised 
marketplace. Growing international competition has seen the export value of Australian dairy 
decrease by 2.0 % annually since 2000 (Dairy Australia, 2015). Ultimately, the issues 
associated with NEB/metabolic disruption (such as ketosis and acidosis) is occurring as a 
result from this pressure on production. Over the last 20 years, maintaining compact calving 
patterns used in pasture based systems has become increasingly challenging due to declining 
fertility in dairy herds (Lucy, 2001, Pedernera et al., 2008). Cows must be pregnant within 60-
70 days of parturition which coincides with or immediately follows a potential period of 
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NEB. Every 1000_kg increase in milk production results in an estimated reduction in fertility 
of approximately 6 % (Neville, 2009). A study in the United Kingdom estimated that delays 
in returning cows to milking and animal replacement expenses increase the cost of production 
by an estimated 2 p L-1 (4 cents Australian) (Knabel et al., 1998). 
 
 
1.4 Negative energy balance (NEB) and declining fertility    
Cows are in a state of NEB when the energy demands for lactation and tissue maintenance 
exceed the energy intake through the diet (Thorn et al., 2008). The imbalance between energy 
consumption or utilisation and intake can manifest in a number of ways including decreased 
body condition, metabolic diseases and reduced fertility (Gröhn and Rajala-Schultz, 2000). 
This is due to shifts in the cow’s metabolism that results in the realignment of nutrient 
partitioning to different tissues including the mammary gland (Gröhn and Rajala-Schultz, 
2000) and a shift to catabolic metabolism to maintain homeostasis and production (Gröhn and 
Rajala-Schultz, 2000). Increasing the feed intake could negate the downstream effects of NEB 
however will result in increased costs for producers (Gröhn and Rajala-Schultz, 2000). 
Improved understanding of the cellular mechanisms of the bovine mammary gland may lead 
to better nutritional systems that increase feed efficiency resulting in more milk production.  
 
The nutritional requirement of cows increases at parturition and can lead to NEB. This NEB is 
related to the quantity and quality of dry matter intake and can influence body condition at 
parturition (Butler, 2000). 
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The measure of a cow’s body condition at calving has been shown to relate to the first post-
partum ovulation interval length (Butler, 2000). Further, NEB influences follicle development 
by reducing luteinising hormone (LH) secretion (as seen in Figure 1.1) and further impacts 
fertility by subsequently effecting the ovaries response to LH (Butler, 2000).  
 
Figure 1.1. Follicle development and energy balance. 
Dominant follicle development (circles) and function relative to energy balance, and 
metabolic and reproductive hormones. The events represented are during the first 
follicular wave postpartum in dairy cows. The follicle can follow alternate paths, either 
ovulating (*) or undergoing atresia. LH production frequency is influenced by when LH 
levels are at the lowest point. The upward arrows indicate an increase in insulin-like 
growth factor-I (IGF-I) and insulin. The levels of these two factors influence the 
responsiveness to LH. This in turn increases oestradiol (E2) production by the dominant 
follicle. From Butler, 2000. 
 
A reduction in fertility has been linked to NEB during pregnancy by a number of researchers 
(Watson and Kreuzaler, 2011, Roche et al., 2000, Spain et al., 2007). This NEB may also be 
exasperated due, in part, to the large demands of the foetus which are estimated to be in 
excess of 1600 kcal per day at day 270 of gestation (Bell et al., 1995, Spain et al., 2007). The 
daily energy requirements for large breed cows to produce 20 kg of milk per day in addition 
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to maintaining bodyweight during early lactation is estimated to be 23 kcal  (National 
Research Council, 1978). When combined with the anorexia exhibited in the few days before 
parturition, serious negative energy balance may occur (Spain et al., 2007). Metabolic 
imbalances can lead to conditions such as hypocalcemia, increased risk of d ystocia, retained 
foetal membranes and a predisposition for postparturient uterine disease (Curtis et al., 1983, 
Spain et al., 2007). Indeed, cows that experience postparturient uterine disease have a 
decreased milk yield during lactation (Markusfeld, 1993, Spain et al., 2007). However, other 
factors such as deficiencies in nutrient cofactors, including selenium and vitamin E, and the 
serum concentration of ketones, including beta-hydroxy-butyrate, can also influence fertility 
and increase the risk of failed conception (Miettinen, 1990, Spain et al., 2007). The effects of 
this period of NEB in the cow can extend beyond the current lactation. The subsequent 
fertility of the cow (Roche et al., 2000), in addition to the future fertility of the calf (Wathes et 
al., 2007), can be influenced by periods of NEB. 
 
The effects of NEB on the interval between calving and fertility, measured as the firs t post 
calving ovulation, appear to be linked to the actions of insulin, LH, IGF-I and progesterone 
(Spain et al., 2007). Similarly, intermediates in the metabolism of protein and the urea cycle 
(arginine) may alter glucose metabolism by possibly influencing insulin (Spain et al., 2007). 
Insulin responsiveness may also be repressed by subclinical ammonia toxicity as evident in 
steers (Winder et al., 1992). It has been shown that when exposed to low levels of IGF-I, 
ovarian follicles fail to develop normally (Thatcher, 1996, Spain et al., 2007). The beginning 
of reproduction can be delayed due to limited release of gonadotrophin from the 
hypothalamus and LH from the pituitary gland (Spain et al., 2007). In addition to these 
pathways, as seen in Figure 1.2, other hormones play a role in the link between negative 
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energy balance and declining fertility. The combination of reduced IGF-1, GHR-1A, IGFBPs 
3-6 and ALS can impair embryo development and uterine repair, and prolong any local 
inflammation seen in the uterus (Spain et al., 2007). The role of reduced IGF-1 can also delay 
ovulation as seen in Figure 1.2. These hormone levels are in response to the energy shortage 
seen in NEB and result from low glucose availability. Further impacts can occur for NEB on 
oocyte quality and developmental potential, the full impact of which may not be seen until the 
resulting cow is itself trying to achieve a pregnancy. This highlights the essential nature of 
this research in alleviating the NEB associated with peak lactation and concurrent pregnancy.  
 
 
Figure 1.2. Influence of negative energy balance on fertility  and effects on the liver, 
ovaries and uterus.  
Oocyte quality can be directly influenced through blood metabolites associated with the 
metabolism of lipids. The growth hormone receptor concentrations in the body can 
influence the persistence and concentration of IGF-1, further impairing the maturing of 
follicles and the production of steroids. (Wathes et al., 2007). 
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If production systems could be manipulated so that the need to conceive is no longer aligned 
with production-associated NEB, there is potential to disentangle the influence of production 
on fertility. Decreasing the limitations of the annual production cycle that aligns conception 
and peak lactation may also alleviate the effects of NEB on production. Another strategy that 
has been suggested to alleviate NEB is to move to a once daily milking regimen (McNamara 
et al., 2008). However, enhancing lactation persistence by manipulating mammary 
cytodynamics is another method, to consider when viewing the work of this thesis. Ultimately 
the goal is to allow cows to produce economically viable volumes of milk for a longer period 
of time and thus allow joining of cows at a time when metabolic demands may be less 
impactful on fertility than peak lactation.  
 
1.5 Embryogenesis of the bovine mammary gland     
The mammary band appears during embryonic development as a thickening of ectodermal 
tissue in the ventrolateral region of the bovine foetus. This mammary band is a descriptive 
term for the first step of the embryonic development of the mammary gland. The 
developmental series that starts with the mammary band progresses to become the mammary 
streak, mammary line, mammary crest, mammary hillock and finally mammary bud (Akers et 
al., 2000). In the bovine embryo, the development of the mammary band occurs at 
approximately 32 days and progressively thickens for a further 7 days (Watson and Khaled, 
2008). These ectodermal cells further differentiate into the mammary line at 4-5 weeks of 
development and expand into a layer of mesenchymal cells. Following this, mammary buds 
appear as the ectodermal cells continue to expand into the mesenchymal cell layer, as seen in 
Figure 1.3. Two mammary buds form on each side of what was the mammary band by about 
week 5-7 of development. Each mammary bud is a precursor for a mammary quarter. When 
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the ectodermal layers further expand into the mesenchyme, a mammary pit is formed. This is 
where the differing species characteristics begin to develop and also where further 
development is determined by the sex of the foetus (Watson and Khaled, 2008).  
 
 
Figure 1.3. Mammary bud formation during embryogenesis. 
Formed by the invagination of surface epithelium, the mammary bud is the basis for 
development. (Johnson and Riddick, 2004). 
 
During the period of development in the female bovine embryo (between 60-80 days), the 
area containing the mammary bud will be vascularised, raising the bud and the surrounding 
surface. The cells further develop into the mesenchymal cell layer and form the primary spout 
by day 80. The primary spout will ultimately become the gland cistern. Following this the 
primary spout branches after 13-14 weeks of development. After 100 days of development in 
the bovine embryo, the solid core of the primary and secondary spouts expands in diameter 
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and begins to form a lumen. The tip of the teat also undergo changes, invagination occurs 
from the outside and tissues develops a more skin like appearance (Watson and Khaled, 
2008). These mammary buds appear around day 40 of bovine gestation. Over the next 60 days 
of gestation, the teat and teat cistern will form as a result of cell migration and apoptosis. A 
large amount of mammary development occurs before birth as the teats are developed. The 
secondary spouts are canalized with solid cores of cells, limited tertiary spouting occurs and 
the connective tissue, blood vessels and lymphatic systems develop(Watson and Kreuzaler, 
2011). Although this physiological development occurs, there is only a rudimentary ductal 
structure present until puberty (Watson and Kreuzaler, 2011). 
 
Mammary gland growth occurs at a fast rate prior to parturition and slows dramatically after 
birth (Meyer et al., 2006b). Ductal elongation occurs at puberty within the mammary fat pad 
and a highly branched ductal epithelium fills the mammary fat pad (Watson and Kreuzaler, 
2011). The postnatal development of the mammary gland is the largest of any organ (Watson 
and Kreuzaler, 2011). The bovine mammary gland at birth is composed of a rudimentary 
ductal network and a cisternal cavity (Ellis, 2011). As the mammary gland develops, a highly 
compact and branched mass of cells forms (Capuco et al., 2002a, Wallace, 1953). In 
prepubertal heifers, the mammary gland consists of a mammary fat pad composed of 
differentiating epithelial and myoepithelial cells (Figure 1.4) that act under the influence of 
numerous hormones including IGF-1 and oestrogen (Thorn et al., 2008) some of which can be 
seen in Figure 1.4 and Figure 1.5.  
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Figure 1.4. Outline of mammary growth and development. 
A general outline of mammary growth and development from foetal life to the end of 
lactation (Zwierzchowski et al., 1999). 
 
The relatively simple ductal network present at birth increases in size until it plateaus 
following puberty. The level of mammary tissue development and cell number in the non-
pregnant heifer fluctuates in response to the oestrous cycle, but overall remains relatively 
stable until pregnancy. Compared to the long branching network and terminal end buds (TEB) 
of the murine mammary gland, the prepubertal ruminant mammary network is compact and 
highly branched within loose connective tissue. Further branching of ductal and alveolar 
structures occurs in response to pregnancy in addition to the formation of lobuloalveolar 
structures and de-differentiation of mammary fat pad adipocytes (Watson and Kreuzaler, 
2011). The subsequent elongation results from coordinated growth of terminal ductal units 
(TDUs) along with the connective tissue surrounding the TDUs. The TDUs in the bovine 
mammary gland comprise epithelial cells that invade the stromal tissue extending into the 
mammary fat pad. Individual TDU comprise 5-10 ductal outgrowths around the 4-8 layers of 
epithelial cells that comprise the epithelial cord. On the basal layer of the TDU are 
undifferentiated cells, presumed to be myoepithelial cells due to high cytokeratin-19 (CK-19) 
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expression and little if any expression of smooth muscle actin (SMA) (Capuco et al., 2002a). 
The solid mass of the epithelial cords in the TDUs is followed by the lumen hollowing by 
apoptosis, as observed in murine mammary gland development (Humphreys et al., 1996). 
Apoptosis alone has not been shown to account for ductal formation in the bovine mammary 
gland (Capuco et al., 2002a). Throughout the process of mature ductal network formation, 
TDUs form as out-growths from new ducts and an enlargement of the luminal spaces within 
the gland are observed (Figure 1.4).  
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A.  
B.  
Figure 1.5. The mammary alveoli. 
Image A – A mammary alveolus surrounded by blood vessels and myoepithelial cells. 
From (Erickson et al., 2015). Image B - Immunofluorescence from a stained histological 
section showing myoepithelial cells surround the exocrine glands of the mammary buds. 
The influence of oxytocin on these myoepithelial cells (red) causes contraction, 
squeezing the mammary secretory cells (green) and facilitating milk let down (Ross et 
al., 2003). 
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1.6 Bovine mammary gland development and cytodynamics of lactation 
The mammary glands of various species, while exhibiting some differences, are generally 
similar in gross anatomical and cytological arrangement and function. The term ‘mammary 
parenchyma’ is used to describe the secretory and ductal epithelial tissues of the mammary 
gland. The other cellular and non-cellular components that support the parenchyma are 
referred to as the ‘stroma’. The cellular elements of the stroma include primarily fibroblasts, 
adipocytes, immune cells and other tissues such as blood vessels and lymphatics. Non-cellular 
elements of the stroma consist primarily of collagen and elastin. Epithelial ducts populate the 
stromal tissue of the mammary gland, which from birth to maiden pregnancy, is known as the 
mammary fat pad in many species. During lactation this fat pad or stroma contains many 
highly active secretory cells of the mammary parenchyma. This activated state, seen during 
lactation, involves an extensive Golgi apparatus, numerous mitochondria and well developed 
rough endoplasmic reticulum (RER) within these secretory cells (McManaman and Neville, 
2003), as seen in Figure 1.6. The secretory epithelial cells connect strongly to each other 
through adherens and other tight-junction elements (Pitelka et al., 1973, Nguyen and Neville, 
1998). The base of the alveolar cells articulates with myoepithelial cells and the basement 
membrane, creating further selective barriers to control the components of the milk secretions 
(McManaman and Neville, 2003). 
 
 17 
 
Figure 1.6. Summary of milk secretion processes in alveolar epithelial cells.  
This diagram is a basic representation of the pathways of milk secretion in an alveolar 
epithelial cell. The milk components are secreted into the lumen through a number of 
pathways. Pathway I is used for the exocytotic secretion of milk proteins, calcium and 
lactose. Pathway II represents the secretion of milk fat in the form of cytoplasmic lipid 
droplets (CLDs) that combine at the apical membrane to form a membrane bound milk 
fat globule (MFG). Pathway III represents the movement of proteins, including 
immunoglobulins, by vesicular transcytosis. Pathway IV represent the ion dependent 
movement of ions, water and glucose across basal and apical membranes of the alveolar 
cell. Pathway V is only open during pregnancy, involution and mastitis and other states 
of inflammation. Pathway V is a paracellular pathway for the movement of leukocytes 
and components of plasma. Abbreviations: SV, secretory vesicle; RER, rough 
endoplasmic reticulum; BM, basement membrane; N, nucleus; PC, plasma cell; FDA, fat 
depleted adipocyte; JC, junctional complex containing the tight and adherens junctions; 
GJ, gap junction; ME, myoepithelial cell (From McManaman and Neville, 2003). 
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During pregnancy in cows, mammary lobo-alveolar growth is driven through the combination 
of oestrogen and progesterone (Ambrose and Emmanuel, 2008). Oestrogen and progesterone 
regulate growth and differentiation through their influence on the expression of transcription 
factors (Arendt and Kuperwasser, 2015). There are two mechanisms through which oestrogen 
influences cellular behaviour (Boulanger et al., 2015). Elements of the oestrogen signal 
cascade can bind directly to gene targets (Castoria et al., 2010). In addition, the expression of 
gene elements can be modulated by the oestrogen complex binding to other proteins, such as 
AP-1 and SF-1 (Castoria et al., 2010). Progesterone has been shown to have a role in early 
pregnancy to stimulate alveologenesis and side branching (Ismail et al., 2002). When a cow is 
pregnant, the cell populations expand in the mammary gland allowing the gland to produce 
milk, the primary function of the gland (Watson and Kreuzaler, 2011). The development of 
alveoli is usually associated with pregnancy, but has been seen in cases of ovarian neoplasms 
and toxicosis (Ambrose and Emmanuel, 2008).  
 
Developed mammary glands are composed of multiple alveolar glands. Multiple alveoli and 
ducts that drain discrete groups of alveoli are referred to as a lobule. The lobules open into 
progressively larger ducts leading to the teat. The cellular architecture of the lobule consists 
of a single-cell layer lining the alveoli with two or more layers of epithelium lining the non-
secretory ducts. The initial lobuloalveolar structure is developed during gestation, but 
expansion and differentiation in addition to biochemical changes must occur in preparation 
for milk secretion (Ackers, 2002). The sequential addition of insulin, glucocorticoids and 
prolactin to in vitro cultures results in casein and lactose synthesis (Erb, 1977; Ritter and 
Mueller, 2014; Kobayashi et al., 2016).  
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There are two principal differentiated cell types associated with the mammary glands of 
humans and mice: glandular/secretory and myoepithelial (Bocker et al., 2002). There have 
been studies investigating the presence of stem cells in the mammary gland from an 
immunohistochemical, proliferation, developmental, transplantation and molecular 
perspective in a number of species (Bocker et al., 2002). In cows, the cell types that have been 
studied are divided into putative stem cells which differentiate into putative progenitor cells 
and basal cells (Rauner and Barash, 2012). The basal cells give rise to the differentiated 
myoepithelial cells (Rauner and Barash, 2012). The putative progenitor cells give rise to the 
luminal population of mammary cells (Rauner and Barash, 2012).  
 
During pregnancy in cows, there is a shift and reorganization of the mammary gland from an 
organ composed of largely adipose tissue to one with epithelial secretory capacity 
(McManaman and Neville, 2003). However, studies in mice show that not all alveolar 
secretory cells produce milk before activation (McManaman and Neville, 2003). When the 
mammary gland becomes activated, there is a change in the cells to homogenous expression 
of milk protein genes (Cox et al., 1999). This model has been developed through the analysis 
of murine mammary glands to give the most complete picture of the cellular hierarchy of a 
mammalian mammary gland (Visvader, 2009). The model seen in Figure 1.7 is continually 
evolving and recently a new intermediary cell type (common progenitor) has been proposed 
along the murine mammary cellular hierarchy (Visvader, 2009). 
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Figure 1.7. Proposed mammary gland differentiation hierarchy. 
Image showing a proposed differentiation hierarchy within mammary epithelium. The 
cell surface markers shown in blue are those used to facilitate mouse mammary cells 
isolations. The red cell surface markers are those used for the isolation of the different 
populations of human mammary cells (Visvader, 2009).  
 
With the mass of the bovine mammary gland increasing by 5.5 kg (Capuco and Akers, 2010) 
or more during pregnancy and lactation, the mammary epithelium develops into a fully 
expanded and differentiated lobuloalveolar network capable of producing large volumes of 
milk. This process of development is regulated by hormones, paracrine and autocrine factors, 
and by the interactions of the cell types present in mammary tissue including stromal cells, 
epithelial cells, myoepithelial cells, progenitor cells and stem cells. Milk production can be 
influenced by other factors such as nutrition, food additives and photoperiod; however, it is 
the number and activity of differentiated milk-producing cells that ultimately determines milk 
yield (Boutinaud et al., 2012). The data in Table 1.1 draws comparisons between a number of 
lactation-associated characteristics of different animals. 
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Table 1.1. Lactation variation between species. 
Table outlining the variation in lactation characteristics for Cows, humans, rabbits and 
pigs. Adapted from (McClellan et al., 2008). (MCFA: Medium chain fatty acid, LCFA: Long 
chain fatty acid, SCFA: Short chain fatty acid) 
 Cows Humans Rabbits Pigs Mice 
Wild or 
Domesticated 
Domesticated Domesticated Wild Domesticated Wild 
No. of Young 1 1 6 4-13 1-10 
No. of Nipples 4 2 8-10 12-16 10 
Length of Lactation 
(days) 
180-300+ 105-126 28-35 56 28 
Daily Milk 
Production (g) 
10,000 450-1126 140-320 4500-5700 - 
Fat Concentration 
(gL-1) 
48 38 22 55 11 
Fatty Acid Substrate Acetate Glucose Acetate 
and 
Glucose 
Acetate and 
Glucose 
- 
Predominant Fatty 
Acid 
MCFA and 
LCFA 
LCFA SCFA LCFA - 
Protein 
Concentration (gL-1) 
32 (80% 
Casein) 
9 (17% Casein) 103 56 - 
Predominant 
Carbohydrate 
Lactose Lactose Lactose Lactose Lactose 
Lactose 
Concentration (gL-1) 
48 70 22 55 - 
 
The apocrine and merocrine nature of the secretions (as seen in Figure 1.8) from the 
mammary gland alludes to the glands evolutionary origin. Apocrine-type secretions observed 
in sweat glands, where a portion of the secretory cell wall buds to form part of the secre tion, 
are also seen in the mammary gland for the secretion of the lipid component of milk. 
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Progressively enlarging lipid droplets from within the cells protrude into the lumen of the 
alveoli and subsequently pinch off to become the fat content of the milk. Merocrine 
secretions, observed in sebaceous glands where products are secreted from the cell with the 
cell remaining intact, can also be seen in the mammary gland to facilitate secretion of 
carbohydrate and protein components of milk. When the cells package lactose within the 
golgi apparatus and subsequently fuse the packages with the inner cell membrane to be 
exocytosed, this is a form of merocrine secretion (Figure 1.8). The apocrine and merocrine 
nature of mammary secretions alludes to the suggestion that the mammary gland may be a 
modification of both sebaceous and sweats glands (Blackburn, 1991).  
 
 
Figure 1.8. Secretory processes of lactation. 
This diagram outlines the two types of secretory processes. The merocrine process 
involves fusion of vesicles with the cell membrane to release their contents. This is the 
mechanism used for sweating. The apocrine process involves the pinching off of vesicles 
from the cell surface in order to release the contents. Adapted from (Kulbitska, 2016).  
 
The intracellular origins of lipid droplets and milk fat droplets have been revealed by the 
increased knowledge of the mechanisms behind milk secretion (seen in Figure 1.6). This has 
also provided insight into the nutritional regulation of milk fats and the relat ionship between 
digestive processes, dietary intake and milk biosynthesis. The process used by milk producing 
 23 
cells that generate the milk lipid droplets is outlined in Figure 1.9. Originating in the rough 
endoplasmic reticulum (RER), the lipid milk droplets converge after pinching off the RER to 
coalesce into microlipid droplets. As more droplets combine, a cytoplasmic lipid droplet 
forms and then pinches off the apical plasma membrane of the milk producing cell to become 
a milk lipid droplet. The smaller microlipid droplets need not coalesce into larger droplets and 
can leave the cell, entering the apical space alone. The casein micelles, which are also  formed 
in milk producing cells, begin in the Golgi Apparatus of the cell where they are packaged in a 
secretory vesicle prior to leaving via the apical membrane.  
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Figure 1.9. Milk secretion pathways. 
An overview of the major pathways used for the secretion of milk components during 
lactation. Pathway A is the cytoplasmic lipid droplet pathway; Pathway B is the 
microlipid droplet pathway; Pathway C is the secretory pathway for skim milk 
components (Bauman et al., 2006). 
 
During lactation, the number of milk producing cells and the volume of milk produced by 
each individual milk-producing cell in the mammary gland determines the production level 
(Boutinaud et al., 2012). It is further considered that the number of cells present in the 
mammary gland is a function of cell proliferation and apoptosis (Boutinaud et al., 2012). As 
the number of milk producing cells increases, so too does the lactation output until peak 
lactation is reached. At this point, the number of milk-producing cells start to decline as the 
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rate of proliferation decreases and the cells undergoing apoptosis  increases (Capuco et al., 
2003). Mechanisms that determine and influence these cellular responses are still relatively 
unknown (Boutinaud et al., 2012). However, understanding the cellular cytodynamics of the 
bovine mammary gland can be used to understand the productive capacity of each animal.  
There is evidence that increasing the frequency mammary gland emptying through 
mechanical stimulation (milking) plays a role in the rate of prolife ration and cell turnover in 
the bovine mammary gland (Annen et al., 2008). Due to reduced milking a build-up of milk in 
the cistern of the mammary gland creates hydrostatic pressure, as well as solute equilibrium 
resulting in a reduction in milk yield of 10-30 % observed in cows milked only once daily 
compared to the standard twice daily milking (Littlejohn et al., 2010). Hormones and 
hormone ratios, such as that of prolactin, progesterone and oestrogen, also play a possible role 
in the maintenance of proliferation and induction of apoptosis processes that occur during 
lactation (Boutinaud et al., 2012). Using this underlying influence it may be possible to 
modulate the persistence of lactation by shifting the rate of cell turnover and preserving more 
of the secretory cells. With the cessation of lactation, the ratio of proliferation to apoptosis 
changes heavily in favour of apoptosis as the tissue remodels for the dry period (Capuco and 
Akers, 1999). This leads to a turnover of cells and if milking is not initiated, further 
involution and remodelling will begin (Capuco and Akers, 1999). 
 
Involution involves remodelling the mammary gland cellular architecture in order to remove 
the milk producing cells, alter the blood supply to the gland and re-differentiation of adipose 
tissue to reform the mammary fat pad (Watson and Kreuzaler, 2011). In mice, the involution 
of the mammary gland occurs in two phases, aptly named phase one and two (Watson and 
Kreuzaler, 2011). The first phase, in the mouse, is reversible and lasts 48 hours after pup 
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removal or teat sealing to cease lactation, the second phase remodels the  gland (Watson and 
Kreuzaler, 2011). The process of involution in cows is characterized by decreases in size of 
alveoli, number of alveoli, metabolic activity of the mammary gland and alveolar collapse 
(Turner & Huynh, 1991). 
 
Also seen on a molecular level are the detachment and necrosis of epithelial cells, invasion of 
adipose tissue into the parenchyma and little to no inflammation (Katawatin, 2011). This 
process of expansion and involution seen in lactation is influenced by the basic programming 
of the cells, cell signals within the mammary tissue and systemic signals from the body.  
 
1.7 Hormones influence on cell turnover and apoptosis in the bovine 
mammary gland 
1.7.1 Hormone receptors 
A review of the cellular processes that occur in bovine mammary gland development during 
embryogenesis, neonatal development, puberty and pregnancy is important in assisting with 
the understanding of the role of stem cells in lactation. Several hormonal factors (including 
oxytocin, prolactin, progesterone and oestrogen) influence the initiation, maintenance and 
components of lactation secretions. The pituitary hormone, oxytocin, is released in response 
to suckling or milking and promotes milk let down into the ducts and cisterns of the 
mammary gland. This is mediated by the contraction of myoepithelial cells that force milk 
from the milk producing alveoli (Schmidt, 1971).  
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The coordination of ductal growth during mammary gland development is coordinated by 
oestrogens (Bocchinfuso and Korach, 1997). This is particularly driven through oestrogen 
receptor alpha (ERα) as the oestrogen receptor beta (ERβ) and associated pathway is more 
associated with driving terminal differentiation of mammary epithelium (Krege et al., 1998). 
The presence of the ER on cells with stem cell functions in the mammary gland tissues has 
some conflicting evidence (Boulanger et al., 2015). Evidence exists for a modulating cell 
population of cells that do express oestrogen receptor (ER) and influence the behaviour of ER 
negative mammary stem cells in a paracrine fashion (Kordon and Smith, 1998). The other 
theory is based on the stem cell characteristic of asymmetric division (Smith, 2005). Assays 
utilising radiolabelled thymidine show that the stem cells retain the radiolabeled genome  but 
the differentiating daughter cells do not (Smith, 2005). The cell population that retained the 
label were found to be positive for ER in 30-40_% of observed immunohistochemical assays 
(Booth and Smith, 2006).  
 
From what evidence is available regarding bovine mammary stem cells, it is hypothesised that 
an ER positive population of progenitor cells propagate the oestrogen hormone signals in a 
paracrine fashion to the ER negative stem cells (Capuco, 2007). This made the ER a less than 
ideal candidate marker for use in the positive selection studies planned for this project. The 
use of the ER marker in studies of mammary tissues is more focused on human breast 
cancers. 
 
The ERα isoform appears to be the major oestrogen receptor that mediates mammary 
morphogenesis (Bocchinfuso and Korach, 1997). The expression of ERα has been observed in 
a portion of cells in the parenchymal and stromal regions of the deve loping mammary gland. 
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One third of fibroblasts and adipocytes in the stromal tissue of the mammary gland have been 
shown to express ERα (Meyer et al., 2006a). The number of ERα positive cells in the 
mammary gland changes dramatically in response to oestrogen stimulation. Greater than 99 % 
of epithelial cells within the mammary gland are ERα negative following oestrogen 
stimulation (Capuco et al., 2002a). This suggests the response to oestrogen influences ERα 
positive cells to signal the ERα negative cells to proliferate and differentiate. This paracrine 
modulation mechanism of stimulation signals for proliferation and growth has also been 
reported in the murine mammary gland (Mallepell et al., 2006). The observed expansion of 
ERα negative cells within the mammary gland following oestrogen stimulation may be due to 
the expansion of ERα negative stem cells in order to maintain the ERα negative phenotype in 
progeny cells so that there is some measure of control of cellular responses to systemic 
hormones at an organ level. 
 
Progesterone (PR) is known to act through its nuclear receptor (which is induced by 
oestrogen) to modulate lobular development (Boulanger et al., 2015) in particular the side 
branching and generation of alveoli (Ismail et al., 2002, Ismail et al., 2003, Lydon et al., 
1995). The role of the PR extends to cells of the stroma, where PR expression is necessary for 
ductal development (Humphreys et al., 1996, Humphreys et al., 1997).  
 
Prolactin is a known driver of differentiation in other mesenchymal stem cells, and neural, 
hematopoietic and oligodendrocyte cells in mice models (Shehu et al., 2008). In the mammary 
gland, prolactin has mammotrophic and lactogenic properties and is also a known mitogen 
(Boulanger et al., 2015). Prolactin has been demonstrated to act through Jak2/Stat5 pathway 
to induce milk producing genes in addition to alveolar differentiation (Miyoshi et al., 2001). 
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Controlling the behaviour of the secretory cells, by increasing or maintaining the cell 
population, may increase the persistency of lactation resulting in higher milk production. In 
the early stages of lactation, it is the number of milk-producing cells (mammary epithelial 
cells) that determines milk yield (Capuco et al., 2001). Therefore, increasing the number of 
milk-producing cells may result in more milk production. Changes are observed later in 
lactation where lower numbers of milk-producing cells are observed, however each cell has a 
greater milk output maintaining the lactation levels (Capuco et al., 2001). It is through this 
change that the cytodynamics of lactation could potentially be harnessed. By understanding 
more about the turnover of cells in these two phases, it might be possible to maintain the high 
cell numbers seen in the initial stages of lactation (peak yield) and use the natural increase in 
individual cell milk production seen in later lactation to increase the persistency and output 
for each cow.   
 
1.8 Mammary stem cells         
The programming for an organism’s development rests within its genome, which contains the 
genetic information necessary for the development of a multicellular organism. The series of 
genome influenced events includes proliferation, differentiation, inhibition and apoptosis of 
individual cells. In combination, the multitude of differentiated cells comprises the tissues and 
organs of an organism following this sequential programming. A small number of cells cease 
development and become reserve precursor cells that play a role in the maintenance and repair 
of tissues throughout the lifetime of an organism. Precursor cells were thought to be lineage-
committed progenitor cells of the tissues they occupied; however evidence suggests that this 
is not the case (Kucia et al., 2004). It has been suggested that these precursor cells within the 
organs and tissues of developed organisms fall into one of two categories: The first being 
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multi-, tri-, bi-  or unipotent lineage-committed progenitor cells (Young and Black Jr, 2004), 
the second being pluripotent (ectodermal, mesodermal and endodermal) lineage-uncommitted 
stem cells (Young and Black Jr, 2004). During development, stem cell division is responsible 
for multiple cell types. Although the majority of cells differentiate, some do not and as a 
result remain adult tissue stem cells. Adult lineage-committed progenitor cells have been 
identified in many tissues (Mauro, 1961, Pittenger et al., 1999).  
 
1.8.1 Understanding mammary stem cells 
Of the livestock species, the mammary gland and mammary stem/progenitor cell biology of 
the dairy cow has been the most intensely studied. However, the majority of literature of the 
mammary gland cell biology concerns mouse and human mammary glands. Knowledge of the 
cell lineages involved in bovine mammary development is limited. Little is known about the 
possible markers of differentiation and plasticity of mammary cell phenotypes during 
development in cows (Ellis, 2011). This may be due to limited confirmed bovine antigen 
reactive antibody-types for use in studies. Also, unlike mice, a bovine mammary 
transplantation model has not been developed. Such a model would be useful to identify and 
characterise cells including cellular proliferation and differentiation. In addition to this, 
limited antibodies specific to this study were found that had known cross reactivity with 
bovine antigens. The results in this thesis are from a great deal of trial and error to finding an 
appropriate suite of antibodies. The cow is also a costly test animal due to its size (500 kg+) 
and feed requirements, and this would further hamper efforts to study aspects of its 
microscopic biology.  
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1.8.2 Stem Cells 
The cells of an adult organism are referred to as somatic or germ cells. Germ cells can 
undergo mitosis as well as asymmetric division to fulfil the transfer of genetic information. 
These characteristics differ from somatic cells (differentiated body cells) that develop and 
maintain the tissue health and execute cellular functions of an organism. Somatic cells that 
retain differentiation and self-renewing potential are referred to as tissue specific stem cells. 
Although the regulatory and signalling pathways of tissue specific stem cells are poorly 
understood, it is hypothesized that over the lifetime of an organism, tissue specific stem cells 
develop, maintain and repair resident tissues through proliferation and differentiation (Kucia 
et al., 2004).  
 
Understanding of the tissue’s developmental hierarchy has given insight into normal as well 
as aberrant development. Stem cells occupy the apex of this hierarchy and the study of stem 
cell biology and use of stem cell models has furthered the understanding of tissue and organ 
function leading to further hypotheses about stem cell niche function, tissue regulation and the 
development of cancer.  
 
1.8.3 Cancer development in breast tissue 
The accumulation of genetic mutations in the long lived stem and progenitor cells of tissues 
can give rise to different tumor phenotypes and subtypes (Visvader, 2011). As seen in Figure 
1.10, the influence of mutagens can give rise to different cancer subtypes, but the influence of 
the mutagen on a stem vs. further differentiated cells is also hypothesized to give rise to 
different tumour subtypes (Visvader, 2011).  
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Figure 1.10. Diagram of the genetic model of cancer. 
In the genetic mutation model of cancer (a), different types of mutations/mutagens 
determine the phenotype and morphology of the tumour. In the cell-of-origin model (b), 
different cell populations in the hierarchy serve as cells of origin for the different 
tumour subtypes arising within that organ or tissue (Visvader, 2011). 
 
Stem cells are also regulated within the niche of the organs and tissues they occupy. A tight 
regulatory program is in place to control how many stem cells are present in a tissue or organ 
at a given time. Given the potential of stem cells to produce tumours that resemble the tissue 
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of origin after an oncogenic transformation (Lobo et al., 2007), these measures of control are 
necessary and seem particularly effective for the bovine mammary gland. Despite the 
intensive inspection of millions of bovine mammary glands at slaughter, the number of 
reported cases of bovine mammary cancer is rare. This may be due to the slaughter occurring 
before the ‘cancer age’ (Povey and Osborne, 1969). However in a sample of 428 cows, heifers 
and freemartins, the  31% that were aged 8 years or older, supposedly beyond the ‘cancer 
age’, exhibited no increase in observed neoplasms (Swett et al., 1940). Furthermore, in a 
survey of the literature performed by Povey and Osborne (1969), only 11 out of 2,999 bovine 
neoplasms reported involved the tissues of the mammary gland/udder. In a study performed 
on 1535 samples of suspected neoplasm from Canadian slaughterhouses (Dukes et al., 1982), 
there was no listing of mammary neoplasm, although the authors do note that the tissue type 
of a number of samples could not be reliably identified. More recently there have been limited 
reports of bovine mammary neoplasia (Petrites-Murphy, 1992, Orr, 1984, Beamer and Simon, 
1983). It has been suggested that cancers, including mammary and breast cancer, arise due to 
the influence of changes to the stem cells within the tissue of origin (Visvader, 2011). As 
mentioned, these cancers utilise some of the characteristics seen in stem cells to continue 
dividing. 
 
1.8.4 Different types of stem cells 
The self- renewal potential of somatic stem cells is the result of a specialized mitotic division 
resulting in one or both daughter cells retaining the ability to differentiate and self- renew as 
the parent stem cell (Ying et al., 2008). These somatic stem cells can divide extensively but, 
when signalled, also differentiate and proliferate into progenitor (intermediate) cells and the 
specialized cells of the resident tissue or organ. Progenitor cells have a uni- or oligopotent 
 34 
nature compared to the multipotency demonstrated by stem cells (Seaberg and van der Kooy, 
2003). Relative to the unlimited self- renewal in vitro and in vivo exhibited by stem cells, the 
self- renewal capacity of progenitor cells is limited (Seaberg and van der Kooy, 2003). To be 
a somatic stem cell in adult tissue, the cell must also be able to self- renew to maintain a 
resident population of adult somatic stem cells. The ability to self-renew in response to 
largely unknown local and systemic signals is perhaps the most important function of stem 
cells. It is this function that is studied and exploited in stem cell models. Over the lifetime of 
an organism, a stem cell can produce the entire repertoire of cell types required for the 
function of a particular tissue or organ. Intermediate progenitor cells that are derived from 
stem cells, given the appropriate signals, have a similar potential for differentiation as stem 
cells. These progenitor cells do not possess self- renewal potential but merely support 
intermediate tissue maintenance or regeneration. Progenitor cells are present in tissues and 
organs in greater numbers than stem cells possibly indicating active mitotic cycling. 
  
Stem cells also function to differentiate into highly specialized cells that comprise a tissue, 
with the differentiation of a cell inversely proportional to a cells ability to divide (Clarke and 
Fuller, 2006). Investigations of the stem cell systems within blood tissues have revealed that 
the process of stem cell differentiation produces progenitor cells that pro liferate rapidly in the 
short term (Reya et al., 2001). This is followed by terminal differentiation into the specialized 
tissues of the body followed by cycling into quiescence or undergoing apoptosis (Reya et al., 
2001). Progenitor cell populations have also been considered stem cells based on work done 
with lymphoma (Bernt and Armstrong, 2009).  
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Stem and progenitor cells have been identified in the tissues of the mammary gland. The 
mammary epithelium encompasses cells of the myoepithelial and luminal-epithelial cell 
lineages that form ducts and lobuloalveolar structures within the mammary gland. As seen in 
Figure 1.11, the two main epithelial cell types (myoepithelial and luminal-epithelial) are 
hypothesised to descend from a common progenitor cell. The capacity for multiple programs 
of expansion, turnover and replacement of the cells within the mammary gland supports the 
hypothesised existence of stem/progenitor cells (Capuco and Ellis, 2005).  
 
 
Figure 1.11. Cell hierarchy present in the mammary microenvironment.  
Also outlined are the fates of non-mammary stem cells. From (Kelly, 2009). Cells from 
the mammary niche expand in number through transit amplifying cells to develop the 
luminal and myoepithelial cells. The empty stem cell niche can also be filled by a non-
mammary stem cell that can build a similar repopulation hierarchy.  
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The proliferation of mammary stem cells (MaSC) yields tissue expansion observed during 
puberty, reproductive cycles and pregnancy. This proliferation of the MaSC population 
prepares the mammary gland for lactation (Daniel and Smith, 1999). Evidence for the 
existence of MaSC has come from the transplantation of enzymatically dissociated mouse 
mammary epithelial tissue into the cleared (epithelium-free) fat pads of immunodeficient mice 
(Daniel et al., 1968, Smith and Medina, 1988, Wagner et al., 2002). Furthermore, it has been 
demonstrated that a single epithelial cell can give rise to an entire mammary gland through 
transplantation (Kordon and Smith, 1998, Shackleton et al., 2006). The undifferentiated cells 
hypothesised to be MaSC, can divide asymmetrically to provide a committed progenitor 
(epithelial or myoepithelial) and a stem cell or produce, by symmetrical division, two 
identical stem/progenitor cells (Chepko and Smith, 1999).  
 
1.8.5 Methods to identify mammary stem cells 
Histologically, putative mammary stem cells have been identified as pale cells, with limited 
cytoplasmic organelles, a lightly staining cytoplasm and limited membrane contact with 
surrounding cells (Chepko and Smith, 1999). Further, morphological characterisation 
classified these putative MaSC as small light cells (SLCs) that contain condensed 
chromosomes, limited organelles and limited secretory capacity (Chepko and Smith, 1999). 
Compared with populations of large light cells (LLCs), SLC population frequencies varied 
little through the developmental phases (Chepko and Smith, 1999). From this, it was 
postulated that the SLC population contains the true stem/progenitor cells that differentiate 
into the cell types comprising the mammary gland; the LLCs were hypothesised to be a 
population of differentiated progenitor cells that develop into secretory cells (Chepko and 
Smith, 1999).  
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The ability to exclude dyes (Hoechst dyes in particular), a characteristic of a number of stem 
cells, has been observed in potential MaSC (Goodell et al., 1996, Zhou et al., 2001, Bunting, 
2002). This small side population (SP) of cells capable of dye exclusion, are also capable of 
long-term repopulation, another characteristic of stem/progenitor cells (Bunting, 2002); this 
has been demonstrated by transplanted murine SP cells that regenerated semi-functional 
mammary glands (Alvi et al., 2003, Welm et al., 2002).   
 
The evidence for potential morphologically identifiable bovine mammary stem cells has been 
demonstrated through labeled DNA retaining cells and Bromodeoxyuridine (BrdU) label 
retaining cells in prepubertal heifers (Capuco, 2007). Initially these label-retaining cells in the 
bovine mammary gland were thought to be quiescent; however, these cells have been reported 
to divide asymmetrically in a similar fashion to BrdU label-retaining cells of the murine 
mammary gland (Smith, 2005). Later studies have shown that a bipotent MaSC exists in mice 
and are responsible for coordinating ductal maintenance and remodelling (Rios et al., 2014).  
 
1.8.6 Cell sorting and CD Markers 
Mammary stem cell purification still remains constrained by the limited number of reliable 
markers for identification. Methods to date have been similar to those used for the isolation 
and identification of hematopoietic stem cells. Studies using surface markers to identify sub-
populations of cells from fresh cell preparations have had some success (Bouras et al., 2008). 
 
Methodologies such as dye efflux, DNA labelling and histological observations have been 
utilised to identify and enumerate mammary stem cell number and location. The most 
 38 
contemporary approach, used due to speed and variation of application, is employing antibody 
binding specific for cell surface markers to identify the location or to facilitate the isolation of 
mammary stem cells. The ability of a cell to efflux dyes, such as Hoechst 33342, is used as an 
indication of the presence of the ABCG2 membrane transporter (Scharenberg et al., 2002). 
This allows cells to transport large molecules such as antibiotics and chemotherapeutic 
compounds in addition to the Hoechst dyes. The expression of this membrane transporter is 
associated with an undifferentiated/stem cell and also cancer cell phenotype  (Zhou et al., 
2001, Doyle and Ross, 2003). This is also one of the markers that influence the survival of 
cancer cells. 
 
Cluster of differentiation (CD) markers, in particular CD24, CD29 and CD49f (and 
combinations), are used to isolate and identify putative mammary stem cells in human and 
mouse tissue studies (Shackleton et al., 2006, Stingl et al., 2006). These integrin anchorage 
proteins have been associated with mammary stem/progenitor cells in other species 
(Shackleton et al., 2006, Stingl et al., 2006). Stem cell antigen 1 (Sca-1) and Muc1 have also 
been utilised in attempts to characterise mammary stem cells (Motyl et al., 2011).  
 
Table 1.2 outlines the most common markers used for isolating and characterisation of 
mammary stem/progenitor cells in a number of mammalian species. A single reliable marker 
for mammary stem cells is yet to be elucidated. Some markers have a controversial 
publication history and their use as markers of mammary stem cells can be variable based on 
experimental conditions for example, MUC1 (Motyl et al., 2011). A number of markers are 
yet to be trialled in species other than mice/rats and humans. Experiments in other organisms 
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are also subject to the availability of antibodies that are cross reactive to the species under 
investigation. 
 
Mammary stem cells are known as adult stem cells that have been shown to differentiate into 
cells of the myoepithelial and luminal lineages (Choudhary, 2014). The mammary stem cells 
are known to be epithelial in origin and exist in conjunction with cells of the connective tissue 
and fat pad, which are of mesenchymal origin (Choudhary, 2014). The gold standard for the 
assessment of the self-renewal capacity of mammary stem cells has been the transplantation 
of dispersed cells into the mammary gland of an immunocompromised mouse that has had the 
native epithelium removed (Kordon and Smith, 1998, Shackleton et al., 2006). Other research 
has also shown putative mammary stem cells to be bipotent and unipotent (Van Keymeulen et 
al., 2011). For the subtypes of mammary stem cells, identified as progenitor cells, 
investigations have also included the in vitro colony formation assay (Dey et al., 2009, 
Smalley et al., 1998, Stingl et al., 2005).  
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Table 1.2. Commonly used surface markers for mammary stem and progenitor cells. 
 Species 
Marker Function/Expression Cow Human Mouse/
Rat 
Dog Horse 
CD10/ 
CALLA 
Membrane-bound protein, highly 
expressed on myoepithelial and basal 
cell 
N/A + + or - N/A N/A 
CD24 P-selectin ligand, expressed on 
luminal cells 
+ + Medium N/A N/A 
CD29 Beta1 integrin, highly expressed on 
basal cells 
+ + High + + 
CD31 Endothelial cell marker - - - N/A N/A 
CD44 Involved in cell–cell interactions, 
adhesion, and migration. Highly 
expressed on basal cells 
+ High + + + 
CD45 Regulates cell growth, differentiation, 
and oncogenic transformation 
- - - N/A N/A 
CD49f Alpha6 integrin with low expression 
on luminal cells and high expression 
on basal cells 
+ High High + + 
CD61 Beta 3 integrin N/A + + N/A N/A 
EpCAM 
(CD326) 
Epithelial-specific antigen with high 
expression on luminal cells and low 
expression on basal cells 
N/A Low or 
+ 
+ N/A N/A 
MUC1 Epithelial membrane antigen with 
high expression on luminal cells 
N/A - or + - or + N/A N/A 
Sca-1 Stem cell antigen-1 - - or + Low or 
+ 
N/A N/A 
Ter119 Associates with murine glycophorin A - - - N/A N/A 
ER Oestrogen receptor -or + - - N/A N/A 
PR Progesterone receptor N/A - - N/A N/A 
Adapted from (Borena et al., 2013, Stingl, 2009, Visvader and Smith, 2011, Woodward et 
al., 2005, Molyneux et al., 2007, Dontu et al., 2003).  
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1.8.7 Isolating mammary stem and progenitor cells. 
Among the methods that have been used for the isolation of stem/progenitor cells of the 
mammary gland, the use of cell surface markers is the most prevalent (Choudhary, 2014). 
This method has been used to identify mammary stem cells in a number of species including 
cows (Rauner and Barash, 2012), mice (Shackleton et al., 2006, Meier-Abt et al., 2013) and 
humans (Eirew et al., 2008, Stingl et al., 2006) This sorting based on the surface markers of 
the cell has used a cocktail of antibodies to a number of cluster of differentiation (CD) 
markers and FACS sorting (Choudhary, 2014). The combination of CD24 and CD49f has 
revealed subtypes of bovine mammary stem cells in other studies (Rauner and Barash, 2012). 
The population of CD24med/CD49f+ was associated with bovine mammary stem cells, the 
CD24-/CD49fpos population was determined to be a basal bipotent progenitor cell population 
(Rauner and Barash, 2012). Luminal unipotent progenitors were shown to be 
CD24high/CD49f- and luminal unipotent cells were shown to be CD24med/CD49f-  (Rauner and 
Barash, 2012). Another study has utilised the CD24 and CD49f markers, in addition to Sca-1 
to study the mammary stem cell population of murine mammary glands (Meier-Abt et al., 
2013). The gene expression profile of cells sorted with the markers Sca-1, CD24 and CD49f 
demonstrated two populations of luminal cells (Sca-1+ and Sca-1-) with high CD24 expression 
(Meier-Abt et al., 2013). Myoepithelial cells were shown to have a marker profile of Sca-
1neg/CD24low/CD49flow and the basal cell type was associated with Sca-
1neg/CD24low/CD49fhigh (Meier-Abt et al., 2013). The use of these markers in conjunction with 
FACS does not provide information about the stem cell niche within the tissues. This is due to 
the disruption of the tissue layer, cellular and extracellular attachments through enzymatic 
digestion required for FACS analysis (Choudhary, 2014). An alternative strategy of BrdU-
label retention has been used to study the niche of bovine mammary stem cells in the tissue 
(Choudhary et al., 2013). The method of BrdU-label retention has been shown to identify 
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mammary stem cells and progenitor cells in cows (Choudhary et al., 2013). These cells were 
characterised due to higher levels of the nucleotide analogue BrdU, which was retained due to 
asymmetric division (a stem cell characteristic) (Choudhary et al., 2013). The cells that 
retained the BrdU-label were termed label retaining epithelial cells (LRECs). The LRECs 
were isolated and studied further and found to express low levels of the oestrogen receptor 
and high levels of aldehyde dehydrogenase (ALDH3B1) in addition to higher levels of a 
known pluripotency transcription factor (NR5A2) (Choudhary et al., 2013).  
 
1.8.8 Methods to expand the in vivo population of bovine mammary stem cells 
During the postnatal development of the mammary gland, the expansion of mammary stem 
and progenitor cells drives ductal growth (Rios et al., 2014, Capuco et al., 2012). There are 
three possible fates for the stem cells of the mammary gland: asymmetrical division to 
maintain their numbers, divide symmetrically to increase their numbers or thirdly to 
differentiate (Choudhary, 2014). In order to expand this population via artificial means, a 
number of methods have been trialled. These methods include the use of endogenous factors 
and compounds such as oestrogen, progesterone, growth hormone, bovine somatotrophin 
(bST), xanthosine and inosine (Capuco et al., 2001, Capuco et al., 2009, Joshi et al., 2010, 
Rahal and Simmen, 2011, Choudhary and Capuco, 2012). There are also natural variations in 
the stem and progenitor cell population of the mammary gland, pregnancy associated with 
increases in progenitor cell populations in the mammary gland (Choudhary, 2014). These 
cells have also been identified in nulliparous (Booth et al., 2007) and multiparous mice 
(Boulanger et al., 2005) and are named parity based progenitor cells and have been located in 
the alveolar subunit, in particular in the terminal duct (Choudhary, 2014). Higher numbers of 
the parity based progenitor cells have been found in multiparous mice compared to 
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nulliparous (Wagner and Smith, 2005). This highlights another finding in studies of mammary 
stem cells in cows where novel markers of mammary stem and progenitor cells (NUP153, 
NR5A2 and HNF4A) (Choudhary et al., 2013) were more elevated in lactating multiparous 
cows when compared to nulliparous heifers (Choudhary et al., 2013).  
 
1.8.9 Nucleosides and xanthosine to increase mammary stem and progenitor cell 
numbers 
The introduction of xanthosine or inositine (precursors of guanine ribonucleotides  
(Choudhary, 2014)) into the mammary gland has been shown to promote symmetric division 
of stem cells (Lee et al., 2003). The mechanism of this division is driven by the bypassing of 
p53 mediated asymmetric division (Sherley, 1991, Sherley, 2002). The p53 mediated 
asymmetric division occurs through the down-regulation of the inosine-5’-monophosphate 
dehydrogenase (IMPDH) enzyme limiting the availability of guanine nucleotides (Choudhary, 
2014). The increased availability of the guanine nucleotides due to the administration of 
xanthosine or inositine bypasses this regulation, promoting symmetric cell division (Lee et al., 
2003).  
 
1.8.10 Growth hormone and oestrogen to increase mammary stem and progenitor 
cell numbers 
Ductal growth during puberty is driven by oestrogen and growth hormone (Choudhary, 2014). 
This process may be driven by the mammary stem and progenitor cells within the tissue 
(Asselin-Labat et al., 2007). This association was tested by the addition of growth hormone 
and oestrogen to a population of cultured Sca-1pos  cells (Dou et al., 2012). The result was an 
 44 
increase in the number of mammospheres and the differentiation potential of the cells isolated 
from the cultured mammospheres (Dou et al., 2012).  
 
1.8.11 Progesterone and progestin to increase mammary stem and progenitor cell 
numbers 
Progesterone is associated with the maintenance of pregnancy (Choudhary, 2014) and has 
been shown to increase DNA replication and the progenitor cell population in human breast 
tissues (Graham et al., 2009). Progesterone acts in a paracrine fashion through the 
progesterone receptor (PR) (Beleut et al., 2010). The PR has been found in the nuclei of 
stromal, epithelial and endothelial cells of the bovine mammary gland (Schams et al., 2003). 
The mitogenic action of progesterone is ameliorated by the WNT4 and RANKL pathways 
(Joshi et al., 2010, Roarty and Rosen, 2010). However, the hypothesised location of 
mammary stem cells, the basal epithelial layer, is usually devoid of PR expression (Capuco, 
2007, Schams et al., 2003) and also shows increased RANKL and RANK (RANKL receptor) 
expression (Choudhary, 2014). Studies in mice have shown that progesterone can drive the 
generation of mammary alveoli in mammary tissue (Joshi et al., 2010). In addition, the 
population of CD24pos/CD49fhigh was shown to expand in the presence of progesterone (Joshi 
et al., 2010). When progesterone is used in combination with oestrogen, higher mammary cell 
proliferation was observed compared to oestrogen alone (Wood et al., 2013). 
 
1.8.12 Management of dry period for improved subsequent lactation 
The dry period, normally 50-60 days, between lactations is a period of recycling and 
regeneration for the mammary gland (Choudhary, 2014). Reducing the length of this dry 
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period to 30 days and the addition of a synthetic hormone bovine somatotrophin (bST) 
hormone treatment was shown to have little effect on milk production at the subsequent 
lactation (Annen et al., 2004) removing one possible avenue for investigation.  
 
1.8.13 Milk cell isolation    
This basis of this analysis is that there may be a population of cells in milk that have some 
function in the development of the neonate. The initial observations of human milk containing 
some live cells that exhibited cell surface markers that previously had been associated with 
potential stem cells was first reported by Cregan et al. (2007). These initial reports have 
subsequently been further expanded and recently reviewed in detail (Hassiotou et al., 2013a). 
This review includes a discussion of the observations of stem cells in human milk including 
investigations of cells expressing markers of pluripotency (OCT4, SOX2, and NANOG). 
Evidence of microchimerism (cells from the mother implanting in neonatal tissues)  
demonstrates that there could be some role for cells within the neonate. This transfer of cells 
is potentially possible, if only for short time (hours to days) as seen in a baboon model (Jain et 
al., 1989), there have been no similar investigations in bovine milk that we are aware of 
although a study utilising labelled cells in lambs has been reported. This study identified milk 
cells labelled with fluorescent markers in the blood of lambs several hours after consumption 
(Schnorr and Pearson, 1984). 
 
There is little understanding of the role and presence of stem/progenitor cells in bovine milk, 
however initial investigations in humans and other species have raised the concept that milk 
may be a medium for cell directed modulation of neonatal development through micro-
chimerism (Zhou et al., 2000a). Controlling the differentiation and delaying the apoptosis of 
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bovine mammary stem and progenitor cells both in vitro and in vivo potentially could alter the 
lactational persistence. This could further enhance the value of milk well beyond its 
constituent nutritional value and could lead to a variety of applications. The concept of 
stem/progenitor cells in the milk of dairy cattle will also be investigated in this thesis. 
 
This thesis involved the histological identification of cells within the bovine mammary gland 
that were positive for a number of markers (CD24, CD29, CD49f and CD61) associated with 
putative mammary stem/progenitor cells in other species (human and mouse). Following this, 
cultures of bovine mammary epithelial cells were grown and sorted by FACS utilising the 
markers from histological studies of bovine mammary tissue. These isolated cells were 
assayed for proliferative potential and mammosphere formation efficiency as measures of 
some stem/progenitor properties. Given the difficulties faced isolating these populations, 
another possible source of stem/progenitor cells was investigated. The cellular component of 
bovine milk was assayed for cells positive for known markers of stem/progenitor cells in 
other species demonstrating another potential source of stem/progenitor cells for mammary 
gland studies. 
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1.9 Specific aims and objectives of this thesis      
1.9.1 Aims 
 To identify potential bovine mammary stem and progenitor cell markers in 
histological sections of bovine mammary tissue at three stages of lactation (late 
pregnancy, peak lactation and involution).  
 To isolate and investigate the proliferative capacity and mammosphere formation 
efficiency of putative stem and progenitor cell side populations of bovine mammary 
epithelial cells isolated from bovine mammary tissue biopsied in late pregnancy. 
 To analyse the transcriptome of putative bovine mammary stem and progenitor cells 
vs. control cell populations to identify potential key expression patterns of 
multipotency/pluripotency and potential key cellular regulatory mechanisms. 
 To immunophenotype of the cells found in bovine milk using a suite of antibody 
markers (CD24, CD29, CD34, CD44, CD49f, CD61, Sca-1, Ki67 and Nestin) and to 
correlate the levels of positive cells with days in lactation and number of lactations.  
 
1.9.2 Objectives 
 To determine the tissue integrity of biopsy samples from bovine mammary tissue at 
late pregnancy, peak lactation and involution using H&E staining.  
 To determine the number and location of proliferating and apoptotic cells in tissue 
sections from three stages of lactation (late pregnancy, peak lactation and involution) 
using colourimetric methods (light microscopy) to detect the Ki-67 antibody and 
apoptotic cells (marked by the ApopTag® apoptosis detection kit).  
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 To determine the number and location of the putative mammary stem and progenitor 
cell marker CD24 and the putative progenitor cell marker CD61 positive cells in tissue 
sections from three stages of lactation (late pregnancy, peak lactation and involution) 
using colourimetric methods (light microscopy) to visualise.  
 To determine the number and location of the putative mammary stem and progenitor 
marker CD29 and the putative mammary stem cell marker CD49f positive cells in 
tissue sections from three stages of lactation (late pregnancy, peak lactation and 
involution) using fluorescence microscopy. 
 To develop a method to isolate populations of putative mammary stem cells from 
bovine mammary epithelial cells in suspension using the markers CD24, CD29 and 
CD49f and FACS. 
 To develop a method to isolate populations of putative mammary progenitor cells 
from bovine mammary epithelial cells in suspension using the markers CD24, CD29 
and CD61 and FACS. 
 To develop a method to determine the functional proliferative capacity of putative 
bovine mammary stem/progenitor cell side populations. 
 To develop a method to determine the functional mammosphere formation capacity as 
an indirect measure of differentiation capacity of putative bovine mammary 
stem/progenitor cell side populations. 
 Determine the number and identity of significantly differentially expressed genes in 
the putative bovine mammary stem cell side population vs. control cells.  
 Perform pathway analysis of the differentially expressed genes to determine the 
biological pathways that are more active or less active in putative bovine mammary 
stem cell side populations vs. control cells. 
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 Determine the number and identity of significantly differentially expressed genes in 
the putative bovine mammary progenitor cell side populations vs. control cells.  
 Perform pathway analysis of the differentially expressed genes to determine the 
biological pathways that are more active or less active in putative bovine mammary 
progenitor cell side populations vs. control cells. 
 Develop a method to stain internal and external antigens to immunophenotype the 
cells isolated from bovine milk. 
 Develop a method for the characterisation of CD24, CD29, CD34, CD44, CD49f, 
CD61, Sca-1, Ki67 and Nestin positive cellular fractions from bovine milk. 
 Develop a method to determine the viability of the cells isolated from bovine milk. 
 Use data generated to investigate the temporal nature of the expression of 
immunophenotype antigens across a lactation cycle.  
 Use data generated to investigate the relationship of antigen expression and lactation 
number.  
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Chapter 2  
Histological Investigation of Bovine Mammary 
Tissue for Putative Stem & Progenitor Cell 
Markers 
 
2.1 Introduction          
The use of haematoxylin & eosin staining of bovine mammary tissue to determine 
cellular architecture 
The architecture of the mammary gland has frequently  been analysed using the haematoxylin 
and eosin (H&E) staining protocol on histological sections (Narendran et al., 1974). Studies 
using this method describe tissues beginning to lactate (similar state to late pregnancy/early 
lactation) as clusters of alveoli containing tall columnar epithelial cells and parenchymal cells 
separated by connective tissue (Narendran et al., 1974). Tissue sections of bovine mammary 
tissue from glands with more established lactation (closely resembling peak lactation) were 
shown to have distinct alveoli with a reduction in the intra- lobular connective tissue volume 
(Narendran et al., 1974). The cells of the alveoli appeared flattened in most observations with 
few remaining alveoli containing columnar epithelium (Narendran et al., 1974). Histological 
studies of involuting bovine mammary gland tissues showed that at day 0 of involution 
(cessation of milking) the cells contain numerous secretory vesicles with more prominent 
apical microvilli and the presence of myoepithalial cells at the basal side of the secretory 
alveoli (Holst et al., 1987). The histological appearance of the mammary gland is altered at 
day 2 post milking cessation with the appearance of large vacuoles in the cytoplasm of the 
alveolar cells in addition to an enlarged appearance and bulging of the cells into the alveolar 
lumen (Holst et al., 1987). As involution progressed there were fewer cell to cell junctions 
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observed in tissues from days 4, 7 and 10 post milking cessation, although only minor 
changes, such as reduced appearance of cell to cell connection proteins, were observed in 
overall tissue ultrastructure (Holst et al., 1987). 
 
In this Chapter, H&E staining was used to determine the cellular integrity of bovine 
mammary tissue sections at late pregnancy, peak lactation and involuting stages. The cellular 
integrity was investigated to ensure the tissue samples had remained intact following storage 
in a -80 ○C freezer. This tissue was then used to determine the presence of apoptotic and 
proliferative cells, and also to investigate putative stem and progenitor cell marker location 
and abundance. 
 
Investigating proliferative & apoptotic cells in bovine mammary tissue sections to 
determine cellular milk producing capacity 
The proliferation marker Ki-67 (Kiel-67) has been used in studies of bovine mammary glands 
to quantify areas of epithelial proliferation (Connor et al., 2008). This marker has also been 
used to localise putative stem cell populations within bovine mammary tissue sections  
(Capuco, 2007). The ratio of the proliferating and apoptotic cells in the mammary gland can 
be used as an indicator of the milk producing capacity (Capuco et al., 2001). Milk yield is as 
much a function of the number of secretory cells as it is a function of the level of activity by 
the secretory cells (Capuco et al., 2001, Capuco and Ellis, 2005). In dairy cattle, the early 
peak (peak lactation) in milk production results from increased secretory activity per cell  
(Capuco et al., 2001), which contrasts to other species, such as goats, where the activity of 
cell milk production increases in addition to the number of cells in the mammary gland  
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(Knight and Peaker, 1984). As lactation progresses, it has been observed in rodents and cows 
that the number and activity of lactating cells decreased (Capuco et al., 2003, Hadsell et al., 
2007, Thatcher and Tucker, 1968). Overall, milk yield exists as a result of this balance 
between proliferation and apoptosis; increased cell turnover without cell replacement is 
largely responsible for the decline in milk yield (Capuco et al., 2003). 
 
The ratio of proliferative vs. apoptotic cells from bovine mammary tissues at the three stages 
of lactation (late pregnancy, peak lactation and involution) were investigated in this Chapter 
to ensure the ratios corresponded with previous research (Hvid et al., 2012, Capuco, 2007) . 
These tissues were further investigated to determine if putative stem and progenitor cell 
markers were present using the CD markers CD24, CD29, CD49f and CD61 (Stem Cell: 
CD24+/CD29+/CD49f+ and Progenitor: CD24+/CD29+/CD61+).  
 
Investigation of putative stem and progenitor cell markers in bovine mammary 
tissues 
Histological investigations of bovine mammary tissue have revealed the presence of putative 
bovine mammary stem cells (Capuco et al., 2012). Originally based on a characterisation 
system developed by Chepko and Smith (1999), cells of the mammary gland were classified 
by staining characteristics, frequency and cytological appearance using electron microscopy. 
A population of these cells were identified as Small Light Cells (SLCs) in the mammary 
parenchyma (Chepko and Smith, 1999). Small light cells (SLCs) are estimated to constitute 
approximately 10 % of the total cells in the bovine mammary tissue (Capuco et al., 2012); 
0.2_% of the SLCs population exhibited stem cells characteristics, such as asymmetric 
 53 
division, that was determined by cells retaining a labelled DNA strand for extended periods of 
time (Capuco, 2007). This prevalence of 0.2 % was also seen in mouse mammary gland 
studies (Kordon and Smith, 1998, Stingl et al., 2006). Further, SLCs have been hypothesized 
to be responsible for the proliferative capacity of the bovine mammary gland (Ellis and 
Capuco, 2002).  
 
Combinations of the cell surface markers CD24 (Shackleton et al., 2006), CD29 (Shackleton 
et al., 2006) and CD49f (Matulka et al., 2007) have been identified to enrich populations of 
mammary stem and/or progenitor cells in human and mouse cell populations 
(CD24+/CD29+/CD49f+ and CD24+/CD29+/CD61+) (Capuco et al., 2012). Analysis using the 
marker CD61 (β3 integrin), in combination with other markers (CD24 and CD29), has also 
been used to identify mammary progenitor cells (partially differentiated cell) in mice (Vaillant 
et al., 2008). The use of these CD markers has built on previous work to show mammary 
repopulation and regrowth from isolated portions of the mammary gland (Shackleton et al., 
2006). A number of transplantation experiments have hinted at the presence of mammary 
stem cells using CD24 (DeOme et al., 1959, Smith and Medina, 1988). The use of a cleared 
mouse mammary fat pad for a transplantation assay by Kordon and Smith (1998) using CD24 
and CD44 marker positive cells revealed a clonal differentiation hierarchy (hinted by 
conserved X-inactivation patterns in individual mammary lobules), this has also been seen in 
studies of mammary cancers (Tsai et al., 1996).  
 
This chapter investigated the location of the stem/progenitor cell markers CD24, CD29, 
CD49f and CD61 within the bovine mammary tissues section at the three stages of lactation 
(late pregnancy, peak lactation and involution) using immunohistochemistry (IHC) and 
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imaging techniques (colourimetric and fluorescence microscopy). The surface markers used in 
this chapter have been reported to identify mammary stem cells in other species including 
mice and humans (Rauner and Barash, 2012). The niche of the mammary stem cells in mice 
has been suggested to be in close proximity (separated by one or two cells) to the epithelial 
basement membrane (Chepko and Smith, 1999, Chepko and Dickson, 2003). This localisation 
of mammary stem cells has also been described in studies of the prepubertal bovine mammary 
gland (Choudhary et al., 2010). 
 
2.2 Aims            
To identify potential bovine mammary stem and progenitor cell markers in histological 
sections of bovine mammary tissue at three stages of lactation (late pregnancy, peak lactation 
and involution). 
 
2.3 Objectives           
 To determine the tissue integrity of biopsy samples from bovine mammary tissue at 
late pregnancy, peak lactation and involution using H&E staining. 
 To determine the number and location of proliferating and apoptotic cells in tissue 
sections from three stages of lactation (late pregnancy, peak lactation and involution) 
using colourimetric methods (light microscopy) to detect the Ki-67 antibody and 
apoptotic cells (marked by the ApopTag® apoptosis detection kit).  
 To determine the number and location of the putative mammary stem and progenitor 
cell marker CD24 and the putative progenitor cell marker CD61 positive cells in tissue 
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sections from three stages of lactation (late pregnancy, peak lactation and involution) 
using colourimetric methods (light microscopy) to visualise.  
 To determine the number and location of the putative mammary stem and progenitor 
marker CD29 and the putative mammary stem cell marker CD49f positive cells in 
tissue sections from three stages of lactation (late pregnancy, peak lactation and 
involution) using fluorescence microscopy.  
 
2.4 Materials and Methods         
2.4.1 Animals used for mammary tissue biopsies 
Mammary tissue was obtained from pregnant Holstein-Friesian cows (n = 5) from a dairy 
herd at the University of Sydney, Camden, NSW, Australia. No clinical signs of mastitis were 
observed (Sheehy et al., 2004). These cows were allowed a 75 day dry period prior to the 
expected calving date by ceasing all milking from the previous lactation. Mammary biopsies 
were collected at a) 5 days following cessation of milking from the previous lactation 
(involution), b) 20 days prior to expected calving date ( late pregnant) and c) 30 days after 
parturition (peak lactation). 
 
The tissue samples from the mammary glands of multiparous Holstein-Friesian cows were 
biopsied in the lateral aspect of the dorsal third of the forequarter as previously described by 
(Sheehy et al., 2004) – details are presented in Table 2.1. The mammary tissue biopsies were 
washed in phosphate buffered solution (PBS, pH 7.4, P4417, Sigma-Aldrich, Australia) and 
placed in Hank’s Buffered Salt Solution (HBSS, 1x, H9269, Sigma-Aldrich, Australia) 
containing sodium hydrogen carbonate (NaHCO3, 4.2 mM), penicillin (50 U mL
-1), 
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streptomycin (50 mg mL-1), kanamycin (50 µg mL-1) and Fungizone (625 ng mL-1, pH 7.4). 
Approximately 8-10 g of mammary tissue was collected in total per cow. These mammary 
tissue biopsies were cryopreserved in liquid nitrogen and stored in a -80 °C freezer (Revco 
Scientific Inc. ULT1386-39) until further use.  
 
Table 2.1. Details of the biopsy sampling and cows used for histology. 
Cow ID Involution 
Biopsy  
Late Pregnancy 
Biopsy 
Peak 
Lactation 
Biopsy 
Previous 
lactations at 
sampling 
1419 5 days post 
dry-off 
8 days prior to 
calving 
33 days post 
calving 
2 
1442 5 days post 
dry-off 
15 days prior to 
calving 
34 days post 
calving 
2 
1446 5 days post 
dry-off 
22 days prior to 
calving 
34 days post 
calving 
2 
1490 5 days post 
dry-off 
21 days prior to 
calving 
30 days post 
calving 
2 
1592 5 days post 
dry-off 
15 days prior to 
calving 
35 days post 
calving 
1 
 
PART A 
Determination of tissue integrity of biopsy samples from bovine mammary 
tissue taken at late pregnancy, peak lactation and involution 
2.4.2 Preparation of paraffin embedded bovine mammary tissue sections.  
Tissues to be embedded in paraffin were stored at -80 °C (Revco Scientific Inc. ULT1386-39) 
prior to use. Tissue samples were taken from -80 °C storage and placed in 50 mL of formalin 
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solution, neutral buffered (NBF, 10%, HT501128-4L, Sigma-Aldrich, Australia) per 1 cm3 of 
tissue for 48 h. The fixed tissue was either stored in 70 % ethanol (for long-term storage) or 
transported in NBF prior to paraffin embedding.  
 
Paraffin embedding was performed using a series of increasing ethanol concentrations 
involving two changes of 70 % ethanol for 1 h each, two changes of 80 % ethanol for 1 h 
each, two changes of 95 % ethanol for 1 h each followed by three changes of 100_% ethanol 
for 1 h each. This was followed by three changes of xylene for 1 h each. The tissue samples 
were then placed in paraffin (P3558, Sigma-Aldrich, Australia) wax heated to 56–58 °C for 
two changes of 1.5 h each. 
 
2.4.3 Paraffin embedded tissue sectioning of bovine mammary tissue 
The tissue samples embedded into paraffin blocks were sectioned at 5 μm on a Leica RM2235 
Microtome. The resulting ribbon of sections was placed in a 40–45 °C Leica HI 121D water 
bath and each individual section was mounted onto StarFrost® Superclean, hydrophilic glass 
slides. The tissue section slides were dried overnight at 37 °C in a Labtec drying oven 
(Labtec, U.A.E). Tissue sections were then de-waxed prior to use through 3 x 5 min xylene 
immersions (534056, Sigma-Aldrich, Australia), 2 x 10 min 100 % ethanol (459836, Sigma-
Aldrich, Australia) immersions and a series of 2 dips in 2 slide staining dishes containing 
95_% ethanol and 70 % ethanol. The sections were then washed in dH2O to complete de-
waxing prior to use. 
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2.4.4 Haematoxylin-Eosin (H&E) staining of cryosections and paraffin embedded 
bovine mammary tissue  
Samples from the 5 cows were assessed to determine the cytological integrity and 
morphology prior to assessment for proliferation, apoptosis and putative stem and progenitor 
cell markers.  
 
The tissue slides were immersed in Harris Modified Haematoxylin solution (HHS16, Sigma-
Aldrich, Australia) in a slide staining dish (H425, ProSciTech, Australia) for 30 s. This was 
immediately followed by rinsing under running tap water until the water ran clear. The slides 
were then immersed in Bluing solution (0.2 % ammonium hydroxide, pH 10.0) for 1 min and 
washed in running water for 2 min. The slides were put through a dehydration series with 2 
dips in 2 slide staining dishes containing 70 % ethanol and 95 % ethanol, respectively. The 
ethanol dilutions were made from 100 % ethanol (459836, Sigma-Aldrich, Australia) and 
dH2O. Immersion for 3 min in 100 % ethanol was performed followed by a series of 3 xylene 
(534056, Sigma-Aldrich, Australia) treatments for 3 min each. Following the ethanol and 
xylene treatments, a drop of DPX mountant (44581-100ML, Sigma-Aldrich, Australia) was 
placed on the StarFrost® Superclean, hydrophilic slides (24 mm x 60_mm, G311SF-W, 
ProSciTech, Australia) and a coverslip (24 mm x 60 mm, G418, ProSciTech, Australia) was 
attached ensuring no bubbles were present above the tissue section. These slides were then air 
dried in a fume hood for 24 h protected from light ensuring the slides remain horizontal 
during transport and incubation. 
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2.4.5 Light microscopy of H&E stained bovine mammary tissue  
The slides were imaged using an Olympus BX51 Microscope with an Olympus DP70 camera 
running the DP Controller software ver. 2.1.1.183 and the DP manager software ver. 2.1.163 
(Olympus Australia Pty. Ltd.). Five images were taken per tissue section at 200X 
magnification.  
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PART B 
Colourmetic determination of proliferating and apoptotic cells, and 
putative stem and progenitor marker positive cells in late pregnancy, peak 
lactation and involuting bovine mammary tissue 
2.4.6 Preparation of paraffin embedded bovine mammary tissue sections.  
Preparation of paraffin embedding of bovine mammary tissue sections were performed as 
outlined in section 2.4.2. 
 
2.4.7 Paraffin embedded tissue sectioning of bovine mammary tissue 
Sectioning of paraffin embedded bovine mammary tissue was performed as outlined in 
section 2.4.3. 
 
2.4.8 Antibody staining of paraffin embedded bovine mammary tissue 
The bovine mammary tissue samples that had been embedded in paraffin were placed in 
sodium citrate buffer (10mM sodium citrate with 0.05 % Tween 20, pH 6.0) and placed in a 
microwave (MR-5400, Hitachi) on high for 13 min for antigen retrieval. Following this, the 
slides were incubated in 200 µL of 3 % H2O2 (DAKO
® Peroxidase Blocking Reagent, S2001, 
DAKO Corporation, USA) for 5 min at room temperature to quench endogenous peroxidases. 
The slides were washed in 10 mM Tris buffer (pH 7.6, S3001, DAKO Corporation, USA) to 
ensure the slides did not dry out between washes. Each slide was carefully blotted dry and a 
wax circle drawn around the sample using the miniPAP pen (00-8877, Invitrogen, Australia). 
The slides were incubated in the protein block, serum free solution (X0909, DAKO, 
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Australia) for 30 min. The antibodies (either CD24, Ki-67 or CD61 - Table 2.2) were added 
separately to the protein block, serum free solution for a final concentration of 1 in 100. These 
slides were incubated overnight at 4 °C in a sealed plastic container with moistened paper. 
The slides were washed 3 times with 10 mM Tris buffer (pH 7.6) prior to a 30 min incubation 
at room temperature with a peroxidase linked secondary antibody (as per kit instructions) 
(K4065, EnVision™  Detection Systems Peroxidase/DAB, DAKO Corporations, USA). This 
was followed by 3 further Tris buffer (10 mM, pH 7.6) washes and a final incubation with 
DAB chromogen (as per kit instructions) (SK007, DAKO Corporations USA) for 5 min at 
room temperature. The slides were washed 3 times with Tris buffer (10 mM, pH 7.6) and 
placed in a solution of haematoxylin (see section 2.4.4) for 30 s followed by a water rinse and 
1 min in bluing solution (see section 2.4.4). The slides were dehydrated through an ethanol 
and xylene series (2 x 70 % EtOH, 2 x 95 % EtOH, 2 x 100 % EtOH and 2 x 100 % xylene) 
prior to the addition of a few drops of DPX mountant and a coverslip. Each slide was 
complemented with appropriate controls.  
 
Table 2.2. Details of antibodies used for immunohistochemistry staining of bovine 
mammary tissue samples. 
Antibody Clone 
Number  
Supplier Catalogue 
Number 
Role 
CD24 TS2/16 Auspep P/L Custom 
made 
Mammary stem/progenitor 
cell marker in human & mice 
Ki-67 MIB-1 DAKO 
Corporation, USA 
F726801 Proliferation marker in 
mammalian tissue 
CD61 VI-PL2 BD Biosciences 555754 Progenitor cell marker in 
mice 
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2.4.9 Apoptosis analysis of bovine mammary histological sections  
The analysis of apoptosis positive cells in the bovine mammary tissue histological sections 
were conducted using the ApopTag® Peroxidase In Situ Apoptosis Detection Kit as per 
manufacturer’s instructions (S7100, Millipore, Australia). The basis of the assay is the 
labelling of DNA fragmented in the process of apoptosis with the enzyme terminal 
deoxynucleotidyl transferase (TdT). This enzyme labels fragmented DNA with digoxigenin-
conjugated nucleotide and unlabelled nucleotide in a random sequence (Figure 2.1). The 
digoxigenin is detected with a specific antibody (comparable to traditional 
immunohistochemistry) that is labelled with a peroxidase enzyme. A chromogenic product is 
formed upon substrate application that can be detected visually.  
 
Figure 2.1 Diagram of apoptosis detection in ApopTag® Peroxidase In Situ Apoptosis 
Detection Kit. 
The mechanism of immunohistochemistry in situ apoptosis detection using the 
ApopTag® Peroxidase In Situ Apoptosis Detection Kit. (Gavrieli et al., 1992, Gorczyca et 
al., 1992, Li et al., 1995, Thiry, 1992, Wijsman et al., 1993).  
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The sections utilized for apoptosis detection studies were placed in sodium citrate buffer (10 
mM sodium citrate with 0.05 % Tween 20, pH 6.0) and microwaved on high for 13 min for 
antigen retrieval. Following this, the slides were incubated in 200_µL of 3 % H2O2 at room 
temperature for 5 min to quench endogenous peroxidases. The slides were washed 3 times in 
10 mM Tris buffer (pH 7.6), then treated with 75 μL of equilibration buffer (Supplied in kit) 
and incubated for 10 s at room temperature. The excess liquid was tapped off and 55 μL of 
working strength TdT enzyme (diluted in reaction buffer from the kit) was added to the slide. 
Following this, the slide was incubated for 1 h at 37 °C in a sealed plastic container with a 
moistened paper to prevent evaporation. Slides were washed with working strength stop wash 
buffer (supplied in kit) for 10 min at room temperature. The slides were then washed 3 times 
in 10 mM Tris buffer (pH 7.6). Slides were incubated in 65 μL of anti-digoxigenin peroxidase 
conjugate (included with kit) in a sealed plastic container with a moistened paper for 30 min 
at room temperature. The slides were washed in 4 changes of PBS for 2 min per wash at room 
temperature. A working solution of peroxidise substrate was prepared by adding 1.5 μL of 
concentrated kit reagent to 1_mL of 5 mM Tris buffer (pH 7.6). The slides were incubated in 
75 μL of working strength peroxidase substrate for 6 min at room temperature. The slides 
were washed three times with dH2O. Methyl green was prepared at a concentration of 0.5 % 
(w/v) by dissolving 0.5 g of methyl green (M8884, Sigma-Aldrich, Australia) in 100 mL of 
0.1 M sodium acetate (pH 4.0, S8388, Sigma-Aldrich, Australia). The sections were 
counterstained with 0.5 % methyl green for 10 min at room temperature. The specimen was 
washed three times in dH2O, then washed three times with 100 % N-Butanol (B7906, Sigma-
Aldrich, Australia) and then washed three times with 100 % xylene for 2 min each. Two drops 
of DPX mounting medium were added to the slides followed by a coverslip and allowed to 
dry prior to imaging. Appropriate control slides (no enzyme, no antibody, no substrate 
controls) were used to confirm the specificity of the methodology.  
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2.4.10 Light microscopy imaging and image analysis of immunostained bovine 
mammary tissue sections 
Slides of biopsied mammary tissue from the 5 cows collected at the 3 different stages of 
lactation (late pregnancy, peak lactation and involution) were analysed by colourimetric 
antibody staining and light microscopy for the antigens of CD24, CD61 and Ki-67, apoptotic 
cells and the respective control slides. The slides were imaged using an Olympus BX51 
Microscope with an Olympus DP70 camera running the DP Controller software ver. 2.1.1.183 
and the DP manager software ver. 2.1.163 (Olympus Australia Pty. Ltd.). Five images were 
taken (n = 5) for each lactation stage per animal for both treatment and control samples. A 
total of 15 images were analysed per animal for each of the five animals. The controls for Ki-
67, CD24, CD61 and apoptotic cells included no antibody control and isotype controls. The 
apoptosis control included no TdT enzyme control and no substrate control. The controls were 
used to ensure that any stained percentages identified were not due to artefacts of the analysis 
or non-specific antibody staining. 
 
Image analysis was performed utilising the MetaMorph microscopy automation & image 
analysis software (Ver. 7.6, Molecular Devices, U.S.A). The cells were counted using the 
count cells function. The cells were classified based on size and shape following 
configuration through the configure object standards function. Manual counting of images 
was performed Adobe Photoshop CS6 Extended Edition (Ver. 13.0 x32) and each cell marked 
with the point identification function.  
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2.4.11 Statistical analysis 
Statistical analysis was performed using the analysis toolpak add-in of Microsoft Excel 2010 
(Ver 14.0.7116.5000, Microsoft, U.S.A). Statistically significant differences between stages 
of lactation were assessed using the paired T-Test (2-tail) (p < 0.05). Statistical difference 
between counting methods were determined using ANOVA (p < 0.05).  
 
PART C 
Fluorescence detection of putative stem and progenitor marker positive 
cells in late pregnancy, peak lactating and involuting bovine mammary 
tissue. 
Colourimetric analysis (Part B) was performed for CD24 and CD61 cell surface marker 
detection due to low numbers of positive cells and high background autofluorescence using 
fluorescence detection. Tissues treated with antibodies to CD29 and CD49f were analysed 
using fluorescence which may have been possible due to the higher numbers of cells positive 
for these markers allowing the signal from these antibodies to be detected over the 
autofluorescence. Lower prevalence markers (CD24 and CD61) were difficult to resolve due 
to high tissue autofluorescence, this necessitated the use of colourimetric analysis (Part B) and 
stopped the full suite of markers being used on a single tissue section for fluorescence 
analysis. The methods used to image and analyse histological sections of bovine mammary 
tissue treated with fluorescent-tagged antibodies to CD29 and CD49f are presented below.  
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2.4.12 Bovine mammary tissue preparation for fluorescence analysis  
Tissue samples were removed from -20 °C and embedded in OCT medium (IA018, 
ProSciTech, Australia) and sectioned using a Cryocut 1800 (Leica Biosystems). The 10 µm 
sections were mounted on StarFrost® Superclean, hydrophilic slides, air dried and 
subsequently fixed in acetone (650501-1L, Sigma-Aldrich, Australia) for 20 min at -20 °C. 
The cryosections were used for the fluorescence analysis of CD29 and CD49f expression. 
 
2.4.13 Antibody staining for bovine mammary stem/progenitor cell markers, CD29 
and CD49f 
Late pregnancy, peak lactation and involution samples from all 5 cows (n = 45) were 
incubated in PBS with 5 % horse serum (H1138-500ML, Sigma-Aldrich, Australia) for 
20_min at room temperature prior to antibody incubation to block non-specific binding. All 
antibodies (Table 2.4) were diluted in PBS with 5 % horse serum. Sections were labelled with 
primary antibodies CD29 – Alexa Fluor 488 (303016, Australian Biosearch, Australia) and 
CD49f – PE (313612, Australian Biosearch, Australia) at recommended dilutions (1 in 100 
and 1 in 200, respectively) and incubated overnight at 4 °C in a sealed plastic container with a 
moistened paper to prevent drying of the sections. Samples were washed 3 times for 5 min in 
PBS, once with deionised water and then air-dried in a slide staining dish protected from 
light. The cells' nuclei was counterstained with 0.29 mM 4',6-diamidino-2-phenylindole 
(DAPI) (D9542-10MG, Sigma-Aldrich, Australia) by incubating the slides for 5 min. The 
slides were then washed with 10 mL of PBS (pH 7.4) in a slide staining dish.  
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Table 2.3 Antibodies used for fluorescent staining of bovine mammary tissue sections. 
Antibody Clone 
Number  
Supplier Catalogue 
Number 
Role 
CD29 M1/69 Australian 
Biosearch 
300016 Mammary stem/progenitor cell 
marker in human & mice 
CD49f GoH3 Australian 
Biosearch 
313612 Mammary stem cell marker in 
human & mice 
 
2.4.14 Determination of non-specific binding using isotype control antibodies for 
CD29 and CD49f 
Isotype control antibodies (comparable non- immunised antibody type and donor species) for 
CD29 and CD49f were used to determine any non-specific binding levels. The PE/Cy5 Rat 
IgG2a isotype control antibody (400510, Australian Biosearch, Australia) were used for 
CD49f and the Alexa 488 Mouse IgG1, K isotype control antibody (400134, Australian 
Biosearch, Australia) were used for CD29. Bovine mammary tissue samples were prepared as 
outlined in section 2.2.6 using the control antibodies. Analysis of CD29 and CD49f was 
measured against the background level binding of the respective isotype control antibodies 
and the negative control (no antibodies) to determine the number of fluorescent CD29 and 
CD49f cells. 
 
2.4.15 Fluorescence microscopy analysis of CD29 and CD49f populations in late 
pregnancy, peak lactating and involuting bovine mammary tissue  
The slides were examined using an FV 1000 laser scanning confocal microscope (Olympus 
Optical Co., Hamburg, Germany). The results were then analysed using Imaris® software 
(Ver. 7.6, Bitplane, Australia) and Microsoft Excel (2010, Microsoft, USA). All samples were 
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imaged at 5 random locations using an Olympus FV1000 with a 63X oil objective to 
determine the number of nuclei in each field of view and the relative localization and of CD29 
and CD49f antibody fluorescence for each cell. Similar to the colour imetric analysis of the 
bovine mammary tissue, 5 images were taken for each lactation stage per cow. The counts 
were performed using the spots function to create a manual spot option. A single spot was 
assigned and the colour sampled. This colour sampling was then applied to the image as a 
whole and all spots of similar intensity, size and shape were enumerated.  
 
2.4.16 Statistical Analysis 
Statistical analysis was performed as per section 2.4.11.  
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2.5 Results           
PART A 
Determination of tissue integrity of biopsy samples from bovine mammary 
tissue taken at the three stages of lactation studied using haematoxylin & 
eosin (H&E) staining. 
 
2.5.1 H&E stained bovine mammary tissue  
Assessment of the histological morphology of bovine mammary tissue from the three 
lactation states (late pregnancy, peak lactation and involution) was performed using the H&E 
staining method (as outlined in section 2.4.2). Images of the late pregnancy (Figure 2.2), peak 
lactation (Figure 2.3) and involution (Figure 2.4) tissue sections are presented in this results 
section (n = 25 per state for all 5 cows combined).  
 
The bovine mammary tissue biopsied at late pregnancy shows a closed and tightly packed 
arrangement of alveoli (Figure 2.2 at marker A). There is little space between individual 
alveolar subunits. The alveoli vary in size throughout this section which was common 
throughout late pregnant tissues examined in this study and show each milk-producing sub-
unit surrounded by epithelial cells (Figure 2.2 at marker B). The connective tissue (stroma) 
surrounding the lobe is composed of components that exhibited weak staining (light pink) as 
indicated in Figure 2.2 at marker C. Remnant milk components were present in the alveoli 
demonstrated by the darker pink staining (Figure 2.2 at marker D). The late pregnancy 
sections isolated from all of the 5 animals used in this study showed similar morphology. 
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Figure 2.2 Late pregnancy H&E image. 
Representative H&E stained bovine mammary tissue cryosection (10 µm) showing 
tissue harvested during late pregnancy and imaged using light microscopy (100X). This 
image highlights the cross section of mammary alveoli (Marker A and B) as well as 
stromal tissue (Marker C), ducts, (Marker D) and blood vessels. Many of the mammary 
alveoli are still compressed although at this point many have expanded and potentially 
began milk biosynthesis. Sample from cow 1419 at 8 days pre-parturition.  
 
Tissue at peak lactation is shown in Figure 2.3 exhibits a normal appearance with alveoli of 
various sizes observed throughout the tissue. The darker haematoxylin stained nuclei are 
predominantly located in the alveolar associated cells (indicated by arrows in Figure 2.3). The 
stroma of the mammary tissue sample has been stained a light pink as a result of the eosin 
staining. The regions within the alveoli that appear as a slightly darker pink would seem to be 
a reaction of the eosin stain to the protein and other elements of milk secreted into the interior 
of the alveoli by the milk producing luminal cells of the alveoli. The section of tissue at peak 
B A 
C 
D 
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lactation as shown in Figure 2.3 shows expanded alveoli (when compared to the late pregnant 
tissue shown in Figure 2.2). The cells of the milk producing subunits surround the alveoli 
with a number of cells occupying the spaces between the alveoli. There is variation in the size 
of the alveoli shown in Figure 2.3. This reflects the natural variation in the tissues of the 
mammary gland; however there is also a three-dimensional structure to alveoli that cannot be 
fully demonstrated with 5-10 µm tissue sections.  
 
Figure 2.3. Peak lactation H&E image. 
Representative H&E stained bovine mammary tissue cryosection (10 µm) showing 
tissue harvested during peak lactation and imaged with light microscopy (100X). This 
tissue from peak lactation differs from the late pregnancy tissue with expanded space of 
varying size (arrows) within the alveoli to accommodate the production and distribution 
of milk. Sample from cow 1446, 34 days post-parturition.  
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The H&E staining of involuting tissue shown in Figure 2.4 demonstrates the dissociation of 
the cellular architecture of the alveoli. The haematoxylin positive nuclei are more dispersed 
throughout the connective tissue of the mammary stroma. This lack of milk producing 
architecture in the mammary gland during involution is due to the cessation of milking. This 
begins the drying off period of the mammary gland and the beginning of tissue remodelling 
associated with involution. There is also a decrease in the number of alveolar structures 
recognisable in the involuting tissue sections imaged.  
 
Figure 2.4. Involution H&E image. 
Representative H&E stained Bovine mammary tissue cryosection (10µm) showing tiss ue 
harvested during involution and imaged with light microscopy (100X). The involution 
tissue differs from the late pregnancy and peak lactation tissue in Figure 2.2 and Figure 
2.3 with the loss of the alveolar structures and signs of tissue remodelling. Sample from 
cow 1592 at 5 days post cessation of lactation. 
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Figure 2.2, Figure 2.3, and Figure 2.4 represents the normal tissue architecture of the bovine 
mammary gland at the three stages of lactation that were investigated in this study. These 
tissue sections reflect the general tissue architecture seen across the tissue samples from the 
five animals used for this study.  
 
PART B 
Colourmetic determination of proliferating and apoptotic cells, and 
putative stem and progenitor marker positive cells in late pregnancy, peak 
lactation and involuting bovine mammary tissue 
 
2.5.2 Cell proliferation marker indicated by Ki-67 antibody binding in paraffin 
embedded bovine mammary tissue sections.  
The marker Ki-67 is used to identify cells that are proliferating. In order to determine the 
number and proportion of cells positive for the proliferation marker Ki-67, each tissue section 
from each of the 5 animals were compared to a no-treatment control where the slides were 
treated identically except for the addition of further antibody diluent in place of the antibody. 
In addition to this, each antibody tested was also tested against an isotype control antibody to 
demonstrate the level of background nonspecific binding exhibited by the specific cell surface 
marker directed antibodies. For all of the animals at each state of lactation, both the no 
antibody control; and the isotype control; sections showed no positive cells (Figure 2.5).  
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Figure 2.5. Peak lactation control image  
Representative untreated control tissue section counterstained with haematoxylin at 
peak lactation and imaged by light microscopy (400X). There are no clear visible 
positively stained cells in these and similar controls. Sample from cow 1490 30 days 
post parturition. 
 
The localisation of Ki-67 positively stained cells (Figure 2.6 and Figure 2.7) appears to be in 
close association with the mammary alveoli and the epithelial cell layer lining the lumen. The 
Ki-67 antigen is localised at the nucleus and therefore the stain localisation is similar to that 
for nuclei stained by the haematoxylin stain. This differs from the other cell surface markers. 
The staining in these images is difficult to capture and visualise but is more evident under the  
microscope (Figure 2.6, Figure 2.7 and Figure 2.8). 
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The tissue section seen in Figure 2.6 is a representative image of late pregnancy tissue that 
has been stained with anti-Ki-67 antibodies. The Ki-67-positive cells within the tissue are 
primarily located in close association with the mature epithelial cells lining the alveoli. All 
samples (n = 5 animals x 3 sections) of late pregnancy tissue displayed a similar cellular 
distribution of anti-Ki-67 antibody positive stained cells with visible alveolar and ductal 
structures and stroma of the mammary gland between the structures. This representative 
image of late pregnant bovine mammary tissue shows small to medium alveoli and ductal 
structures in preparation for the beginning of lactation. The anti-Ki-67 antibody positive cells 
in this image are localised within the first two layers of the cells surrounding the alveoli – this 
was also observed in the late pregnant sections from the other tissue biopsied from the 5 cows 
in this study. There are a few positive cells seen in the stroma of the bovine mammary tissue. 
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Figure 2.6. Late pregnancy Ki-67 image. 
Representative late pregnancy (cow 1490, 21 days prior to parturition) colourimetric 
IHC analysis (Ki-67 positive stained cells are brown) counterstained with haematoxylin 
at late pregnancy and imaged with light microscopy (400X). The arrow in section A 
shows a ductal structure. A) alveoli is shown in the zoomed section, B) The three arrows 
show representative Ki-67 positive cells and their positions within the alveoli.  
 
A representative image of peak lactation tissue stained with anti-Ki-67 antibodies is shown in 
Figure 2.7. The peak lactation tissue exhibited similar characteristics to the late pregnancy 
tissue shown in Figure 2.6. The Ki-67 positive cells within the tissue were also primarily 
located in close association with the mature epithelial cells lining the alveoli. Small to 
medium alveoli and ductal structures in preparation for the beginning of lactation were also 
observed. All samples (n = 5 animals x 3 sections) of the late pregnancy tissue displayed a 
similar cellular distribution of anti-Ki-67 antibody positive stained cells with visible alveolar 
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and ductal structures and stroma of the mammary gland between the structures. The anti-Ki-
67 antibody positive cells in this image were also localised within the first two layers of the 
cells surrounding the alveoli (also observed in the late pregnant sections from the other cows). 
There were a few positive cells seen in the stroma of the bovine mammary tissue.  
 
 
Figure 2.7. Peak lactation Ki-67 image. 
Representative peak lactation (cow 1490 30 days post-parturition) colourimetric IHC 
analysis (Ki-67 positive stained cells are brown) counterstained with haematoxylin 
(blue nuclei) and imaged with light microscopy (400X)  A) field of view for quantitative 
analysis, B) enlarged image (indicated on image A) showing positively labelled cells. 
 
Figure 2.8 depicts an example of bovine mammary tissue from an involuting mammary gland. 
The cellular architecture was shown to be loosely arranged with fewer recognizable alveoli 
structures in comparison to the late pregnancy and peak lactation tissues. In addition, fewer 
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Ki-67-positive cells were observed throughout the involuting tissue sections (Figure 2.8) 
compared to the late pregnancy (Figure 2.6) and peak lactation (Figure 2.7) tissue sections.  
 
 
Figure 2.8. Involution Ki-67 image. 
Representative involution (cow 1490 5 days post cessation of lactation) colour imetric 
IHC analysis (Ki-67 positive cells are stained brown) counterstained with haematoxylin 
and imaged with light microscopy (400X). A) Field of view for quantitative analysis, B) 
Enlarged image (indicated on image A) showing positively labeled cells (arrows). 
 
As shown in Figure 2.9, a low percentage of cells exhibited positive staining for Ki-67 from 
the images analysed. Tissues from late pregnancy exhibited the highest percentage for Ki-67 
positive cells with 1.69 % ± 0.65 % Ki-67 positive cells for manual counting and 1.80 % ± 
0.69 % Ki-67 positive cells from MetaMorph counting. Peak lactation tissues showed a 
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similar low percentage of Ki-67 positive cells. Mean numbers from manual counting was 1.10 
% ± 0.61 % with MetaMorph at 1.18 % ± 0.64 %. The involution tissue sections exhibited the 
lowest mean percentage of cells positive for Ki-67 with a mean of 0.60 % ± 0.29 % for 
manual counting and a mean of 0.94 % ± 0.39 % for MetaMorph counting. There was no 
significant difference between the manual or automated cell counting for each stage of 
lactation as determined by T-Test (p<0.05). The number of Ki-67 positive cells in late 
pregnancy was found to be statistically different to Ki-67 positive cells in involution for both 
the manual and MetaMorph counts (p < 0.05).  
 
 
 
Figure 2.9. Mean Ki-67 positive cells at three stages of lactation. 
Mean percentage (Mean ± SEM) of Ki-67 positive cells (n = 5 animals x 5 images per 
animal per stage of lactation) assessed by manual (hand) counting and automated 
(MetaMorph) cell counting. Significant difference (*) between lactation stages was 
assessed using the paired T-Test (2-tail) (p<0.05). 
0
0.5
1
1.5
2
2.5
3
Late pregnancy Peak Lactation Involution
P
o
si
ti
ve
 K
i6
7
 C
e
ll 
C
o
u
n
t 
(%
)
Lactation Stage
Manual Cell Count
Metamorph Cell Count
*
*
Mean Percentage of Ki-67 Positive Cells in Tissues Biopsied from 
Different Stages of Lactation 
 80 
2.5.3 Determination of apoptotic cells in biopsied bovine mammary tissue using 
the ApopTag® Peroxidase In Situ Apoptosis Detection Kit (Millipore) 
The control (antibody only – no labelling reaction performed) for apoptosis detection is 
shown in Figure 2.10. This section was treated with methyl green to counterstain the nuclei of 
the cells. The control representative image shows late pregnancy tissue with a number of 
alveolar and ductal structures visible. The methyl green stained nuclei are concentrated in the 
alveolar and ductal structures; however there are a few cell nuclei visible between these 
structures in the stroma of the mammary gland. All other control samples (no enzyme control 
and no substrate control) were similarly negative for apoptotic cells.  
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Figure 2.10. Late pregnancy apoptosis control image. 
Representative antibody treatment-only control (no labelling reaction performed) tissue 
section (400X) counterstained with methyl green at late pregnancy and imaged with 
light microscopy. No brown (apoptotic cells) were evident. Sample is from cow 1446 , 21 
days prior to parturition. 
 
Figure 2.11 shows a representative enzyme only control image from the apoptosis treatment at 
late pregnancy. Similar controls were run for each tissue from each animal. As one of the 
recommended controls in the apoptosis detection kit, this representative image shows no 
apoptotic positive cells. The tissue does appear histologically normal by exhibiting a large 
number of alveoli of varying sizes. The tissue also shows cells with nuclei (methyl green 
counterstain) predominantly surrounding the alveolar spaces. Similar to the no treatment 
control (Figure 2.10), some cells are present in the stroma of the mammary tissue.  
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Figure 2.11. Late pregnancy enzyme only apoptosis control image. 
Representative enzyme treatment only control tissue section (400X) counterstained 
with methyl green at late pregnancy and imaged with light microscopy. Sample is from 
cow 1442, 15 days prior to parturition. 
 
The late pregnancy tissue treated to detect apoptosis is shown in Figure 2.12. Arrows in the 
image indicate the apoptotic cells (brown) (Fig. 2.12B). The tissue exhibits similar 
characteristics to control tissues including alveolar structures as indicated by the arrows in A. 
The positive cells appear to be located in close association with the alveoli although there are 
some present in the stroma. Similar observations were made in all late pregnancy tissues for 
all animals analysed. 
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Figure 2.12. Representative image of late pregnancy tissue stained to detect apoptosis. 
Apoptotic cells are brown and imaged with light microscopy (400X). Methyl green was 
used as to counterstain the nuclei. The arrows in the magnified image B show apoptotic 
positive cells (brown cells). The alveoli of the mammary tissue are still visible as 
indicated by the circles in image A. Sample is from cow 1446, 22 days prior to 
parturition. 
 
The cells potentially undergoing apoptosis during peak lactation are found distributed across 
the mammary tissue ultrastructure. As shown in Figure 2.13, apoptotic cells are seen in both 
the alveolar mammary epithelial cell layer as well as the stromal t issue. There did not appear 
to be a specific location within the tissue where apoptosis was observed as seen with other 
markers e.g. Ki-67 (Figure 2.7). 
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Figure 2.13. Representative image of peak lactation tissue stained to detect apoptosis 
Representative colourimetric IHC analysis (apoptosis positive cells are stained brown) 
counterstained with methyl green stain at peak lactation and imaged with light 
microscopy (400X). A) field of view for quantitative analysis, B) enlarged image 
(indicated on image A) showing positively labelled cells. Sample is from cow 1419 at 31 
days post parturition. 
 
Within the representative involution tissue sample (Figure 2.14) there is a reduced appearance 
of tissue architecture. There does not appear to be a particular localisation or tissue structure 
where apoptosis marker positive cells were observed. The arrows in Figure 2.14B show some 
of the higher concentrated regions of the apoptosis marker. A proportion of the remaining 
cells still show some staining for apoptosis marker.  
A 
B 
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Figure 2.14. Representative image of apoptosis tissue stained to detect apoptosis 
Representative colourimetric IHC analysis with apoptosis positive cells shown in brown 
(arrows). Imaged with light microscopy (400X) and counterstained with methyl green at 
involution (cow 1446, 5 days post dry-off). The enlarged section shows some apoptosis 
positive cells that have strong regions of chromogen. Some tissue architecture is still 
remaining in the wider view of the section. 
 
These tissues in Figure 2.10, Figure 2.11, Figure 2.12, Figure 2.13 and Figure 2.14 were 
counterstained with methyl green to image the nuclei and structure of the tissue. A number of 
alveoli and ductal structures were observed particularly in the late pregnancy and peak 
lactation images. The apoptotic positive cells were predominantly localised around the 
histological structures facilitating lactation (mammary alveoli) with a few cells present in the 
stroma of the mammary gland in these two stages.  
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For each of the 5 animals and each of the 3 states of lactation, 3 slides were analysed and 5 
images were taken at random locations. For each of these five images, the total cell count and 
the number of apoptotic positive cells were counted manually and with the MetaMorph 
software suite. This data was combined and the mean across the 3 states of lactation are 
shown respectively.  
 
The mean percentage of apoptotic positive cells at the 3 stages of lactation is shown in Figure 
2.15. The average percentage of apoptotic positive cells in tissue samples from late pregnant 
animals was 17.81 % (±_4.29 %) for the MetaMorph image analysis software and 19.13 % (± 
4.52 %) from the manual counting method. The mean number of cells positive for apoptosis 
was shown to increase in the sections from peak lactation with the MetaMorph software 
identifying a mean percentage positive of 20.88 % (± 3.62 %) apoptosis positive cells and 
manual identification exhibiting a mean percentage of 20.95 % (± 3.21 %) positive cells for 
the n = 25 sample images. The mean percentage of cells positive for the apoptosis marker 
further increased to 30.80 % (± 4.68%) cells positive (MetaMorph) and 30.61 % (± 3.86 %) 
cells positive (manual counting) for involuting tissue samples. There was no significant 
difference between manual or automated cell counting for all 3 lactation stages as assessed by 
paired T-Test (p<0.05). There was a statistically significant d ifference found between the 
number of apoptosis positive cells in late pregnancy and peak lactation tissues for both 
manual and MetaMorph counts. 
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Figure 2.15. Mean percentage (Mean ±SEM) of apoptotic positive cells.  
Positive cells were assessed by manual counting or automated counting (n = 5 animals x 
5 images per animal per stage of lactation). Statistically significant difference (*) 
between lactation stages assessed using paired T-Test (2-tail) p<0.05. 
 
2.5.4 Comparison between proliferating and apoptotic cells in bovine mammary 
tissue samples at the three different stages of lactation. 
A general overview of the cytodynamics of the mammary tissue at late pregnancy, peak 
lactation and involution was determined by comparing the mean percentage of manual and 
MetaMorph automated cell counts of Ki-67-positive cells with the mean percentage of 
apoptotic marker positive cells (Figure 2.16). The mean percentage of cells positive for 
apoptosis markers in late pregnancy samples determined by manual counting was 19.13 % 
(±_4.52 %), there was an increased mean percentage of apoptosis marker positive cells in 
tissues sampled at peak lactation at 20.95 % (± 3.21 %). The highest mean percentage of cells 
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positive for apoptosis markers was determined in the tissues from involuting mammary glands 
with 30.62 % (± 3.86 %). This increasing trend was also seen in the sampled mean 
percentages determined by MetaMorph counting with late pregnant tissues showing a mean 
percentage of 17.81 % (± 4.29 %), peak lactation with a mean percentage of 20.88 % 
(±_3.62_%) and involution with 30.80 % (± 4.68 %). For the Ki-67 samples, the mean 
percentage of cells positive in late pregnancy was 1.69 % (± 0.65 %) for manual counting and 
1.80 % (± 0.69 %) for MetaMorph counting. Tissues from peak lactation exhibited a mean 
percentage of cells positive for this marker of 1.10 % (± 0.61 %) for manual counting and 
1.18 % (± 0.64 %) for MetaMorph analysis. The tissue samples from involuting animals 
showed mean percentage of cells positive for the Ki-67 marker of 0.60 % (± 0.29 %) for 
manual counting and 0.94 % (± 0.39 %) for MetaMorph analysis. There is some inverse 
correlation between the two measures. This is shown with a reduction in the percentage total 
of Ki-67 marker positive (‘proliferating’) cells across the lactation cycle corresponding to an 
increase in the number of apoptosis marker positive cells.  
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Figure 2.16. Mean number of total cells for apoptotic positive and Ki-67 positive cells at 
the three different lactation stages. 
Determined by manual (Hand count) counting and MetaMorph software analysis (Mean 
± SEM) (n = 5 animals x 5 images per animal per stage of lactation). 
 
Figure 2.17 highlights the trend relationships between cellular proliferation and apoptosis 
over the lactation cycle. The relationship between the values in Graph A is represented with a 
trend line. The percentage of Ki-67 marker positive cells decreases as the apoptotic markers 
positive cells increase over the course of lactation. Graph B represents the values ±SEM.  
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A.  
B.  
Figure 2.17. Mean number of cells positive for Ki-67 versus apoptosis. 
Graphed for each measured state of lactation visualised with trend line –curvilinear 
decrease- (Graph A) and ± SEM (Graph B). Each value is derived from n = 25 images. 
Image A) contains the trend line data for this analysis with image B) representing the 
measured values ± SEM. 
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2.5.5  Immunohistochemistry of cell surface markers to determine the presence of 
putative stem/progenitor cells on bovine mammary tissue at three different 
stages of lactation 
For all antibodies used in this section, no-treatment and isotype control tissues were prepared 
to measure any non-specific binding. Haematoxylin was used to counterstain the nuclei of the 
cells (indicated by the blue cells). Due to the low levels of expression, the CD24 molecule 
remained undetectable while using the fluorescent antibody suites. As a result of this, the 
methods were changed to colourimetric for the enumeration of CD24 and other markers (Ki-
67, apoptosis, CD61).  
 
2.5.5.1 CD24 – Stem/progenitor cell marker 
For the mammary stem/progenitor cell marker CD24, the no-treatment control and isotype 
control images did not exhibit any significant colourimetric staining (as seen in Figure 2.18). 
The architecture of the representative late pregnancy mammary tissue in Figure 2.18 exhibits 
a number of alveolar subunits throughout the tissue section (circles).  
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Figure 2.18. Late pregnant tissue isotype control image. 
Representative colourimetric IHC analysis of an isotype control sample (400X). (Cow 
1442, 15 days prior to parturition) Alveolar subunits are visible throughout the tissue 
(circles). 
 
Figure 2.19 is a representative image of late pregnancy tissue stained with haematoxylin and 
anti-CD24 antibodies. The CD24 positive cells were found in the stoma adjacent to functional 
alveoli (Figure 2.19 indicated by brown cells). There were only a small number of CD24+ 
cells per image.  
 93 
 
Figure 2.19. Late pregnant tissue CD24 analysis image. 
Representative colourimetric IHC analysis (CD24 positives = brown) (400X) 
counterstained with haematoxylin stain at peak lactation. A) Field of view for 
quantitative analysis, (B) Enlarged image (indicated on image A) showing CD24-positive 
labelled cells. Cow 1442 15 days prior to parturition. 
 
Figure 2.20 shows the total percentage of CD24 positive cells found at the three stages of 
lactation. The late pregnancy tissue manual counting had a mean percentage of 0.37 % (± 0.12 
%) with MetaMorph showing 0.39 % (± 0.11 %). The total percentage of CD24 positive cells 
decreased as lactation continued. Peak lactation manual counting revealed a mean CD24 
percentage positive of 0.15 % (± 0.06 %) with MetaMorph revealing 0.15 % (± 0.06 %). 
Involuting tissue samples had the lowest percentage with an average of 0.02 % CD24 positive 
cells (± 0.01 %) for manual counting and 0.01 % (± 0.01 %) for MetaMorph. There was a 
statistically significant difference found between the number of CD24 positive cells in all 
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comparisons (late pregnancy vs. peak lactation, late pregnancy vs. involution, peak lactation 
vs. involution) for both manual and MetaMorph counting.  
 
 
 
Figure 2.20. Mean percentage of CD24 positive cells. 
Measured by manual (Hand count) and MetaMorph software analysis (Mean ± SEM). 
There was no significant difference between manual or automated counting as assessed 
by T-Test (n = 5 animals x 5 images per animal per stage of lactation at each stage of 
lactation). Statistically significant difference (*) between lactation stages assessed using 
paired T-Test (2-tail) p<0.05. 
 
2.5.5.2 CD61 – Progenitor cell marker 
CD61 is a murine mammary progenitor cell marker that has been used in combination with 
other markers (particularly CD24, CD29, CD49f and CK14) to identify stem and progenitor 
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cells within mammary gland tissues (Shackleton et al., 2006, Stingl et al., 2006, Asselin-Labat 
et al., 2007, Visvader and Smith, 2011). Unlike Ki-67 labelled cells, the majority of CD61 
cells appear to be in the stromal compartment (Figure 2.21) and not directly associated with 
the mammary alveoli.  
 
 
Figure 2.21. Representative image of peak lactation tissue treated with CD61. 
Representative colourimetric IHC analysis of CD61 positive cells (brown) 
counterstained with haematoxylin stain at peak lactation and imaged with light 
microscopy (400X). (A) Field of view for quantitative analysis, B) Enlarged image 
(indicated on image A) showing CD61-positive labeled cells. Cow 1446, 34 days post 
parturition. 
 
The results represented in Figure 2.22 shows a decrease in the mean percentage of CD61-
positive cells as lactation progresses from late pregnancy, to peak lactation then involution. 
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The mean percentage of cells positive for CD61 in late pregnancy tissues was 0.33 % 
(±_0.02_%) for manual counting, with MetaMorph analysis slightly higher at 0.34 % 
(±_0.01_%). Peak lactation showed a mean of 0.14 % (± 0.02 %) for manual counting and 
0.15 % (± 0.03 %) for MetaMorph counts. Involution tissue showed a mean number of CD61 
positive cells of 0.06 % (± 0.02 %) for manual counting and 0.07 % (± 0.04) for MetaMorph.  
All comparisons (late pregnancy vs. peak lactation, late pregnancy vs. involution, peak 
lactation vs. involution) of CD61 positive cells were significantly different for both the 
manual and MetaMorph counting. 
 
 
 
Figure 2.22. Mean percentage of CD61 positive cell counts. 
Tissues were analysed manually (Manual cell count) and with MetaMorph software 
analysis (Mean ± SEM). There was no significant difference between manual or 
automated counting as assessed by T-Test (n = 5 animals x 5 images per animal per 
stage of lactation). Statistically significant difference (*) between lactation stages 
assessed using paired T-Test (2-tail) p<0.05. 
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PART C 
 
Fluorescent detection of putative stem and progenitor marker positive cells 
in late pregnancy, peak lactating and involuting bovine mammary tissue. 
 
2.5.6 Fluorescent detection of cell surface markers to determine the potential 
presence of putative stem/progenitor cells on bovine mammary tissue at 
three different stages of lactation 
Fluorescent staining was used for CD29 and CD49f marker visualisation with the ultimate 
goal of multiplexing, or discerning multiple markers on the same tissue, something 
colourimetric staining has limited capacity to achieve.  
 
Similar to the IHC analysis of putative mammary stem and progenitor cell markers, no 
treatment and isotype controls were prepared to ensure that non-specific antibody binding was 
not evident in the analysis. The control slides (Figure 2.23) and isotype control slides (data 
not shown) demonstrated nuclei cells stained with DAPI but no regions of localised green 
fluorescence from the anti-CD29 or red from the anti-CD49f antibodies.  
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Figure 2.23. Peak lactation control fluorescent image. 
Representative IHC image of a control peak lactation bovine mammary tissue sample 
stained with DAPI only and imaged by fluorescence microscopy. Cow 1490, 30 days post 
parturition. 
 
2.5.6.1 CD29 – Mammary stem progenitor cell marker 
The cell surface marker CD29 is a human and murine mammary stem cell marker. In this 
investigation, an antibody with Alexa Fluor 488 (green) conjugated fluorophore was used to 
localise CD29 surface markers. The green fluorophore was chosen in conjunction with the 
Phycoerythrin (PE – red conjugated to anti CD49f antibody) so that both markers could be 
visualised together to look for areas of co- localisation. The tissue sections were 
counterstained with DAPI to visualise the nuclei of the cells (blue) in the sections.  
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The localisation of CD29 staining (green) is predominantly away from the epithelial layers of 
differentiated mammary epithelial cells (blue). These cells surround the alveoli in the lactating 
mammary tissue (Figure 2.24).  
 
 
Figure 2.24. Representative peak lactation image of CD29 treated sections.  
Representative fluorescent IHC analysis of CD29 positive cells (green) (620X) at peak 
lactation. A) Field of view for quantitative analysis, B) Enlarged image (indicated on 
image A) showing CD29 positive labeled cells (green). Blue coloured regions are nuclei 
stained with DAPI. Cow 1490, 30 days post parturition.  
 
The percentages presented in Figure 2.25 show the number of cells co-localised with DAPI 
and CD29 cells. In the tissue sections from late pregnancy, manual counting showed 97.35 % 
(± 0.63 %) and MetaMorph showed 97.17 % (± 0.38 %) CD29 positive cells. Imaris counting 
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showed 96.83 % (± 0.38). For the peak lactation tissue sections, CD29 positive cells counted 
manually were 97.70 % (± 1.00 %) of the cells imaged. The MetaMorph count showed 97.79 
% (± 1.38 %) CD29 positive cells and the Imaris counting showed 98.16 % (± 1.39 %). 
Manual counting of CD29 positive cells in involution tissues showed 87.67 % (± 3.40 %), 
MetaMorph analysis revealed 88.34 % (± 3.40 %) with Imaris analysis at 88.59 % (± 3.67 %). 
There was a statistically significant difference between the number of CD29 positive cells in 
all comparisons (late pregnancy vs. peak lactation, late pregnancy vs. involution, peak 
lactation vs. involution) for manual, MetaMorph and Imaris counting as determined by paired 
T-Test (2-tail) (p<0.05). 
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Figure 2.25. Mean percentage of CD29 positive cell counts. 
Samples were analysed manually (hand count), and with MetaMorph and Imaris 
software (Mean ± SEM). There was no significant difference between manual or 
automated counting as assessed by ANOVA (n = 5 animals x  5 images per animal per 
stage of lactation). Statistically significant difference (*) between lactation stages 
assessed using paired T-Test (2-tail) p<0.05. 
 
2.5.6.2 CD49f – Mammary stem cell marker 
The cell surface marker CD49f is a human and murine mammary stem cell marker. The anti-
CD49f antibody used was labelled with PE (red) to facilitate co-localisation of CD29 and 
CD49f within the same tissue section (refer to section 2.5.7).  
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As seen in Figure 2.26, the localisation of CD49f is very distinct in that the antibody to this 
marker binds to the basal surface of the mammary epithelial layers of the alveoli. There is 
some minor staining of cells within the stromal compartment. This staining is clearly localised 
in the same region as Ki-67 which is encouraging as a marker for bovine mammary stem 
cells. 
 
 
Figure 2.26. Representative fluorescent image of CD49f treated late pregnant tissue. 
Representative fluorescent IHC analysis of CD49f positive cells (red) (400X) at peak 
lactation. A) Field of view for quantitative analysis, B) Enlarged image (indicated on 
image a) showing positively labelled cells (red). Blue coloured regions are nuclei stained 
with DAPI. Cow 1419, 33 days post parturition. 
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The data represented in Figure 2.27 shows that the late pregnancy tissues had an average of 
85.46 % (± 3.48 %) cells positive for CD49f when determined by manual counting. This 
differed slightly from MetaMorph counting of CD49f positive cells that showed 85.85 % 
(±_3.60 %) and Imaris counting showing 85.64 % (± 3.25 %). Peak lactation tissues had an 
overall higher percentage CD49f positive cell counts. Manual counting showed 94.0 3% 
(±_1.70 %), MetaMorph 94.12 % (± 1.90 %) and Imaris showing 93.47 % (± 1.40 %) positive 
for CD49f. Involution tissues showed a lower level of CD49f positive cells with a manual 
count of 62.35 % (± 12.67 %), MetaMorph of 63.12 % (± 12.55 %) and Imaris of 63.35 % 
(±_12.54 %). The number of CD49f positive cells in the comparisons between late pregnancy 
vs. involution and peak lactation vs. involution were determined to be significantly different 
for the manual, MetaMorph and Imaris counting.  
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Figure 2.27. Mean percentage of total CD49f positive cells. 
Images were analysed manually (Manual cell count) and with MetaMorph and Imaris 
software (Mean ± SEM). There was no significant difference between manual or 
automated counting as assessed by ANOVA (n = 5 animals x 5 images per animal per 
stage of lactation). Statistically significant difference (*) between lactation stages 
assessed using paired T-Test (2-tail) p<0.05. 
 
2.5.7 Dual labelled CD29 and CD49f bovine mammary tissue at the three stages 
of lactation 
Dual labelling of the tissue sections was done in an attempt to determine the tissue position of 
putative bovine mammary stem/progenitor cells. The combination of markers allowed for the 
visualisation of a single cell expressing both CD29 and CD49f.  
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Figure 2.28 highlights the dual- labelled cells for CD49f and CD29. The potential mammary 
stem cells are exhibited to be in close proximity to the basal surface of the epithelial layer of 
the alveoli (Figure 2.28). The region where the dual labelled cells are seen appears to be one 
layer back (arrows) from the cells lining the interior surface of the alveoli.  
 
 
Figure 2.28. Composite overlay image of fluorescent confocal microscopy. 
Imaged at 630X, bovine mammary tissue was biopsied from lactating cow 1490 (30 days 
post parturition) observed at 3 different wavelengths following IHC staining. Blue = 
DAPI nuclear stain, Green=Anti-CD29-Alexa Fluor 488 positive cells, Red = Anti-CD49f –
Phycoerythrin (PE) positive cells. Regions of dual localization of CD29 and CD49f are 
indicated by the arrows.  
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Figure 2.29 shows the mean number of cell nuclei in each lactation state and the mean 
number of cells positive for both CD29 and CD49f markers as analysied by Imaris analysis. 
There is a sharp decline during involution in the number of dual- labelled positive cells (Figure 
2.29) which is similar to the trends observed for the individually labelled CD29 and CD49f 
cells (Figure 2.25 and Figure 2.26). The mean total number of cells for late pregnant tissues 
was 618.80 (± 32.09) with peak lactation at a mean of 585.24 (± 35.23) and involution 
showing a mean of 598.64 (± 38.19). The mean number of cells positive for both CD29 and 
CD49f across late pregnancy tissues was 427.44 (± 19.05), with peak lactation showing mean 
dual positives of 414.48 (± 13.59) and involution tissues with a mean dual positive count of 
233.26 (± 51.76). 
 
Figure 2.29. Mean total cell numbers of positive CD29 and CD49f cells. 
Analysed using the Imaris software analysis (Mean ± SEM) (n = 5 animals x 5 images per 
animal per stage of lactation).  
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2.5.8 Combined graph of surface antigens – CD24, CD29, CD49f and CD61 
Due to the low numbers of cell positives seen for CD24 and CD61  (integrins and suggested 
stem and progenitor cell markers respectively), these markers could not be resolved above the 
autofluorescence seen in the mammary tissue sections. This necessitated the use of 
colourimetric analysis using light microscopy and impaired the application of the full suite of 
markers on a single tissue section for fluorescence microscopy analysis.  
 
Figure 2.30 shows the mean percentage of cells positive for each of the markers investigated 
in this chapter, in addition to the apoptosis markers. This is plotted for each of the three stages 
of lactation that were investigated and includes all the methods of counting. For CD24, CD61, 
Ki-67 and apoptosis, this was a mean percentage of the manual counting and MetaMorph 
counts. For CD29 and CD49f (cell surface integrins), the mean percentage was determined 
from Imaris counts in addition to the manual and MetaMorph counts. The mean percentage of 
CD24 positive cells in late pregnant tissues was 0.38 % (± 0.05 %). The peak lactation tissues 
showed a mean percentage of 0.16 % (± 0.03 %). For the involuting tissues, the mean 
percentage was 0.02 % (± 0.01 %). The mean percentages for CD29 in late pregnancy were 
97.96 % (± 0.44 %), for peak lactation it was 97.87 % (± 0.46 %) and for involution it was 
87.92 % (± 2.26 %). The mean percentage positives for CD49f were 85.41 % (± 1.63 %) for 
late pregnancy tissues. For peak lactation tissues the mean percentage CD49f positive was 
93.83 % (± 0.49 %) and for involution tissues, the mean percentage positive for CD49f was 
63.07 % (± 4.02 %). The mean percentage positives for CD61 at late pregnancy were 0.34 % 
(± 0.04 %), peak lactation was 0.15 % (± 0.02 %) and involution was 0.07 % (± 0.02 %). For 
the Ki-67 proliferation marker the mean percentage positive was 1.73 % (± 0.23 %) for late 
pregnant tissues. For the peak lactation tissues the mean percentage positives was 1.16 % 
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(±_0.12 %) and for involution it was 0.77 % (± 0.13%). For the apoptosis marker the mean 
percentage positive for late pregnancy was 18.57 % (± 1.54 %). For peak lactation tissues, the 
mean percentage positive was 21.08 % (± 1.27 %) and for involution tissues the mean 
percentage positive was 31.02 % (± 1.58 %). The markers CD29 and CD49f were measured 
through fluorescence microscopy. It is possible that the higher numbers recorded for these 
markers are directly related to the imaging modality.  
 
 
 
Figure 2.30. Mean total percentage of cells positive for the markers CD24, CD29, CD49f, 
CD61 Ki-67 and Apoptosis. 
Levels were determined by an average of the percentages for all counting methods 
(manual counting, MetaMorph and Imaris software) expressed as mean ± SEM with n = 
50 for CD24, CD61, Ki-67 and Apoptosis counts and n = 75 for CD29 and CD49f (due to 
the addition of Imaris counting to the manual and MetaMorph counts). 
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2.6 Discussion           
The tissue used in this chapter had been collected for a previous study (Riley et al., 2008). 
These samples were employed for the histological study with the consideration of cost, and 
the nature and time required for ethical approval. It should be noted that the involution 
samples were collected from a different (earlier) lactation cycle to the late pregnancy and 
peak lactating samples. With this in mind, the main concept for this chapter is to present a 
comparison of significant change due to tissue remodelling during the three stages of 
lactation. Although some of the images may have benefited from colour correction or other 
image correction, little to no image correction was applied to give the truest representation of 
the tissues studied. 
 
PART A 
Determination of tissue integrity of biopsy samples from bovine mammary 
tissue taken at the three stages of lactation studied using haematoxylin & 
eosin (H&E) staining. 
2.6.1 Haematoxylin & eosin stained bovine mammary tissue. 
The bovine mammary tissue used in this chapter was stained with H&E to determine the 
structural integrity of the tissue samples following –80 °C freezer storage for over 5 years 
(section 2.4.6). Overall, there were consistencies between the 5 animals at each of the 3 states 
of lactation in terms of alveoli and stromal arrangements.  
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2.6.1.1 Tissue appearance 
From the results presented in section 2.5.1, the H&E stained tissue exhibited variation in 
alveolar size and tissue ultrastructure relative to the lactation stage. For instance, the late 
pregnancy H&E stained tissue exhibited a tightly packed arrangement of alveoli with alveolus 
units composed of a single layer of epithelial cells surrounded by highly packed stroma 
(Figure 2.2). The representative image from H&E stained lactating mammary tissue (Figure 
2.3) exhibited a similar histological ultrastructure to the late pregnancy tissue biopsies. 
However, in comparison to the late-pregnancy sample, a higher number of alveoli were 
observed in the lactating tissues that were enlarged in size. For both the late-pregnancy and 
lactating tissues, remnant milk was visible within the alveoli as an eosin stained film. 
Previous studies have described similar structural arrangements of alveoli and stroma in 
bovine (Wilde et al., 1997a), murine (Lund et al., 1996), and H&E stained bovine lactating 
and mid-pregnancy tissue (Brennan et al., 2008). The alveoli and stromal arrangement has 
also been described to differ between the first and subsequent lactations with smaller alveoli 
and denser stromal tissues observed in subsequent lactations (Knight and Wilde, 1993).  
 
The involuting tissue samples (Figure 2.4) exhibited a different architecture to the late 
pregnancy and lactating tissues. The representative image of H&E stained mammary tissue 
from involuting tissue exhibited a significant change in mammary tissue ultrastructure 
associated with tissue remodelling for the drying off period. The alveoli arrangements were 
dissociated with haematoxylin positive nuclei cells more dispersed throughout the stroma of 
the mammary tissue compared to the late pregnancy and peak lactation tissues and no remnant 
milk constituents were observed in the involuting tissues. The involuting tissues in Figure 2.4 
showed similar ultrastructure arrangements of alveoli and stroma with dissociated 
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arrangement of cells throughout the tissue to those observed by Wilde et al. (1997b) and 
Brennan et al. (2008). Studies of bovine mammary tissue involution, which differs from 
studies of mice mammary involution due to concurrent pregnancy, describe two phases of 
remodelling (De Vries et al., 2010). The first phase is characterised by increases in stromal 
area and a reduction of areas described as parenchymal (De Vries et al., 2010). Three weeks 
after this phase the second phase of involution occurs (Capuco and Akers, 1999). This second 
phase is characterised by mammary gland redevelopment and increases in luminal area and 
decreasing levels of parenchymal tissues (De Vries et al., 2010). From the observations in 
section 2.5.1, the mammary tissues utilized in this investigation were histologically similar to 
those described in previous reports (Capuco and Akers, 1999, Capuco, 2007). 
 
It is important to note that other cellular components may be present throughout the cellular 
compartment that forms the bovine mammary tissue. In a previous study, immune cell types 
(T-cells) have been described to assist apoptotic activities (Holst et al., 1987). Although these 
cell types were not investigated, it is possible that immunological cells may have been present 
throughout the bovine mammary tissue sections, but elevated in mid to late involution and if 
mastitis were present. In addition, the structural arrangement of the bovine mammary cells 
may play a role in other activities of the gland. Previous reports have linked the cytodynamics 
(apoptosis and proliferative activities) of the bovine mammary tissue to the lactation state  
(Capuco and Akers, 1999).   
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PART B 
Colourmetic determination of proliferating and apoptotic cells, and 
putative stem and progenitor marker positive cells in late pregnancy, peak 
lactation and involuting bovine mammary tissue 
2.6.2 Positive cell proliferation marker indicated by Ki-67 antibody treatment in 
paraffin embedded bovine mammary tissue sections 
Cells are positive for Ki-67 staining at all stages of the cell cycle apart from G0 (Baldwin et 
al., 2004), and thus is recognized as a marker for cellular proliferation (Scholzen and Gerdes, 
2000). The use of Ki-67 in this chapter was an indirect measure of proliferation rate of cells 
within the bovine mammary gland across the three lactation states.  
 
2.6.2.1 Location of Ki-67 positive cells within the tissues 
In other studies, Ki-67 positive cells have been identified as potential bovine mammary stem 
cells (Capuco, 2007). The Ki-67 antibody was applied in this chapter to investigate the 
possible location of proliferative cells in the 3 different lactation tissues. The results in, Figure 
2.6 revealed low levels of the Ki-67 marker, predominantly in the stromal areas. However, 
there were Ki-67 positive cells found elsewhere within the tissues, for instance, in the cells 
lining the alveoli and within the connective tissue. The Ki-67 antigen is a marker of 
proliferation and when combined with histology represents a single time point in the tissue 
dynamics of the mammary gland. 
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2.6.2.2 Number of Ki-67 positive cells within the tissues 
From section 2.5.2, the late pregnancy tissue was observed with the highest percentage of Ki-
67 positive cells with the involuting tissue sections exhibiting the lowest percentage (Figure 
2.9). This result corresponds with previous research that reports the highest level of Ki-67 
positive cells in tissue samples from late pregnant animals tissue relative to lactation and 
involution tissue samples from bovine mammary glands (Capuco et al., 2001, Sorensen et al., 
2006a). From a biological perspective, there is a reduced need for proliferation in the tissues 
of the mammary gland after the cell architecture for lactation has been established; therefore 
as proliferation decreases the level of cell turnover within the gland increases. This 
phenomenon is not common to all animals. Conversely, Ki-67 positive cells were reported 
highest at lactation in sheep (Colitti and Farinacci, 2009) and in horses (Spaas et al., 2012). 
While it is difficult to make clear conclusions due to animal variation, there is a trend toward 
a decline in the number of proliferating cells as the lactation cycle progressed from late 
pregnancy, some increase at peak lactation and an overall decline at the onset of tissue 
involution (Figure 2.16). 
 
2.6.3 Determination of apoptotic cells in biopsied bovine mammary tissue using 
the ApopTag® Peroxidase In Situ Apoptosis Detection Kit (Millipore)  
The presence of apoptotic cells within the bovine mammary tissue sections may be an 
indication of tissue development and changes or, in the case of involution tissue samples, an 
indication of profound tissue remodelling. The use of an apoptosis detection assay in this 
chapter was to determine the number of apoptotic cells within the bovine mammary gland 
across the three lactation states investigated.  
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2.6.3.1 Number and trends of apoptotic cells within the biopsied mammary tissues 
The level of apoptosis increased during involution with an observed decrease in tissues 
biopsied from other stages of lactation (Figure 2.17). These observations correspond to 
previous research into bovine mammary cytodynamics, with the report of an approximately 
50 % decrease in the number of milk producing cells being observed over the course of 
lactation (Capuco et al., 2001). However, it has been shown that milk production per cell as 
well as the amount of cell differentiation increases to counteract this increase in cellular 
apoptosis (Capuco et al., 2001). The mammary gland then transitions towards what is termed 
regenerative involution (Capuco and Akers, 1999) where it has been suggested that the 
concurrent pregnancy allows for the replacement of the regenerative cells of the mammary 
gland (Capuco et al., 1997). It has been shown that although the stem cells do not appear to be 
progesterone receptor positive, the cells of the mammary gland ductal network in addition to 
nearby daughter cells remain positive for the progesterone receptor (Capuco et al., 2002a). 
This allows the mammary gland ultrastructure to remain responsive to progesterone and 
influence the stem cell activity, indirectly, through local secretory messengers (Capuco et al., 
2002a).  
 
The manual cell counting and automated cell counting analysis exhibited similar trends in the 
mean cell numbers identified as apoptosis positive for all three lactation states (Figure 2.15). 
The percentage of cells entering apoptosis increased slightly from late pregnancy tissues to 
peak lactation tissues. This may be a result of increased cell turnover due to the mammary 
gland being more metabolically active during this stage of lactation (Capuco and Akers, 
1999). An increase in apoptotic cells was exhibited during involution potentially due to 
significant tissue remodelling (Figure 2.15). The purpose of the non- lactating period in the 
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cow mammary gland is for regenerative apoptotic events in order to maximise the lactation in 
the next cycle (Capuco et al., 1997). The prepartum period of the lactation cycle sees the 
restoration of the regenerative mammary epithelial cells (Capuco et al., 1997). This tissue 
behaviour during the involution stage is influenced by a concurrent pregnancy and the 
mitogenic hormones resulting from the pregnancy (Capuco and Akers, 1999). Regenerative 
involution differs from that seen in the weaning induced invo lution in non-pregnant mouse 
models with two distinct phases of remodelling (De Vries et al., 2010, Capuco et al., 2002a, 
Capuco et al., 2002b). The first phase is characterised by increases in stromal area and a 
reduction of areas described as parenchymal (De Vries et al., 2010). The second phase of 
involution occur three weeks later (Capuco et al., 1997). This second phase is characterised 
by mammary gland redevelopment, increases in luminal area and decreasing levels of 
parenchymal tissues (De Vries et al., 2010). These distinct phases were not observed in the 
work in this chapter as the mammary tissue sections contained only a single time-point within 
the involution cycle. The further study of the tissue dynamics of involution across more time 
points could be an interesting avenue for further work.  
 
2.6.4 Comparison between proliferating and apoptotic cells in bovine mammary 
tissue samples at the three different stages of lactation 
Interestingly, the data utilised to investigate the bovine mammary gland cytodynamics 
(proliferation (Ki-67) and apoptosis) showed a trend across lactation (Figure 2.17) that is 
consistent with observations from others (Capuco et al., 2003, Capuco et al., 2001). These 
basic trends show an increase in proliferation across late pregnancy and lactation with a 
decline in involution which sharply contrasts with the increase in apoptosis observed across 
the three lactation states (Figure 2.17). These two observations together indicate that a change 
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in the total cell number of the bovine mammary gland over the course of lactation may tend to 
decrease which, in turn, could impact on the productive capacity of the mammary gland as a 
tissue. Longitudinal studies of mammary glands and milk content in the literature has been 
more concerned with the nutrient content rather than cytodynamics (Valdivielso et al., 2015). 
To our knowledge, research into the location and number of proliferative (Ki-67) and 
apoptotic cells across lactation in multiparous cows is limited. The locations of the apoptotic 
cells observed (Figure 2.7) were not in close proximity to the stroma unlike the observed Ki-
67 positive cells (Figure 2.19). This may be due to the cell turnover occurring in the milk 
producing cell types that form the structure of the alveoli (Sorensen et al., 2006b). It could 
also be due to the higher energy demands of the milk producing cells that make them more 
sensitive to changes within the mammary gland (Nørgaard et al., 2005). There is also the 
proximity of these cells to the alveolar space, which is likely to be affected by the negative 
feedback loop of gland filling that also drives cell turnover (Nørgaard et al., 2005). 
 
2.6.5  Immunohistochemistry of cell surface markers to determine the potential 
presence of putative stem/progenitor cells on bovine mammary tissue at 
three different stages of lactation. 
The cellular mechanisms of bovine mammary stem and progenitor cells are yet to be fully 
elucidated. The work presented in this chapter is the first step in investigating the location and 
number of bovine mammary stem/progenitor cells using immunohistochemistry, known 
stem/progenitor cell markers and microscopy (colourimetric and fluorescence). However, for 
CD24 and CD61, autofluorescence from the tissue was unable to be resolved for identification 
of these cell surface markers using fluorescent microscopy. Another method that may be 
added to future work for the amelioration of autofluorescence could be the use of 0.1 M 
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glycine solution, applied overnight. With that in mind a number of techniques (e.g. photo-
bleaching using Hydrogen Peroxide or air dried and exposed to UV light prior to staining) 
(Luquin et al., 2010) were attempted but not successful in eliminating this auto-fluorescence. 
For this reason the experimental process moved away from fluorescent antibody reporters to a 
more traditional colourimetric analysis for CD24 and CD61 and as a result of this, further 
image analysis has taken place utilizing the MetaMorph Image analysis software.  
 
2.6.5.1 CD24 – Stem/progenitor cell marker 
Number and localisation of CD24-positive cells within the biopsied mammary tissues 
In an effort to investigate the location and prevalence of the CD24 antigen within bovine 
mammary tissue sections, a series of histological sections were analysed from three stages of 
lactation (late pregnancy, peak lactation and involution). Despite working through a number 
of commercially available anti-CD24 antibodies, a custom bovine reactive CD24 antibody 
(Auspep) was acquired. The use of this antibody, within a colourimetric analysis system, 
showed low levels of CD24 expression at all three stages analysed (Figure 2.20). There was 
an observed decline in the already low levels of CD24 expression across the lactation cycle - 
the highest was seen in late pregnancy with the lowest seen in involution. It should be noted 
that this work was also designed to test and identify a bovine reactive anti-CD24 antibody for 
use in further sorting studies (Chapter 3). The investigation of the CD24 molecule in systems 
such as human breast cancer stem cells (Al-Hajj et al., 2003) has developed into the use of 
this surface marker for isolating normal stem cells from mammary tissues of mice (Sleeman et 
al., 2005). The authors described the use of CD24 to isolate side populations of mammary 
gland cells for transplantation into mammary fat pads for repopulation assays (Sleeman et al., 
2005). Therefore CD24 is considered an appropriate marker for the isolation of mammary 
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stem/progenitor cells (Rauner and Barash, 2012). It should be noted that the work completed 
by Rauner and Barash was performed on cells isolated from the mammary glands of 7-10 
month old heifers (Rauner and Barash, 2012). 
 
The basal cell type is associated with a CD24- population expressing a medium level of CD24 
(Rauner and Barash, 2012). The bovine mammary stem cell population has been associated 
with high levels of CD24 expression when combined with a CD49f negative population 
(Rauner and Barash, 2012). However in studies of murine cells, low CD24 expression in a 
population of mammary cells was associated with the greatest repopulation capacity in 
repopulation assays (Sleeman et al., 2005). This could be an interesting future direction 
should the CD24 molecule prove effective at generating side populations of putative bovine 
mammary stem/progenitor cells.  
 
2.6.5.2 CD61 – Progenitor cell marker 
The CD61 positive population of mammary cells is a known progenitor cell population in 
mice models of mammary gland function (Oakes et al., 2007). The use of CD61 in 
conjunction with CD24, CD29 and CD49f are the most commonly used markers for the 
isolation of mammary stem cell populations from mammary gland cell suspensions (Kaimala 
et al., 2012). Colourimetric analysis and light microscopy was used to identify the locations of 
CD61 positive cells in the tissues analysed.  
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Location of CD61 positive cells within the biopsied mammary tissues 
The investigation of the CD61 antigen in the bovine mammary tissue sections of this chapter 
revealed low levels of positive cells (Figure 2.22). Similar to CD24, there was a decline 
observed with the highest level in peak lactation tissues and the lowest level in involuting 
tissues. For a marker that is associated with mammary progenitor cells in other species 
(Visvader, 2009), this is an interesting observation in cows. The low levels of this marker may 
indicate that the cells that are positive for CD61 are indeed rare cells, such as progenitor cells, 
within the mammary tissue.  
 
The location of cells exhibiting CD61 (as seen in Figure 2.21) suggests that these cells may 
not be in the stromal areas as seen in the studies of progenitor cells in other species (Visvader, 
2009). Nonetheless, the distance for migration should be considered as it is short enough for 
the possibility of daughter cells to migrate and integrate into mammary epithelial layers of the 
alveoli. The differences in the location of CD61 positive cells in tissue sections between 
species may be explained due to differences in the post birth development of the mammary 
gland. Specifically, mice have a terminal end bud during cell division and alveolar 
development into the mammary fat pad (Kenney et al., 2001), a phenomenon not observed in 
the development of the cow mammary gland (Choudhary, 2014). 
 
The staining in these images is also poorly visualised in this format (Figure 2.21) but is 
identified with reasonable efficiency by the automated counting software (when compared to 
the manual counting process). It has been shown in humans that CD61 positive cells are 
associated with a bipotent luminal progenitor phenotype (Tao et al., 2015) and are part of the 
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luminal lineage of mammary gland cells (Rios et al., 2014). This work in humans and mice 
led to the addition of CD61 detection to the target subpopulation of cells hypothesised to be 
putative bovine mammary progenitor cells. This population of putative bovine mammary 
progenitor cells (CD24+/CD29+/CD61+) will be used for further studies in subsequent 
chapters of this thesis (functional analysis in Chapter 3 and transcriptomic analysis in Chapter 
4). 
 
Cytodynamics of CD61 Positive Cells within the biopsied mammary tissues 
The expression of CD61 on cells in mouse tissues is associated with progenitors moving 
towards a luminal cell fate (Visvader, 2009). In experiments using virgin mammary glands of 
mice, the CD61 molecules has been shown to label close to 30 % of the ductal luminal cells 
(Asselin-Labat et al., 2007, Visvader, 2009). The numbers seen in Figure 2.22 are much lower 
than these reported values. The differing levels of CD61 could be contributed to the two 
different species. In addition, these differences may also be due to the timing of the biopsies 
performed on the bovine tissue. In this chapter, the bovine tissue used was from cows 
undergoing a second pregnancy with the mice investigated in Asselin-Labat et al. (2007) and 
Visvader (2009) were experiencing their first pregnancy. Overall, to understand the cycling of 
CD61 it is possible that due to the requirements of lactation, the number of luminal 
progenitors is reduced and therefore the CD61 positive cells in the bovine mammary tissue 
are expected to be lower (Huh et al., 2015).  
 
  
 121 
PART C 
Fluorescence detection of putative stem and progenitor marker positive 
cells in late pregnancy, peak lactating and involuting bovine mammary 
tissue 
2.6.6 Fluorescent detection of cell surface markers to determine the potential 
presence of putative stem/progenitor cells on bovine mammary tissue at 
three different stages of lactation 
The use of fluorescently labelled cell surface marker detection has the principal advantage of 
reducing the time to perform the assay in histology systems (Coutlee et al., 1989). In addition, 
multiple cell surface markers in a single histological slide are possible using fluorescence 
imaging incorporating fluorophores that have divergent emission wavelengths. As outlined 
previously, the fluorescent labelled antibodies could not be applied to the CD24, CD61 and 
Ki-67 surface marker detection due to the presence of inherent tissue autofluorescence. 
Fluorescence detection of CD29 and CD49f markers was performed (Figure 2.29) for the 
three stages of lactation. The cell numbers and antibody positive cells were enumerated with 
the Imaris software, MetaMorph software and through manual counting. 
 
2.6.6.1 CD29 – Mammary stem/progenitor cell marker 
Number and dynamics of CD29 positive cells within the biopsied mammary tissues 
High levels of CD29 were exhibited in sorted cell experiments in humans and mice are 
associated with mammary stem cells (Huh et al., 2015, Asselin-Labat et al., 2010). Generally 
this marker is combined with CD49f ± CD24 in the cell suspension sort ing protocols (Britt et 
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al., 2009, Cremers et al., 2010, dos Santos et al., 2012, Kaenel et al., 2014, Kaimala et al., 
2012). When viewing the CD29 data seen in Part C (Figure 2.25), it is evident that a 
significant number of total cells are also CD29 positive. This is cons istent between manual 
and automated cell counts (2 different software analyses, Imaris and MetaMorph). The CD29 
marker may persist, but in combination with the other markers used it still proved to be a 
useful marker (discussed later). While there is an increase during lactation and a marked 
decline in total cell number in the images analysed, there are similar patterns of CD29 
expression within the tissues. For instance, the decline in CD29 expression during involution 
is greater than accounted for by the decline in total cell number observed. Importantly this 
observation occurred for all tissues from the 5 animals studied (Figure 2.25). It is possible that 
the expression of CD29 in these tissue sections is indicative of potential mammary stem cells 
similar to work in mice (Kaanta et al., 2013). However, further research is required to fully 
understand the role of CD29 positive cells relative to mammary stem cells.  
 
2.6.6.2 CD49f – Mammary stem cell marker 
Number and dynamics of CD49f positive cells within the biopsied mammary tissues 
The number and location of CD49f positive cells in bovine mammary tissue sections was 
investigated from the three stages of lactation (late pregnancy, peak lactation and involution). 
There was a decrease in detection of positive cells observed (Figure 2.27) at peak lactation, 
where the cell architecture of milk production would be at full development. This tissue has a 
greater number of cells, and thus a greater portion of cell-to-cell interactions to maintain the 
tissue structure (Glukhova and Streuli, 2013). When the mammary gland moves to the 
involution phase after the cessation of milking, the cells of the milk producing architecture are 
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recycled, this would lead to the decreased levels of cell to cell interactions (Choudhary, 2014, 
Glukhova and Streuli, 2013); this was observed in Figure 2.27.  
 
The CD49f surface marker participates in the laminin-1 receptor pathway and is associated 
with the basal cells of the mammary gland (Cravero et al., 2015). The detection of the CD49f 
molecule at high levels in subpopulations of cells is associated with adult mammary stem 
cells and myoepithelial cell progenitors (Eirew et al., 2008, Stingl et al., 2006). The 
expression of the CD49f molecule has been shown to increase in cultured primary bovine 
mammary cells (Cravero et al., 2015) in both ALDH1 positive and negative populations 
(ALDH1+ being associated with luminal progenitors with limited or no regenerative potential) 
(Cravero et al., 2015, Eirew et al., 2008). This might be an interesting avenue to explore in 
future work to identify bovine mammary stem/progenitor cells. As observed with CD29, there 
is a clear difference in the pattern of expression of CD49f between different stages of the 
lactation cycle (Figure 2.27). Although similar to CD29 the CD49f marker may persist, but in 
combination with the other markers used it still proved to be a useful marker (discussed later). 
While the total cell number is comparable to that seen for CD29 (Figure 2.25) with a slight 
increase in cell number per unit area during lactation, the average number of CD49f positive 
cells declines from late pregnancy through lactation and there is a more observable decline 
during involution. This result corresponds with the current knowledge about the reduction of 
cell-to-cell connections during the regenerative involution phase of bovine mammary gland 
lactation (Capuco et al., 2012).  
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2.6.7 Combined graph of surface antigens – CD24, CD29, CD49f and CD61 
From the combined data presented in Figure 2.30, it is evident that for most cell-based 
markers previously associated with mammary stem cells in other species (CD24, CD29, 
CD49f & CD61), there is an increase in the number of cells presenting those markers during 
peak lactation when compared with both pregnancy and involution. There is also an 
observable decline in all markers in bovine mammary tissue cells during involution compared 
to the lactating physiological states. When compared to the apoptosis and Ki-67 (proliferation 
data shown in Figure 2.17) as well as reviewing total cell number quantified from the various 
immunohistochemical analysis of tissues (Figure 2.30), the observed changes in 
immunophenotype markers during involution may be impacted by the decline in total cell 
number per unit area which is, in turn, a product of declining proliferation and increased 
observed apoptosis per unit area of tissue. The high numbers of some markers could be due to 
the persistence of these markers in the daughter cells, rather than retaining their ‘stemness’.  
 
Within a 24 hour period, it has been estimated that 0.3 % of the cells in a lactating mammary 
gland undergo proliferation (Capuco et al., 2002a). A study of the mammary cell numbers 
during goat lactation showed increases in cell number and then a subsequent increase in 
mammary cell activity and production (Knight and Peaker, 1984). This differs from dairy 
cattle where cell number declines but cell activity increases at peak lactation (Capuco et al., 
2001). For both species, the decline in milk production at the end of lactation corresponds 
with a decline in mammary cell number and activity (Capuco et al., 2001, Knight and Peaker, 
1984). The lower numbers of cells in the mammary gland later in the lactation cycle, 
particularly during involution, was also observed in the work on apoptotic cells in tissue 
sections (Figure 2.15). This seems to fit with the notion of regenerative involution, where the 
 125 
milk producing architecture and cell to cell interactions is recycled to prepare for the next 
lactation phase (Choudhary, 2014).  
 
While the aim of this part of the project was to identify the histological location of putative 
bovine mammary stem cells exhibiting the cell surface markers CD29, CD49f and CD24, as 
well as putative bovine mammary progenitor cells exhibiting the cell surface markers CD29, 
CD24 and CD61, it was not possible under these conditions to specifically localise and 
enumerate these cell types. Although the abundant cell surface markers of CD29 and CD49f 
were able to be visualised using fluorescence microscopy, the less abundant markers CD24 
and CD61 were not visible due to tissue autofluorescence and an alternative strategy of 
colourimetric histological observations of single marker localisation and enumeration were 
used. It is also possible that the age of the samples contributed to the levels of 
autofluorescence in the resulting sections although, based on the literature, the 
autofluorescence should decrease as the tissue degrades (Monici, 2005). Unfortunately this 
meant that the fluorescent labelled antibody approach was not utilised to identify cells that 
were expressing the combinations of cell surface markers (such as those demonstrated by 
FACS in Chapter 3). There may be a number of reasons why the fluorescent methodology 
was expressed on fewer cells and might include: a) potential decreased sensitivity for the 
cryosection labelling approach although fluorescent reports are typically considered as more 
sensitive than colourimetric analysis (Coutlee et al., 1989), or b) direct fluorescent labelling of 
antibodies targeted toward the markers limited the scope to alter sensitivity in comparison to 
the colourimetric detection technique which utilised a primary antibody (targeted to the 
marker) and a secondary antibody labelled with an enzyme. The multi- layered detection 
approach (colourimetric) allows for the optimisation of each step to enhance sensitivity. The 
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antibody preparations for the detection of CD24 in particular, may also have impacted on the 
ability to detect this marker histologically. Another reason why the first approach of 
fluorescent detection may not have been successful is that paraffin embedded sectioning 
methodology also included an antigen retrieval step which is designed to alter the antigenic 
components of proteins. This step may have allowed access to antigens that was not possible 
with cryosectioning. Overall, the methods described above, may represent the first study of 
this nature using a bovine specific CD24 antibody.  
 
2.6.8 Dual labelled CD29 and CD49f bovine mammary tissue at the three stages of 
lactation 
The ability to perform dual labelling was technically challenging and necessitated the 
development of additional methods including different tissue fixation, tissue cutting, and 
staining and analysis methodologies. These methods have provided a clearer view of the cell 
cytodynamics and localisation of mammary stem cell surface markers on the bovine 
mammary tissue (Figure 2.28). While recently there have been similar studies in mammary 
tissue from heifers (Rauner and Barash, 2012), the current project is still the most 
comprehensive analysis of cellular cytodynamics in lactating bovine mammary tissue. 
Importantly, using colourimetric detection systems meant that each section could only be 
stained for a single marker which has limited the utility of this approach in identifying cells 
that exhibited all three cell surface markers of interest - either CD49f, CD29 & CD24 for 
‘stem cells’ or CD29, CD24 & CD61 for ‘progenitors’ cells. These cells are defined as cells 
that are not true stem cells yet still are undifferentiated and have some proliferative potential 
(Choudhary, 2014). 
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The images shown in Part C were subsequently analysed using Imaris® (Bitplane) image 
analysis software. This worked very well for CD49f and CD29 (CD24 and CD61 were 
undetectable due to background auto-fluorescence).  
 
Number and dynamics of dual-labelled positive cells within the biopsied mammary tissues 
The decline in total cell number during involution is not as defined as seen in the Imaris® 
image analysis. This is likely due to the randomly selected fields analysed and reinforces that 
the decline in CD29 and CD49f expression in cells during involution is not simply an artefact 
of the total cell number per area changes. The fundamental importance of these observations 
reinforces the theory that any intervention that could facilitate prolonged proliferation or 
inhibit rate of apoptosis over the lactation cycle may also impact the productive potential of 
the bovine mammary gland (Capuco et al., 2012). Investigating such interventions are beyond 
the scope of the current project, however there have been studies demonstrating the utility of 
hormonal intervention in changing the behaviour of progenitor cell populations (Booth et al., 
2010, Booth et al., 2007, Joshi et al., 2010). Other strategies that have been trialled include 
inducing pluripotency (Takahashi and Yamanaka, 2006) and manipulating a number of 
differentiation and proliferation regulatory pathways such as NOTCH, p53, Wnt, BRCA1, 
Pten, p63 and p21 (Dontu et al., 2003, Lindvall et al., 2006, Liu et al., 2008, Sherley, 2002). 
 
2.6.9 Identifying putative mammary stem cells in bovine mammary tissue using 
CD24, CD29 and CD49f 
A combination of CD24, CD29 and CD49f cell surface markers may identify putative 
mammary stem cells (Rauner and Barash, 2012). At this point, these markers were only 
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viewed individually, or in the case of CD29 and CD49f, as co-expressed (due to the use of 
fluorescent markers). Unfortunately, colourimetric analysis (CD24 and CD61) was not 
compatible with multiple marker analysis.  
 
The localisation of CD29 staining is predominantly away from the epithelial layers of the 
differentiated mammary epithelial cells which surround the alveoli in lactating mammary 
tissue (Figure 2.24). This is in contrast to many of the other markers which are closely 
associated with mammary alveoli. This is potentially an important observation in that it 
differs in location from those cells stained positively for Ki-67 which is a marker of 
proliferation and has been used by other researchers as an indication of putative mammary 
stem cells (Capuco et al., 2008). It is reasonable however that the labelling of all 3 markers 
CD49f, CD24 and CD29 may still localise in close proximity to the basal area of the 
mammary alveoli.   
 
The combination of these markers would be ideal for elucidating the location of 
stem/progenitor cells within the investigated tissue section. Based on previous studies, an 
approximate location have identified lightly staining epithelial cells that have been found in 
mammary tissue section in cattle (Ellis et al., 2000), goats (Li et al., 1999), mice and rats 
(Chepko and Smith, 1999, Smith and Medina, 1988), and canines (Ferguson, 1985). Light 
cells have been shown to comprise as much as 10 % of the parenchymal cell mass (Capuco et 
al., 2003). 
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There is reasonable similarity between the cows (indicated by small error bars) in relation to 
the expression levels of these markers between tissues biopsied from the different stages of 
the lactation cycle (Table 2.1). The specific location of cells labelled as positive for various 
markers also needs consideration as the specific localisation of mammary stem cells within 
the tissue is still up for debate. The prevailing theory is that mammary stem cells are closely 
associated with mammary alveoli (Capuco, 2007). This is evident for Ki-67 (proliferating) 
positive cells and CD49f and CD29 dual- labelled cells. The CD24 and CD61 labelled cells 
are not as closely associated with the mammary alveoli and may be that either the level of 
expression on cells that are adjacent to the alveoli is low, that the antibody used is not 
detecting the marker with efficiency or specificity or that these markers may not have the 
same utility in the cow as they do in mouse and human studies. It has been suggested by 
studies in mice that CD24 plays a role in ductal morphogenesis more so than stem cell 
determination although the authors do acknowledge CD24 is still expressed in epithelium 
compartments where stem cells are thought to be localised (Cremers et al., 2010). The 
addition of a late lactation sample would also have been valuable to support the observations 
of changes in cellular cytodynamics across lactation.  
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2.7 Conclusion          
The aim of this chapter was to identify potential bovine mammary stem and progenitor cell 
markers in histological sections at the three stages of lactation (late pregnancy, peak lactation 
and involution). The tissue integrity of biopsy samples was determined using H&E staining. 
The tissue biopsies were shown to be intact and consist of a histological arrangement similar 
to previous reports with distinct alveolar structures present during late pregnancy and peak 
lactation; alveolar structure was not present during involution. The CD markers, CD29, 
CD49f and CD61, used in this study are reactive with other species and have a known cross-
reactivity with bovine; these antibodies to these markers were successfully shown to bind to 
cells of the bovine mammary tissue. The putative stem cell surface markers CD24 was 
identified by colourimetric analysis throughout the stroma of the bovine mammary tissue and 
in close association with the basal layer of the alveoli particularly during late pregnancy and 
peak lactation. The putative progenitor cell marker CD61 was also identified by colourimetric 
analysis throughout the bovine mammary tissue stroma for all three stages of lactation. Low 
levels of these markers were observed and could be a function of the analysis method 
(colourimetric). Fluorescence analysis of CD29 and CD49f identified these markers to also 
reside in the stroma of the bovine mammary tissue with CD49f lining the basal layer of the 
alveoli. Involuting tissue exhibited the loss of alveolar structure but distribution of these CD 
markers throughout the stroma. Co-localisation analysis of these two markers showed the 
majority of co-localisation in the stroma of the tissue regardless of the lactation stage. Being 
integrins, the location of CD markers CD29, CD49f and CD61 could potentially indicate a 
structural role for these cells during lactation and involution in the bovine mammary gland. 
The integrin-associate role of CD24 also indicates a potential role in the structural 
arrangements and activities of the mammary tissue. Further activity of the bovine mammary 
tissue was evaluated by apoptotic and proliferating assays. Colourimetric analysis of apoptotic 
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and proliferating cells identified an inverse relationship with increased levels of apoptotic 
cells as the lactation progressed relative to decreasing numbers of proliferating cells. This 
result indicates an active cell turnover within the bovine mammary gland. 
 
The work completed in this chapter was also helpful in the assessment of antibodies in a 
bovine system form the basis of the next chapter. These antibodies will be utilised in 
conjunction with primary cultures of bovine mammary epithelial cells and FACS to isolate 
and enumerate a population of putative bovine mammary stem and progenitor cells for 
functional analysis.   
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Chapter 3  
Use of Cultured Primary Bovine Mammary 
Epithelial Cells to Isolate Putative Stem & 
Progenitor Cells using Fluorescence Activated 
Cell Sorting  
3.1 Introduction           
The cell surface markers CD24, CD29, CD49f and CD61 have been used to isolate putative 
mammary stem and progenitor cells from mammary glands (dos Santos et al., 2012, Rauner 
and Barash, 2012). The combinations of CD24, CD29, CD49f and CD61 have been 
investigated in mouse models and human mammary tissues studies (Rauner and Barash, 2012, 
Shackleton et al., 2006, Stingl et al., 2006). In this chapter, these cell surface markers were 
used to isolate putative stem/progenitor cells from epithelial cell populations isolated from 
late pregnancy bovine mammary biopsied tissues. One important factor in the following work 
was the use of a magnetic bead depletion step to remove the lineage committed cells prior to 
FACS. The markers utilised for lineage depletion (magnetic separation step) are known 
markers for hematopoietic, endothelial and fibroblast markers (CD45, TER119, CD31 and 
BP-1) (Lawson et al., 2007). Other antibody mediated protocols for the isolation of murine 
mammary progenitor cells incorporate the use of CD61 into the mouse mammary hierarchy 
(Vaillant et al., 2008). This marker was used in combination with CD24 and CD29 to separate 
a population of putative mammary progenitor cells.  
 
The removal of lineage committed cells (Lin-) to enrich stem/progenitor cell populations was 
performed prior to investigating the hypothesised marker combinations in this chapter. The 
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four markers were isolated using FACS in the combinations of CD24, CD29 and CD49f 
(putative bovine stem cells), and CD24, CD29 and CD61 (putative bovine progenitor cells). 
The functional evidence for the presence of putative stem and progenitor cells was elucidated 
by proliferation analysis and mammosphere formation potential. The analysis of proliferation 
investigates the self-renewal potential of the cells and is designed to show which population 
has the greatest self-renewal potential. A greater self-renewal potential would lead to an 
increase in the number of cells in culture relative to control cells over a defined period of 
time.  
 
In this chapter, the investigation of the potential for mammosphere formation was performed 
as an indirect measure of differentiation capacity for stem/progenitor cell function through the 
use of anchorage-dependent conditions (Dey et al., 2009, Dontu et al., 2003, Lan et al., 2007, 
Reynolds and Weiss, 1992). It has been shown that the formation of multicellular spheroids 
that have variable characteristics, such as size, depend on the initial population used (Dey et 
al., 2009).  
 
3.2 Aims            
To isolate and investigate the proliferative capacity and mammosphere formation efficiency 
of putative stem and progenitor cell side populations of bovine mammary epithelial cells 
isolated from bovine mammary tissue biopsied in late pregnancy. 
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3.3 Objectives           
 To develop a method to isolate populations of putative mammary stem cells from 
bovine mammary epithelial cells in suspension using the markers CD24, CD29 and 
CD49f and FACS. 
 To develop a method to isolate populations of putative mammary progenitor cells 
from bovine mammary epithelial cells in suspension using the markers CD24, CD29 
and CD61 and FACS. 
 To develop a method to determine the functional proliferative capacity of putative 
bovine mammary stem/progenitor cell side populations. 
 To develop a method to determine the functional mammosphere formation capacity as 
an indirect measure of differentiation capacity of putative bovine mammary 
stem/progenitor cell side populations. 
 
3.4 Materials and Methods         
3.4.1 Animals using for mammary tissue biopsies 
For this chapter, mammary tissue samples were used to establish a primary mammary 
epithelial cell culture to isolate putative stem/progenitor cells. Samples were collected as 
outlined in Chapter 2, section 2.4.1 and processed as outlined below in section 3.4.2 - 3.4.5. 
Details are presented in Table 3.1.  
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Table 3.1 Details of the biopsy sampling and cows used to establish a primary 
mammary epithelial cell culture. 
Cow ID Late Pregnancy 
Biopsy 
Details of Previous Lactation Previous lactations 
at sampling 
6441 
(Cow 1) 
20 days prior to 
calving 
321 days in lactation. 
Produced 10,165 L of milk (5.17 % 
fat & 3.03 % protein)  
5 
6525 
(Cow 2) 
16 days prior to 
calving 
363 days in lactation. 
Produced 7,907 L of milk (5.13 % fat 
and 3.19 % protein) 
3 
6669 
(Cow 3) 
6 days prior to 
calving 
374 days in lactation. 
Produced 8,296 L of milk (4.08 % fat 
and 3.21 % protein) 
3 
 
3.4.2 Primary bovine mammary epithelial cell isolation from biopsied bovine 
mammary tissues. 
Mammary biopsies were taken from multiparous Holstein-Friesian cows as previously 
described (Sheehy et al., 2004) and outlined in Chapter 2, section 2.4.1. Epithelial cells were 
isolated from the biopsied mammary tissue as described previously in Riley et al. (2008). The 
weight of the tissue was recorded, followed by maceration with scissors. This was followed 
by incubating the sample in 10 mL g-1 predigest medium [1 × HBSS, 1 × minimal essential 
medium (MEM), 5.5 mM-glucose, 4 % bovine serum albumin, 20 μM-CaCl2, 20 μM-MgSO4, 
5_mM-4-(2-hydroxyethyl) piperazine-1-ethanesulphonic acid (HEPES), 200 μM-glutamine, 
10_U mL-1 penicillin/10 μg mL-1 streptomycin, 10 μg mL-1 kanamycin, 250 ng mL-1 
Fungizone, 1 μg mL-1 insulin, 1 μg mL-1 cortisol, 50 U mL-1 DNase I (Roche Molecular 
Biochemicals) pH 7.4] at 37 °C for 10 min at 200 rpm in a shaking incubator (Benchmark 
Incu-shaker Mini, Edwards Instrument Company, Australia). Media was aspirated and 
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replaced by digest media [predigest media + 200 U mL-1 collagenase Type II (CLS-2, 
Worthington Biochemical Corp., USA) 250 U mL-1 hyaluronidase (106500, Roche Life 
Sciences, USA )] and incubated at 37 °C, at 225 rpm for 2 h in a shaking incubator. Digested 
tissue was filtered through a 150 μm nylon mesh. Retained tissue was further incubated in 
fresh digest media until digested. The filtrate was centrifuged (5810, Eppendorf, Austra lia) at 
200 xg for 5_min and the cell pellet was washed three times in 20 mL wash media (1 × 
HBSS, 1 × MEM, 5.5 mM-glucose, 20 μM-CaCl2, 20 μM-MgSO4, 5 mM-HEPES, 2 mM-
glutamine, 100 U mL-1 penicillin/100 μg mL-1 streptomycin, 100 μg mL-1 kanamycin, 
2.5_μg_mL-1 Fungizone, 100 U mL-1 DNase I, 100 μg mL-1 trypsin inhibitor, 5 μg mL-1 
insulin, 1 μg mL-1 cortisol, pH 7.4). The final wash was filtered through a 50 μm nylon mesh 
and the filtrate centrifuged at 200 xg for 5 min. The cell pellet was resuspended in 2.5 mL 1 × 
HBSS and overlayed onto a 17.5 mL 1.01–1.07 g mL-1 Percol-Ficoll step gradient with 
2.5_mL of each density fraction constructed using a 2.5 mL syringe and 19 gauge needle. The 
components of each layer are shown in Table 3.2.  
Table 3.2. Components of each density layer of the Percoll-Ficoll gradient used for cell 
isolation. 
Density 
(g mL-1) 
Percoll 
(mL) 
Water 
(mL) 
Ficoll 
(mL) 
Hepes 
(mL) 
M199 
(mL) 
BSA 
(mL) 
1.01 0.62 12.38 2.0 1.0 2.0 2.0 
1.02 2.16 10.84 2.0 1.0 2.0 2.0 
1.03 3.70 9.3 2.0 1.0 2.0 2.0 
1.04 5.24 7.76 2.0 1.0 2.0 2.0 
1.05 6.75 6.25 2.0 1.0 2.0 2.0 
1.06 8.32 4.68 2.0 1.0 2.0 2.0 
1.07 9.84 3.16 2.0 1.0 2.0 2.0 
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3.4.3 Cryopreserving bovine mammary epithelial cells  
The gradient was centrifuged at 800 xg for 20 min. The BMEC were subsequently collected 
from the 1.03/1.04 density layers and washed in 20 mL of 1 × HBSS. Cells were then 
resuspended in 1 mL of a 50:50 mixture of DMSO (D8418, Sigma-Aldrich, Australia) and 
proliferation media. This cell suspension was transferred to a Greiner Cryovial (V6010, 
Sigma-Aldrich, Australia) and placed in an insulated container and stored at -80 °C (Revco 
Scientific Inc. ULT1386-39) for 12 h prior to transfer to liquid nitrogen for storage until 
further use.   
 
3.4.4 Thawing cryopreserved bovine mammary epithelial cells  
The bovine mammary epithelial cells were thawed in a 37 °C water bath (WB.2, Thermoline, 
Australia) and placed in a 15 mL centrifuge tube (Falcon™, 352097, Interpath Services, 
Australia) containing 8 mL of pre warmed BMEC proliferation media (Dulbecco's Modified 
Eagle's Medium/Nutrient F-12 Ham (D8900, Sigma Aldrich) supplemented with 1.2 g L-1 
sodium bicarbonate (S5761, Sigma Aldrich), 100 U mL-1 penicillin and 100 mg mL-1 
streptomycin (P4458, Sigma-Aldrich), 25 µg mL-1 Amphotericin B (A2942, Sigma-Aldrich), 
5 mg mL-1 Insulin (I6634, Sigma-Aldrich), 1 mg mL-1 Cortisol (H0888, Sigma-Aldrich), 
10_ng mL-1 epidermal growth factor (E4127, Sigma-Aldrich), pH 7.4). The centrifuge tube 
was inverted repeatedly before centrifugation at 124 xg for 5 min. Following this, the 
supernatant was discarded and the pellet resuspended in 1 mL of bovine mammary epithelial 
cell proliferation media before being transferred to a T75 flask (Falcon™, 658170V, Interpath 
Services, Australia) containing 15 mL of bovine mammary epithelial cell proliferation media. 
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The cells were then incubated at 37 °C in 5 % CO2 in a Thermo Scientific incubator (3120, 
Thermo Fisher Scientific, Australia).  
 
3.4.5 Passaging of bovine mammary epithelial cells 
The proliferation media was gently removed by pipette after 2-3 days when the BMEC 
cultures reached 75-80 % confluence. The attached cells were washed once with 10_mL of 
pre-warmed Dulbecco’s Calcium and Magnesium free PBS (D8537-1L, Sigma-Aldrich, 
Australia). The PBS was then removed by pipette and 5 mL of 0.05 % Trypsin/EDTA 
solution (59417C, Sigma-Aldrich, Australia) was added to the flask. This was placed in an 
incubator at 37 °C in 5 % CO2 for 10 min. Following this, the flask was agitated and the cells 
were inspected under a microscope (CKX31, Olympus, Australia) to ensure detachment. Once 
detachment was observed, 5 mL of pre-warmed BMEC proliferation media was added to the 
flask and the cell layer was repeatedly washed using a pipette. This was to ensure maximum 
detachment. If the cells were to be further expanded, the resulting cell suspension was divided 
1 in 3 into fresh T75 flasks containing 15 mL of pre-warmed BMEC proliferation media 
before being placed in an incubator at 37 °C in 5 % CO2.  
 
3.4.6 Staining of bovine mammary epithelial cells for Fluorescence Activated Cell 
Sorting analysis  
The starting numbers of bovine mammary epithelial cells used for isolation by FACS are 
outlined in Table 3.3. 
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Table 3.3 Starting total cell number for the isolation of putative stem cells (Lin-
/CD24+/CD29+/CD49f+) and putative progenitor cells (Lin-/CD24+/CD29+/CD61+) 
from bovine mammary epithelial cells by subsequent FACS. 
Cow No. Starting Cell Number Passage 
Number 
Putative Stem Cell 
isolation 
Putative Progenitor Cell 
isolation 
6441 (Cow 1) 5,100,000 8,075,000 4 
6525 (Cow 2) 24,037,500 16,228, 000 5 
6669 (Cow 3) 21,075,000 39,075,000 5 
 
The total cell number and viability of the cultured bovine mammary epithelial cells were 
determined using trypan blue (T8154-100ML, Sigma-Aldrich, Australia) by mixing 10 µL of 
trypan blue and 10 µL of cell suspension. The 20 µL mixture was placed on the two chambers 
of the Neubauer haemocytometer and counted using the Olympus light microscope (CKX31, 
Olympus, Australia) at 100X magnification.  
 
Two bovine mammary epithelial cell populations were labelled for isolation with 
fluorescently labelled antibodies to cell surface markers: 1) Lin-/CD24+/CD29+/CD49f+ 
(putative stem cell populations, and 2) Lin-/CD24+/C249+/CD61+ (putative progenitor cell 
populations). The isolation of cells from bovine mammary primary culture was performed 
using the EasySep™ Mouse Mammary Enrichment Kit (19757, StemCell Technologies, 
Australia). A concentration of 1x108 cells/mL-1 of primary cell suspension was prepared. To 
this solution, 200 µL of Mouse Epithelial Cell Enrichment Cocktail was added. The 
antibodies in this solution targeted Lin+ cells (non-epithelial cells positive for antibodies: 
CD45, CD31, TER119, BP-1). This mix was incubated for 15 min on ice. Following this, 
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50_µL of EasySep™ Magnetic Nanoparticles was added to the solution and the mixture was 
incubated for a further 15 min on ice. These particles bind to the Lin+ antibody cocktail to 
facilitate removal of Lin+ cells.  
 
Once the incubation was completed, the solution was pipetted through an LS column (130-
042-401, Miltenyi Biotech, Australia) within a magnetic MidiMACSTM Separator (130-042-
302, Miltenyi Biotech, Australia) attached to a MultiStand (130-042-303, Miltenyi Biotech, 
Australia). This process isolated the magnetic particles that have bound to the Lin+ antibody 
cocktail in turn, bound to Lin+ cells. The flowthrough (Lin-) cells were collected and 
processed further. The Lin- cells were subjected to co- incubation with 3 antibodies. For 
putative stem cell populations: CD24 – PE labelled (included in kit), CD29 – FITC (11-0299-
42, Jomar Biosciences, Australia) labelled and CD49f – Pacific Blue labelled (included in 
kit). For putative progenitor cell populations: CD24 – PE labelled, CD29 – FITC labelled and 
CD61 – Pacific Blue (555754, BioLegend, Australia) at a final concentration of each antibody 
of 1 in 100 (optimised- data not shown). Non-specific binding in cell suspensions was assayed 
using isotype controls for CD24, CD49f and CD61 as per Chapter 2, section 2.4.12. The 
antibodies were added the solution, mixed by inversion and incubated on ice for 5 min. 
Following this incubation, the cell suspension was centrifuged at 350 xg for 5 min (5810, 
Eppendorf, Australia). The supernatant was removed and the cells resuspended in stain buffer 
(FBS) (554656, BD Pharmingen, Australia) prior to flow cytometry.  
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3.4.7 Isolation of putative stem and putative progenitor cells from bovine 
mammary epithelial cells using fluorescence activated cell sorting 
Flow cytometry was conducted on a BD FACScanto II using the following voltage settings 
for each analysis: 405 nm at 100 mW (Pacific Blue), 488 nm at 200 mW (FITC) and 561 nm 
at 150 mW (PE). Data was collected and analysed using BD FACSDiva Software Version 
6.1.3 (Build 2009 05 13 13 29). The cell populations isolated were Lin-
/CD24+/CD29+/CD49f+ (putative stem cells) and Lin-/CD24+/CD29+/CD61+ (putative 
progenitor cells).  
 
The cells were initially sorted by shape (1:1 ratio of forward scatter to side scatter to ensure 1 
cell per droplet) for all cell populations including the control cell populations.  
 
The collection tubes and cell samples were maintained at 4 °C during storage and collection. 
The control cell populations were cells that were treated under the exact conditions as the 
putative stem/progenitor populations. These cells were run through FACS and collected in the 
same manner at the putative stem/progenitor cells without the gating strategy applied. 
Essentially these cells were Lin- control cells that were not selected for the marker 
combinations that were under investigations. For putative stem cells, CD49f+ cells were gated 
then cells positive for both CD24 and CD29 were gated. For putative progenitor stem cells, 
CD61+ cells were gated then cells positive for both CD24 and CD29 were gated.  
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Unlabelled cells (control population) were also run through the FACS process without the 
addition of antibodies to ensure the control population differed to the treated population in 
surface markers only.  
 
The cells were sorted into 15 mL centrifuge tubes containing culture media that had been 
stored at 4 °C on ice prior to use. Cells used for RNA extraction (Chapter 4) were centrifuged 
at 350 xg for 5 min (5810, Eppendorf, Australia) the supernatant was removed and the pellet 
resuspended in 700 µL of Buffer RLT (cell lysis buffer, 79216, Qiagen, Australia) containing 
1 µL mL-1 of 2-mercaptoethanol (M6250-10ML, Sigma-Aldrich, Australia). This mixture was 
vortexed then frozen in a container of liquid nitrogen and stored at -20 °C for further use. 
Cells used for proliferation and mammosphere formation assays (following sections) were 
prepared as outlined in sections 3.4.8 and 3.4.9. 
 
3.4.8 In vitro cell proliferation assay of putative stem and putative progenitor cells 
from bovine mammary epithelial cells. 
Initially 10,000 cells per well for the control, sorted putative stem and sorted putative 
progenitor cell populations that had been isolated by FACS were plated in triplicate in a 24 
well plate (662160, Cellstar®, Interpath Services, Australia). These cells were incubated for 7 
days in proliferation media (Riley et al., 2008) with media replaced at 3 days. After 7 days, 
cells were harvested using 1 mL of 0.05 % Trypsin/EDTA per well with a 10 min incubation. 
The cells were placed into a 1.5 mL centrifuge tube (T9661-500EA, Eppendorf®, Sigma-
Aldrich, Australia) and centrifuged at 300 xg (5427, Eppendorf, Australia). The pellet was 
washed with PBS and the cells were counted using trypan blue as outlined in section 3.4.6. 
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3.4.9 In vitro differentiation assay of putative stem and putative progenitor cells 
from bovine mammary epithelial cells 
BD Matrigel™ Basement Membrane Matrix (356234, BD Biosciences, Australia) was used to 
coat the wells of a 24-well plate (353226, Fisher Scientific). Each plate was chilled prior to 
use by resting the plate in a styrofoam box containing 5-7 cm of ice in the base. For each well 
a 75 µL aliquot of BD Matrigel™ Basement Membrane Matrix was added followed by 
spreading with a pipette tip ensuring an even distribution across the bottom of the well. Once 
the BD Matrigel™ Basement Membrane Matrix was evenly distributed, the plate was placed 
in an incubator at 37 °C for 1 hour to set the BD Matrigel™ Basement Membrane Matrix. 
Once completed, 150 µL (50,000 cells) of the control, putative stem and putative progenitor 
cell populations were plated in these treated wells in triplicate, for each population. 
Attachment media (Dulbecco's Modified Eagle's Medium/Nutrient F-12 Ham (D8900, Sigma 
Aldrich) supplemented with 1.2_g L-1 sodium bicarbonate (S5761, Sigma Aldrich), 20 % 
horse serum (H1138, Sigma-Aldrich), 5 % calf serum (F4135, Sigma-Aldrich), 100 U mL-1 
penicillin and 100 mg mL-1 streptomycin (P4458, Sigma-Aldrich), 25 µg mL-1 amphotericin 
B (A2942, Sigma-Aldrich), 5 mg mL-1 Insulin (I6634, Sigma-Aldrich), 1 mg mL-1 cortisol 
(H0888), 10 mg mL-1 transferrin (T8158, Sigma-Aldrich), 1 mg mL-1 bovine prolactin (AFP-
7170E, National Hormone & Peptide Program, USA), pH 7.4) was added to make a total 
volume of 1 mL per well. The cell suspensions were incubated for 24 h in 5 % CO 2. The 
media was changed to differentiation media (Dulbecco's Modified Eagle's Medium/Nutrient 
F-12 Ham (D8900, Sigma Aldrich) supplemented with 1.2 g L-1 sodium bicarbonate (S5761, 
Sigma-Aldrich), 100 U mL-1 penicillin and 100 mg mL-1 streptomycin (P4458, Sigma-
Aldrich), 25 µg mL-1 amphotericin B (A2942, Sigma-Aldrich), 5 mg mL-1 insulin (I6634, 
Sigma-Aldrich), 1 mg mL-1 cortisol (H0888, Sigma-Aldrich), 10 mg mL-1 transferrin (T8158, 
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Sigma-Aldrich), 1 mg mL-1 bovine prolactin (AFP-7170E, National Hormone & Peptide 
Program, USA), pH 7.4) and incubated for 4 days during which mammospheres were formed. 
The media was changed once after 2 days. Five photographs per well were taken at 100X 
magnification. The images were then analysed using a calibrated straight line selection tool in 
the ImageJ software (http://rsbweb.nih.gov/ij/) with 2 axes measured per mammosphere. The 
surface area per mammosphere and total number of mammospheres were determined using 
this software. 
 
3.4.10 Statistical analysis 
Statistical analysis was performed using the analysis toolpak add-in of Microsoft Excel 2010 
(Ver. 14.0.7116.5000, Microsoft, U.S.A.). The mean and standard deviation of mammosphere 
number, size and cell proliferation was calculated. Each mammosphere was measured on two 
axes which were recorded and the area of the mammosphere was calculated using the 
equation (π ∗ r1 ∗ r2) (area of an ellipse calculated as mammospheres are not perfectly 
circular) where r1 = greater radius and r2 = lesser radius and π = 3.14159265358979. 
Statistically significant difference between putative stem/progenitor populations and control 
cells were assessed for mammospheres and proliferation assays using the paired T-Test (2-
tail) (p < 0.05).  
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3.5 Results           
3.5.1 Fluorescence activated cell sorting of putative stem cells  and putative 
progenitor cells isolated from bovine mammary epithelial cell. 
A significant number of cells isolated from the bovine mammary epithelial cell cultures 
exhibited the immunophenotype for putative stem cells markers (Lin-
/CD24+/CD49f+/CD29+) and putative progenitor cells (Lin-/CD24+/CD29+/CD61+). These 
populations ranged from 7 % - 20 % of cells (Table 3.4).  
 
The data presented in Figure 3.1 shows an example of the sorting strategy (FACS) used to 
separate out the putative stem and progenitor populations. Those in Figure 3.1A demonstrate 
the gating for the unlabelled control population. This trend of very few positive cells above 
the established threshold was seen in the isotype control samples (Figure 3.1A). Those 
represented in Figure 3.1B show the shift in sample data points of fluorescence in the blue 
channel (445 nm) in a population labelled with CD49f-Pacific Blue. Those represented in 
Figure 3.1B show the shift within the FITC and PE channels corresponding to CD29 and 
CD24 respectively. 
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A 
 
B  
Figure 3.1. Example of a sorting strategy for the isolation of Lin-
/CD24+/CD49f+/CD29+.  
A) Gates showing cells from unlabelled control samples and B) sample labeled and 
sorted and positive for all three cell surface markers. The y-axis in the graphs of the first 
column is the gradient of CD49f positive cells, column 2 shows the CD24 positive cells 
and the third CD29 positive cells. The x-axis of the first column shows the forward 
scatter, the second and third show further fluorescent comparisons in 561 and 488 nm 
laser channels used for sorting this population. The purple colouration seen throughout 
B series are those events gated positive for CD29. The blue are the events positive for 
CD24. The red events seen in both A and B series are the events gated negative for 
CD49f. 
 
The percentage of initial cell populations that were immunophenotyped as Lin-/CD24+/ 
CD29+/CD49f (putative stem cells) following FACS is shown in Table 3.4. For cow 1 (6441), 
the lineage antibody positive cells (Lin+) were 24 % (these cells were removed),  this reduced 
the number of total cells to 76 % of the initial population and comprised of the 
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immunophenotyped Lin- cells (control cells). The final count of cells that were shown to be 
positive for CD24, CD29 and CD49f was 20 %. For cow 2 (6525), the numbers were 61 % 
Lin- and 11 % positive for CD24, CD29 and CD49f. For cow 3, the Lin- cells were 69 % of 
the population and 7 % of the total cell number was positive for CD24, CD29 and CD49f.  
 
Table 3.4 Percentage of initial cell populations of Lin- (control cells) and 
immunophenotyped Lin-/CD24+/CD29+/CD49f (putative stem cells) following 
Fluorescence Activated Cell Sorting. 
 Cow 1 
(6441) 
Cow 2 
(6525) 
Cow 3 
(6669) 
Lin- 76% 61% 69% 
Triple Positive 20% 11% 7% 
 
The percentage of initial cell populations that were immunophenotyped as Lin-/CD24+/ 
CD29+/CD61 (putative progenitor cells) following FACS is shown in Table 3.5. For cow 1 
(6441), the lineage antibody positive cells (Lin+) were 22 %. The remaining 78 % of the 
initial population with lineage antibody negative cells (Lin-). The final count of cells shown 
to be positive for CD24, CD29 and CD61 was 14 %. For cow 2 (6525), there were 64 % Lin-  
and 12 % positive for CD24, CD29 and CD61. For cow 3, the Lin- cells were 72 % of the 
population and 20 % of the total cell number was positive for CD24, CD29 and CD61.  
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Table 3.5 Percentage of initial cell populations of Lin- (control cells) and 
immunophenotyped as Lin-/CD24+/CD29+/CD61+ (putative progenitor cells) following 
fluorescence activated cell sorting. 
 Cow 1 
(6441) 
Cow 2 
(6525) 
Cow 3 
(6669) 
Lin- 78% 64% 72% 
Triple Positive 14% 12% 20% 
 
3.5.2 Proliferation assay to assess proliferative capacity of control and enriched 
populations of bovine mammary cells 
Figure 3.2 shows the proliferation assay of control and Lin- /CD24+/CD29+/CD49f+ cells 
following 7 days incubation. The initial cell count at seeding for both populations was 10,000 
cells per well with three replicates of each treatment or control group. For cow 1 (6441), the 
mean control cell count after 7 days of culture was 25,900 (± 708.87) compared to the mean 
count for Lin- /CD24+/ CD29+/CD49f+ cells of 39,050 (± 1502.50). The mean control 
population for cow 2 (6525) was 33,450 (± 1969.50) compared to Lin-
/CD24+/CD29+/CD49f+ mean numbers for proliferation of 44,350 (± 1617.87). The mean 
control population for cow 3 (6669) was 34,100 (± 1441.35) compared to Lin-
/CD24+/CD29+/CD49f+ mean numbers for proliferation of 39,450 (±1690.41). Combined 
data was analysed by ANOVA and was shown to be significantly different between control 
and enriched populations for the proliferation rate of all three cows (p < 0.05).  
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Figure 3.2. Proliferation analysis of FACS sorted Lin-/CD24+/CD29+/CD49f+ putative 
bovine mammary stem cells. 
Proliferation of fluorescence activated cell sorted control (no antibody selection) and 
putative mammary stem cell (Lin-/CD24+/CD29+/CD49f+) populations (n = 3). Each 
triple positive population demonstrated an increased rate of proliferation over the 7 
days of culture in comparison to the rate of growth observed for the sorted but not 
enriched (control) population of cells. Combined data analysed by ANOVA were 
significantly different between control and enriched populations for proliferation rate 
for all three cows (p < 0.05). The x-axis is the cow number.  
 
3.5.3 Differentiation assay to assess mammosphere formation capacity of control 
and enriched populations of bovine mammary cells 
Figure 3.3 shows the number of mammospheres counted per image averaged over 5 images 
after 5 days of incubation on BD Matrigel™ Basement Membrane Matrix for control and Lin-
/CD24+/CD29+/CD49f+ cells. The initial cell count at seeding for both populations was 
50,000 per well. For cow 1 (6441), the mean control mammosphere count after 5 days of 
culture was 15.93 (± 3.32) per field of view compared to the mean mammosphere count for 
Lin-/CD24+/CD29+/CD49f+ cells of 12.00 (± 2.32) per field of view. The mean control 
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mammosphere count for cow 2 (6525) was 16 (± 4.41) per field of view compared to Lin-
/CD24+/CD29+/CD49f+ mean mammosphere numbers of 12.33 (± 4.43) per field of view. 
The mean control mammosphere count for cow 3 (6669) was 15.93 (± 4.32) per field of view 
compared to Lin- /CD24+/CD29+/CD49f+ mean mammosphere numbers of 12.00 (± 4.32) per 
field of view. No significant difference in mammosphere number (p < 0.05) between 
treatments was determined using the T-Test on combined data from all three animals.  
 
 
Figure 3.3. Mammosphere formation numbers per field of view for putative bovine 
mammary stem cells.  
The mean (n = 15) number of mammospheres per image taken at 100X magnification 
field of view. The counts were made manually while displaying the images (n = 5 images 
per well, n = 3 wells per treatment for each of the three animals). While there is a trend 
of decreased mammosphere number observed in the putative stem cells populations 
this was also impacted by significant variation. A significant difference in mammosphere 
number (p < 0.05) between treatments was determined using the T-Test on combined 
data from all three animals. 
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Figure 3.4 shows the mean calculated area of the mammospheres counted per image averaged 
over 5 images after 5 days of incubation on BD Matrigel™ Basement Membrane Matrix for 
control cells (sorted but not labelled) and Lin-/CD24+/CD29+/CD49f+ cells. Both cell 
populations were seeded with an initial cell count of 50,000 per well. For cow 1 (6441), the 
mean calculated area of the control cell mammospheres after 5 days of culture was 
1452.65_µm2 (± 616.16 µm2) compared to the mean mammosphere area for Lin-
/CD24+/CD29+/CD49f+ cells of 1455.05_µm2  (± 640.41 µm2). The mean calculated area of 
the control cell mammospheres for cow 2 (6525) was 1408.60 µm2  (± 558.44 µm2) compared 
to Lin- /CD24+/CD29+/CD49f+ mean mammosphere area of 1364.23 µm2 (± 581.62 µm2). 
The mean calculated area of the control cell mammospheres for cow 3 (6669) was 
1361.83_µm2 (± 630.49 µm2) compared to Lin-/CD24+/CD29+/CD49f+ mean mammosphere 
area of 1356.44 µm2 (± 600.66 µm2). There was little observable difference in mammosphere 
area between cell populations. ANOVA analysis of the combined data sets showed no 
significantly difference between the cell populations for mammosphere area. 
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Figure 3.4. Mammosphere mean area for Lin1/CD24+/CD29+/CD49f+ putative bovine 
mammary stem cells.  
The mean mammosphere area (µm2) for each animal and treatment. The mammosphere 
sizes were measured using the ImageJ software (Version 1.46r, National Institutes of 
Health, USA). There was little observable difference in mammosphere area between cell 
populations. ANOVA analysis of the combined data sets showed no significantly 
difference between the cell populations for mammosphere area. The x-axis is cow 
number. 
 
3.5.4 Proliferation Assay of putative bovine mammary progenitor cell populations 
Data in Figure 3.5 shows the number of cells counted after 7 days of incubation for control 
(sorted but unlabelled) and Lin- /CD24+/CD29+/CD61+ cells. Both cell populations were 
seeded with an initial cell count of 10,000 per well. For cow 1 (6441), the mean control cell 
count after 7 days of culture was 36,800 (± 2276.51) compared to the mean count for Lin-
/CD24+/CD29+/CD61+ cells of 45,250 (± 3183.16). The mean control population for cow 2 
(6525) was 34,350 (± 2700.00) compared to Lin-/CD24+/CD29+/CD61+ mean numbers for 
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proliferation of 43,550 (± 2344.68). The mean control population for cow 3 (6669) was 
33,600 (± 2357.44) compared to Lin-/CD24+/CD29+/CD61+ mean numbers for proliferation 
of 46,700 (± 567.89). ANOVA analysis showed a significant difference between control and 
enriched populations for proliferation rate (p < 0.05) for all three cows.  
 
 
Figure 3.5. Proliferation analysis of putative bovine mammary progenitor cells. 
Proliferation of fluorescence activated cell sorted control (no antibody selection) and 
putative mammary progenitor cell (Lin-/CD24+/CD29+/CD61+) populations (n = 3). 
Each triple positive population demonstrated an increased rate of proliferation over the 
7 days of culture in comparison to the rate of growth observed for the control cells. 
Paired T-Test analysis showed a significant difference between control and enriched 
populations for proliferation rate (p < 0.05) for all three cows. X-axis = cow number 
 
Figure 3.6 shows the number of mammospheres counted per image averaged over 5 images 
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0
10000
20000
30000
40000
50000
60000
6441 6525 6669
C
e
ll 
C
o
u
n
t
Proliferation Assay of Control & 
Lin-/CD24+/CD29+/CD61+ Cells
Sorted Control Cells
Sorted Lin-
CD24/CD29/CD61 
Positive Cells
* * *
 154 
/CD24+/CD29+/CD61+ cells. Both cell populations were seeded with an initial cell count of 
50,000 cells per well. For cow 1 (6441), the mean control mammosphere count after 5 days of 
culture was 15.93 (± 4.32) per field of view compared to the mean mammosphere count for 
Lin-/CD24+/CD29+/CD61+ cells of 14.60 (± 4.77) per field of view. The mean control 
mammosphere count for cow 2 (6525) was 16.06 (± 4.47) per field of view compared to Lin-
/CD24+/CD29+/CD61+ mean mammosphere numbers of 12.00 (± 4.15) per field of view. 
The mean control mammosphere count for cow 3 (6669) was 15.73 (± 4.75) per field of view 
compared to Lin- /CD24+/CD29+/CD61+ mean mammosphere numbers of 11.86 (± 4.19) per 
field of view. T-Test on combined data from all three animals showed there was a significant 
difference in mammosphere number (p < 0.05) between the treatments and controls.  
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Figure 3.6. Mammosphere formation numbers for putative bovine mammary 
progenitor cells. 
The mean (n = 15) number of mammospheres per image taken at 100X magnification 
field of view. The counts were made manually while displaying the images (n = 5 images 
per well, n = 3 wells per treatment for each of the three animals). Similar to the 
comparable observation for the putative stem cells, while there is a trend of decreased 
mammosphere number observed in the putative progenitor cells populations this was 
also impacted by significant variation. T-Test on combined data from all three animals 
showed there was no significant difference in mammosphere number (p < 0.05) 
between treatments. (x axis = cow number).  
 
3.5.5 Differentiation assay for putative bovine mammary progenitor cell 
populations 
The data shown in Figure 3.7 is the mean calculated area of the mammospheres counted per 
image averaged over 5 images following 5 days of incubation on BD Matrigel™ Basement 
Membrane Matrix for control (sorted but not labelled) and Lin-/CD24+/CD29+/CD61+ cells. 
Both cell populations were seeded with an initial cell count of 50,000 per well. For cow 1 
(6441), the mean calculated area of the control cell mammospheres after 5 days of culture was 
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1320.64 µm2 (± 581.93 µm2) compared to the mean mammosphere area for Lin-
/CD24+/CD29+/CD61+ cells of 1036.63 µm2 (± 686.25 µm2). The mean calculated area of 
the control cell mammospheres for cow 2 (6525) was 1417.52 µm2  (± 649.76 µm2) compared 
to Lin-/CD24+/CD29+/CD61+ mean mammosphere area of 1407.07 µm2 (± 595.79 µm2). 
The mean calculated area of the control cell mammospheres for cow 3 (6669) was 
1411.56_µm2 (± 631.91 µm2) compared to Lin-/CD24+/CD29+/CD61+ mean mammosphere 
area of 1381.69 µm2 (± 625.48 µm2). There was no significant statistical difference as 
determined by paired T-test analysis of the difference in mammosphere area between cell 
populations, similar to what was observed for the putative stem cells population in the 
comparable assay. 
 
Figure 3.7. Mammosphere size measurements for putative bovine mammary progenitor 
cells. 
The mean mammosphere area (µm2) for each animal and treatment. The mammosphere 
sizes were measured using the ImageJ software (Version 1.46r, National Institutes of 
Health, USA). There was no statistical difference in mammosphere area between cell 
populations, similar to what was observed for the putative stem cells population in the 
comparable assay. (x axis = cow number).  
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3.6 Discussion           
3.6.1 Fluorescence activated cell sorting of putative stem cells and putative 
progenitor cells isolated from bovine mammary epithelial cell populations  
In an effort to isolate and study putative bovine mammary stem/progenitor cells, FACS was 
performed on a population of cultured bovine mammary epithelial cells. The numbers of cells 
isolated and discussion of the resulting functional analysis is detailed below.  
 
3.6.1.1 Percentage of initial cell populations that were immunophenotyped as Lin-
/CD24+/CD29+/CD49f (putative stem cells) and Lin-/ CD24+/CD29+/CD61+ 
(putative progenitor cells) following fluorescence activated cell sorting 
Initially each antibody was analysed for its abundance in the populations of cells grown in 
culture and estimates of the abundance of each of the markers in the cell populations were 
determined by FACS. This analysis also utilised isotype control samples to confirm that the 
cells identified as positive for each antigen were not due to non-specific binding. The initial 
work utilised the FACS machine BD Influx SORP (Becton, Dickinson and Company, NJ, 
USA) with detection at the following wavelengths: 405 nm at 100 mW (Pacific Blue), 488  nm 
at 200 mW (FITC), 561 nm at 150 mW (PE).  
 
Previous reports in other species have described stem and progenitor cells in the mammary 
gland (Shackleton et al., 2006, Stingl et al., 2006, Vaillant et al., 2008). Based on previous 
observations and predictions of the potential number of bovine mammary stem cells isolated 
from mammary tissue (Rauner and Barash, 2012), the number of cells isolated with the 
specific immunophenotype was much higher compared to other studies. Previous estimates of  
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approximately 0.3 % (Capuco et al., 2001) or approximately 5.8_% (Rauner and Barash, 
2012) are much lower than the mean of 11.3 % (Lin-/CD24+/CD49f+/CD29+) or 15 % (Lin-
/CD29+/CD24+/CD61+) from the results presented in this Chapter (Table 3.4 and Table 3.5, 
respectively). It could be that the added density gradient separation step accounts for this 
difference. This may have the effect of increasing the number of epithelial type cells and 
impacting the percentage of cells exhibiting stem or progenitor characteristics. Further, the 
study by Capuco et al. (2001) utilised a DNA labelling technique to estimate proliferation in 
mammary tissue sections and Ki67 staining resulted in an observation of 0.5 % positive cells. 
This analysis was performed on tissue sections, not on cultured cell populations, and may 
account for the differences in the observed cell numbers. There has been other work on 
cultured cell populations of bovine mammary cells, however the conditions of these 
experiments also differed as seen in the study by Rauner and Barash (2012) which utilised 
cells isolated from 7-10 month old heifers rather than multiparous cows. This study detailed 
strict characterisation with respect to immunophenotyping of putative stem (CD24med/CD49+) 
and progenitor (CD24high/CD49f-) cells. The gating strategy used to isolate the cell 
populations presented in this chapter (Figure 3.1) used larger gate sizes with respect to  the 
cells counted as positive relative to the data presented in Rauner and Barash (2012). This was 
due to the nature of the population and the cell numbers required for the work in Chapter 5 
(RNA-seq). This may also account for the higher number of cells determined to be positive 
for the two marker sets (putative stem and putative progenitor cells) relative to the literature 
(dos Santos et al., 2012, Rauner and Barash, 2012). Furthermore, in Rauner and Barash 
(2012) the number of Lin+ cells that were removed was not reported; these numbers may 
have been higher than the numbers observed in this chapter (Table 3.4) potentially resulting 
from the mammary cell isolation procedure that utilised a density gradient to isolate 
mammary epithelial cells. The addition of this step may have increased the number of 
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potential putative stem and progenitor cells by removing other cell lineages prior to the first 
passage. Similarly, Rauner and Barash (2012) described a high percentage (~61.5 %) of dead 
cells due to the enzymatic dispersion technique; this was not an issue with the samples in this 
chapter as the cells were observed to have a high viability, determined by trypan blue 
enumeration, and utilised a different enzymatic dispersion technique. The enzymatic 
dispersion techniques used in this chapter utilised only trypsin-EDTA for cell dispersal and 
not the dispase enzymatic digestion step as used by Rauner and Barash (2012).  
 
The initial flow cytometry gates utilised in this chapter (Figure 3.1) identified cells with a 
higher fluorescence intensity than the control samples. The precise setting of the gates for 
cellular collection is based on the specific population studied in each experiment. The gates 
were standardised for all parts of this chapters work - this may also account for the variation 
in number of cells isolated as putative stem or progenitor cells. Other studies (Rauner and 
Barash, 2012), including the instructions for the EasySep Kit itself, proposed mouse 
mammary stem cells as CD24+/CD49f++, with the suggestion that in mouse mammary tissue 
the range would be between 0.8-5.0 % of positive cells. This method only utilised two 
markers, while the analysis presented in this chapter (Table 3.4 and Table 3.5) utilised two 
combinations of three positive markers to separate two proposed populations (putative stem 
and putative progenitor cell populations). It is also worth noting that the cells with the highest 
CD49f expression were gated, this means there were other cells that were CD49f+ cells that 
were not included in the final triple positive side population. The source of the initial cell 
population (heifers vs. multiparous cows) may have also played a role in the resulting cell 
population. There may be some mitigation of this difference give the 4-5 passages in culture 
prior to analysis. Ideally the isolation of these populations for further study would be 
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performed on dissociated primary tissues from a series of days in lactation and parity 
comparable cows. 
 
A critical step in the development of the technique to facilitate the isolation of cell side 
populations that were positive for the surface markers previously identified as mammary stem 
cells (CD49f, CD29 & CD24) or progenitor cells (CD29, CD24 & CD61) was described in 
the recent publication by Rauner and Barash (2012). In this paper the authors outlined a 
methodology for isolating bovine mammary cells population positive for the key cell sur face 
markers (CD49f & CD24). While this paper is not focused on global expression profiling and 
utilised tissue from pre-pubertal heifers, it did help identify the use of a kit (EasySep Mouse 
Mammary Stem Cell Enrichment Kit (StemCell Technologies) which has been very effective 
in isolating these cells for this project. The same antibody clones were used in preliminary 
studies but the formulation in this kit seemed far more effective particular for the CD24 
antigen. It is possible that the other trialled CD24 antibody clones were not suited to the initial 
histological methods used in this thesis.  
 
The difference in experimental conditions (with regards to starting cell population, different 
markers and gating strategies) can account for the variation in the levels of cells identified at 
stem/progenitor compared to the literature (Rauner and Barash, 2012). When aligned with the 
observations from the functional assays, the populations isolated by the methodology in this 
chapter seem to exhibit some enhancement in proliferative capacity in comparison with the 
sorted non-enriched (control) populations. Long term culture has been shown to increase the 
expression of CD24 and CD29 in cultured bovine mammary epithelial cells with the loss of 
luminal cells throughout passage 0-3 and an increase in cells positive for CD24 and CD29 in 
 161 
passage 5 (Cravero et al., 2015). This may account for the higher levels of these markers seen 
in the sorted populations of cells relative to the tissue sections seen in Chapter 2. For future 
work it may be more efficient to study the populations sorted based on 2 out of the 3 markers 
at a time. 
 
3.6.2 Investigation of proliferation and mammosphere forming efficiency of 
putative bovine mammary stem and progenitor cell populations 
Proliferation and mammosphere formation assays were performed initially to assess if there is 
a functional relationship between proliferative and differentiation capacity of these cells in 
comparison to the parent un-enriched population of cultured mammary primary cell cultures. 
These techniques have required significant development and represent an important step in 
increasing understanding of both the cellular characteristics of mammary stem and progenitor 
cells as well as their contextualised roles within the mammary gland during lactation.  
 
The mammosphere formation assay for putative stem/progenitor cell populations yielded no 
significant difference between control cell populations and the experimental putative 
stem/progenitor cell population (Figure 3.3 and Figure 3.6, respectively). There was no 
significant difference between the between control cell populations and the experimental 
putative stem/progenitor cell population for the size of the mammospheres that were 
generated (Figure 3.4 and Figure 3.7, respectively). The mammosphere formation potential of 
the putative bovine mammary stem/progenitor cells is investigated through the use of low 
attachment (Matrigel) conditions (Dey et al., 2009, Dontu et al., 2003, Lan et al., 2007, 
Reynolds and Weiss, 1992). It has been shown that the formation of multicellular spheroids 
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that have variable characteristics, such as size, depending on the seed population used (Dey et 
al., 2009). It should be noted that in vivo stem cells reside within niches and rely on signalling 
for cues to maintain quiescence or initiate differentiation or division (Dey et al., 2009). The 
conditions encountered by cells in vitro may or may not resemble the natural 
microenvironment of the stem cell and should be considered in the interpretation of any work 
with stem cell populations in vitro. For future experiments, the immunohistochemical 
characterisation of the mammospheres in addition to the generation of multiple generations of 
mammospheres from the initial starting population may be able to elucidate differences 
between the control populations and putative stem/progenitor cells . The mean mammosphere 
count per field of view exhibited a trend toward a decreased mammosphere number in the 
enriched populations. While this trend is subject to considerable variability, it is interesting in 
that it may also indicate that the profile of the enriched and control populations differs in the 
cell types and level of differentiation. The addition of bovine mammary ECM from different 
stages of lactation may also be a useful avenue for the future investigation of the 
mammosphere formation potential of these populations. Mammosphere forming cells have 
been shown to be present in bovine mammary epithelial cell cultures (Cravero et al., 2015). 
This functional analysis has been used in conjunction with the marker Keratin 14 and assays 
that show a diverse mix of cells within the cultured mammospheres (Cravero et al., 2015). 
The keratin 14 molecule was not used in the experimental work in this thesis, but would be 
worth investigating in future studies of bovine mammary stem and progenitor cells. Although 
the end point of the mammosphere assay presented in this chapter was at 7 days, other studies 
(Cravero et al., 2015) have utilised mammosphere culture up to 35 days and observed 
alveolar-like structures with luminal antigens, such as Keratin 18 and EpCAM, and p63 (a 
basal layer antigen). Confirmation of the expression and functionality of these alveolar-like 
structures was done through the use of a NOD-SCID mice xenograft model (Cravero et al., 
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2015) which would be a very appropriate future direction for further investigations of bovine 
mammary stem and progenitor cells.  
 
These observations and the comparisons with other relevant studies in cows highlight the 
challenges with stem cells biology in general, but also with animals other than the well-
developed human and mouse models. The identification of cells based on immunophenotype 
is a challenging approach in that there is typically no cause-effect relationship between the 
marker/s and the cellular characteristics that are being sought to be enriched for (e.g. 
multipotency or proliferative capacity or ‘stemness’). While other approaches have been 
proposed, for example the ALDH1+ marker (Martignani et al., 2014), this method to isolate 
mammary stem cells along with functional assays (e.g. ability to repopulate a mammary gland 
that has been depopulated as was undertaken in mice (Shackleton et al., 2006) remains among 
the methodologies most commonly used. The paper by Rauner and Barash (2012) is, to our 
knowledge, the only other investigation of bovine mammary stem cells that utilised similar 
cell surface markers.  
 
The investigation of human breast stem/progenitor cells through mammosphere culture was 
able to show that primary mammospheres can be dispersed and form secondary 
mammospheres (Dey et al., 2009). This work was built on with the additional investigations 
showing various breast lineages within the mammospheres (Dey et al., 2009). This 
combination demonstrated two essential properties of stem cells in the investigated 
populations – multilineage differentiation and self- renewal potential (Dey et al., 2009). Other 
researchers have been able to demonstrate ductal alveolar growth in mammosphere culture 
with human and mouse cells (Liao et al., 2007, Liu et al., 2008). This work in other species 
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could be applied to future work with putative bovine mammary stem/progenitor cells to 
investigate the potential of these cells and allow a greater understanding of bovine mammary 
stem cell biology. 
 
3.7 Conclusion           
The aim of this chapter was to isolate and investigate the proliferative capacity and 
mammosphere formation efficiency of putative stem and progenitor cell populations of 
bovine mammary epithelial cells from tissue samples from late pregnant animals. The 
isolation of the putative stem cell (Lin-/CD24+/CD29+/CD49f+) and progenitor cell (Lin-
/CD24+/CD29+/CD61+) populations was performed using FACS. These populations have 
been studied in other animals (human and mice) and proposed to be stem and progenitor cells.  
These populations exhibited statistically significantly higher proliferation rates than the 
respective controls following seven days of culture. This observation is potentially due to the 
highly concentrated population of putative stem and progenitor cells that influenced the 
environment creating conditions favourable for proliferation. Analysis of mammosphere 
formation using these populations did not reveal any statistically significant difference with 
the control in terms of size (area) and number of mammospheres; however the mammosphere 
area and number derived from the sorted side populations of cells were found to be 
consistently lower than the control for both side populations. The need to isolate a further 
subpopulation of the putative stem and progenitor cells may assist with mammosphere 
formation of these populations. In addition, further investigations of other ultra-low 
attachment conditions may facilitate mammosphere formation for these populations. The 
isolated populations of putative stem/progenitor cells were subjected to full transcriptome 
analysis (Chapter 4).  
 165 
Chapter 4   
Full Transcriptome Analysis of Putative Stem & 
Putative Progenitor Cell Populations from Bovine 
Mammary Epithelial Cells 
4.1 Introduction          
The application  of transcriptomics and next-generation sequencing offers an economical 
sequencing approach for high- throughput profiling of gene expression (Marguerat et al., 
2008). Among the next-generation sequencing approaches, RNA sequencing (RNA-seq) is a 
technique used to study global gene expression profiles in different cells and tissues  (Cánovas 
et al., 2010) and generates large-scale sequencing data (Marguerat et al., 2008). Venn 
diagrams are often used as a graphic representation to identify the number of genes where 
expression is similar between two or more samples. Previous analysis of bovine mammary 
gland gene expression has been performed on biopsy samples (Boutinaud and Jammes, 2002, 
Finucane et al., 2008) and on cells found in milk during lactation (Boutinaud et al., 2002). 
Studies utilising RNA-seq to compare the transcriptomes of these two sources of cells 
(mammary gland biopsy vs. milk cells) showed a great deal of similarities between these two 
populations (Medrano et al., 2010). Previous studies of the transcriptome of putative bovine 
mammary stem cells (label retaining cells – LREC due to asymmetric division) found 592 
genes differentially expressed compared to terminally differentiated cells from the same 
tissue; the gene analysis was performed using microarray techniques from which 387 genes 
were associated with cell growth and proliferation pathways (Capuco et al., 2012). Of 
particular note in these studies, 6 to 13 individual cells isolated from the stroma of prepubertal 
heifer tissues by laser microdissection showed differential expression of NR5A2 (Capuco et 
al., 2012), a marker of pluripotency (Heng et al., 2010), Nestin- a stem cell marker (Capuco et 
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al., 2012) and cell survival and proliferation factors (IGF2, HSPB6 and LAMC1) (Capuco et 
al., 2012).  
 
In this chapter, RNA-seq was used to investigate potential key expression markers of 
multipotency/pluripotency and to identify any key regulatory mechanisms from bovine 
mammary gland cells. The cells used were cultured from bovine mammary gland biopsies and 
separated with FACS based on the cell surface markers Lin-/CD49f+, CD29+, CD24+ and 
CD61+.  
 
4.2 Aims            
To analyse the transcriptome of putative bovine mammary stem (Lin-
/CD24+/CD29+/CD49f+) and progenitor (Lin-/CD24+/CD29+/CD61+) cells vs. control cell 
populations to identify potential key expression patterns of multipotency/pluripotency and 
potential key cellular regulatory mechanisms. 
 
4.3 Objectives           
 Determine the number and identity of significantly differentially expressed genes in 
the putative bovine mammary stem cell side population vs. control cells.  
 Perform pathway analysis of the differentially expressed genes to determine the 
biological pathways that are more active or less active in putative bovine mammary 
stem cell side populations vs. control cells. 
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 Determine the number and identity of significantly differentially expressed genes in 
the putative bovine mammary progenitor cell side populations vs. control cells.  
 Perform pathway analysis of the differentially expressed genes to determine the 
biological pathways that are more active or less active in putative bovine mammary 
progenitor cell side populations vs. control cells. 
 
4.4 Materials and Methods         
4.4.1 RNA extraction  
The RNA was extracted from FACS sorted cultured bovine mammary epithelial cells isolated 
from prepartum bovine mammary tissue biopsies (Chapter 3, section 3.4.2). The 
cryopreserved and denatured cell cultures were thawed on ice and the RNA purified using the 
RNeasy miniPREP kit (74104, Qiagen, Australia) as per the manufacturer’s instructions. The 
thawed cell cultures were centrifuged at 300 xg for 5 min (5415D, Eppendorf, Australia). The 
supernatant was removed, the pellet resuspended in 350_µL of RLT buffer (79216, Qiagen, 
Australia) and mixed by inversion. The cell suspension was centrifuged at the maximum 
speed (16,100 xg) for 3 min. The supernatant was removed, placed in a fresh 2 mL centrifuge 
tube (supplied in kit) and 350 µL of 70 % ethanol (supplied in kit) was added to the lysate. 
The solution was mixed by pipetting. The sample (700 µL) was transferred to an RNeasy 
Mini spin column, placed in a 2 mL collection tube (supplied in kit) and centrifuged at 
8,000_xg for 15 s. The flow through was discarded and 350 µL of the buffer RW1 (1053394, 
Qiagen, Australia) was added to the RNeasy column. The column was centrifuged at 8,000 xg 
for 15 s. Column DNAse 1 digestion was then performed using 80 µL of a mix made of 10 µL 
of DNase 1 stock solution (made by adding 550_µL RNase-free water (129112, Qiagen, 
Australia) into the DNase 1 vial and mixed by inversion) (AM2222, Life Technologies, 
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Australia) and 70 µL of Buffer RDD (supplied in kit). The mix was incubated for 15 min at 
room temperature. After incubation, 350 µL Buffer RW1 was added to the column and 
centrifuged at 8,000 xg for 15 s. Following this, 700 µL of Buffer RW1 was added to the 
column and centrifuged at 8,000 xg for 15 s. The flowthrough was discarded and 500 µL of 
Buffer RPE (1018013, Qiagen, Australia) was applied to the column. The column was 
centrifuged at 8,000 xg for 2_min. The RNeasy spin column was placed into a new 1.5 mL 
collection tube and 50_µL of RNase-free water was applied directly to the column. The 
column was then centrifuged at 8,000 xg for 1 min to elute the RNA. The resulting RNA yield 
was quantified using the NanoDrop 1000 spectrophotometer (Thermo Scientific) and purity 
determined by spectrophotometry analysis at 260/280 nm.  
 
The RNA yields from approximately 1,000,000 cells are shown in Table 4.1. The RNA yield 
varied widely with the lowest yield of 3.6421 µg (cow 6441 control cells) and the highest 
yield of 14.7264 µg (cow 6669 Lin-/CD24+/CD29+/CD61+ cells). The resultant RNA was 
frozen at -80 °C (Revco Scientific Inc. ULT1386-39). For each of the putative 
stem/progenitor cell side populations, a control population of cells was also sorted and the 
RNA extracted for comparison.  
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Table 4.1. The total RNA yield and purity from approximately 1,000,000 (passage 4-5) 
cells following FACS for each of the three cows utilized for RNA-seq analysis (details of 
initial biopsy in Table 3.1).  
 
RNA Yield RNA Yield 
Control 
260/280 
Lin-/CD24+/ 
CD29+/CD49f+ 
260/280 
Control 
260/280 Lin-/CD24+/ 
CD29+/CD61
+ 
260/280 
Cow 
6441 
3.6421 
µg 
1.99 
11.9567 µg 
2.00 4.4261 
µg 
2.15 
9.9115 µg 
2.08 
Cow 
6525 
12.9906 
µg 
1.89 
5.0841 µg 
1.65 7.9485 
µg 
2.10 
4.6214 µg 
2.05 
Cow 
6669 
7.0896 
µg 
2.14 
10.6428 µg 
1.86 11.24 
µg 
1.93 
14.7264 µg 
1.79 
 
All samples were sent to the Australian Genomic Research Facility (AGRF, Victoria, 
Australia) for analysis. The RNA quality and quantity passed all QC analysis utilising a 
Bioanalyser (Agilent) and deemed to be of appropriate quality and quantity for RNA-seq 
analysis. All samples had very similar electrospectrographs with most receiving a RNA 
Integrity Number (RIN) of 10. 
 
4.4.2 RNA-seq analysis of RNA extracted from bovine mammary epithelial cells 
Subsequent to the submission of the samples to AGRF, all processes were conducted in 
accordance with the AGRF pipelines and QC benchmarks. This included library construction 
for the Illumina Hiseq instrument as well as Illumina Hiseq-2000 RNA-seq sequence 
production of a 50 bp single end (for the putative stem cell side population – Lin-
/CD24+/CD29+/CD49f+ vs. sorted control cells), Hiseq-2000 RNA-seq sequence production 
of a 100 bp single end (for the putative progenitor cell side population – Lin-
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/CD24+/CD29+/CD61+ vs. sorted control cells) and its follow up bioinformatics analysis. For 
each run, RNA extracted from 3 sorted enriched cell populations and RNA from 3 respective 
control cell populations were analysed. The difference in read length between the populations 
were considered to potentially impact the outcomes and comparability of these populations as 
read length differences may introduce bias into pathway analysis of RNA-seq data (Oshlack 
and Wakefield, 2009). This is due to the fact that the total number of reads for a transcript is 
proportional to the total reads multiplied by the length of the transcript (Oshlack and 
Wakefield, 2009). It is worth noting that this investigation was used as a preliminary analysis 
of potential stem/progenitor cell side populations. 
 
For each analysis, the bioinformatics steps involved demultiplexing, alignment, RNA 
counting, normalisation and differential expression analysis, and utilised the Illumina 
CASAVA1.8.2 pipeline. Flowing assessment of sequence quality utilising Illumina scores, the 
sequence reads were then splice aligned against the Bos taurus (Build version baustau 4.0). 
The Tophat aligner (http://tophat.cbcb.umd.edu/) was used to map reads to the genomic 
sequences. The count of reads mapping to each known gene were then summarized and 
differential gene expression was assessed by using the Cuffdiff scripts within the Cufflinks 
application (ver. 2.0.2, Cole Trapnell Laboratory). The B. taurus genome annotation file in 
GTF format was used to merge known gene isoforms and maximize overall assembly quality. 
Lists of differential gene expression (greater than 1.5 fold change with p = 0.05) were 
compiled through comparison between the cells from the three cows with their appropriate 
control population of cells. Additional analysis was conducted with all data combined to look 
for differential expression between enriched and control sorted cell populations derived from 
the 3 different bovine mammary epithelial cell primary culture lines.  
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Additionally, Pathway analysis was conducted using the IPA v5.0 (Integrative Pathway 
Analysis of complex ‘omics’ data) within the Ingenuity Software platform (QIAGEN) for the 
putative stem cell side population RNA-seq analysis. For the putative progenitor cell side 
population analysis, AGRF undertook alternative analysis using the Partek Pathway module  
(Paretk SG Pte. Ltd, Singapore). Gene ontology analysis for the genes identified as 
differentially expressed were assessed utilising DAVID (Database for Annotation, 
Visualization and Integrated Discovery – https://david.ncifcrf.gov/) a web-based program 
used to determine whether clusters of genes with similar expression profile were enriched in 
specific gene ontology functional categories.  
 
4.5 Results           
4.5.1 Differential gene expression in the putative bovine mammary stem cell 
enriched population for Lin-/CD24+/CD29+/CD49f+ cells 
The samples passed all AGRF QC criteria (Ideally a 260/280 ratio of 1.8-2.0. On receipt at 
AGRF samples are run through a BioAnalyzer) prior to and subsequent to sequencing of 
transcripts and determination of sequence quality. Table 4.2 shows the samples from the 
sequencing analysis and are annotated by cow number from which the cells were derived as 
well as the treatment (C refers to the sorted control samples and -3t refers to the triple positive 
cell population). As observed from Table 4.2, an enormous amount of data was generated 
from each RNA-seq analysis for Lin-/CD24+/CD29+/CD49f+ cells. Approximately 30 
million individual reads were sequenced for each sample from which the expression of 
approximately 13,000 genes was estimated. Of the genes that were identified, only 
approximately 9,000 genes had sufficient data (sufficient number of transcripts identified as a 
QC measure, differs for each comparison) to allow for statistical analysis to be conducted for 
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determination of differential expression for each set of paired samples (control vs. enriched 
side populations).  
Table 4.2. Summary of number of single reads per samples for the putative stem cell  
side populations (Lin-/CD24+/CD29+/CD49f+) and paired sorted control samples. 
50bp Single End – Flowcell ID: C1RFYACXX 
Sample Name Single Reads Data Yield (bp) 
6669_c 29,983,530 1.50 Gb 
6669_3t 32,238,365 1.61 Gb 
6525_c 31,037,947 1.55 Gb 
6525_3t 32,185,164 1.61 Gb 
6441_c 30,710,879 1.54 Gb 
6441_3t 30,427,562 1.52 Gb 
Total 186,583,447 9.33 Gb 
 
4.5.2 Descriptive analysis of differential gene expression of putative bovine 
mammary stem cell enriched population from three cows in comparison to 
the control-sorted cell population for Lin-/CD24+/CD29+/CD49f+ cells.  
A total of 4 statistical comparisons were conducted to identify genes that were statistically 
categorised as differentially expressed between the control-sorted and the paired enriched 
population of Lin- /CD24+/CD29+/CD49f+ cell side population. Comparisons were done 
between the paired samples from each cell line as well as between the combined data from all 
cell lines. Statistically differentially expressed genes were only identified when the data was 
analysed between paired samples (control vs. enriched) for each cell line.  
 
 173 
For cow 6669, a total of 254 genes were identified as differentially expressed between the 
control-sorted and enriched cellular side populations. This was comparable to the number of 
genes that were identified as differentially expressed for cow 6641 (311 genes) and 6525 (315 
genes). These were further assessed to determine the number of genes that were common 
between sets and depicted in the Venn diagram in Figure 4.1. The genes differentially 
expressed between control and enriched cell side populations from cell line isolated from cow 
6669 and cow 6441 exhibited 27 genes in common. Similarly, between cell lines derived from 
cow 6669 and cow 6525, 42 genes were shown to be common and between cell lines from 
cow 6525 and cow 6441, there were 77 genes that were identified as differentially expressed 
common to both comparisons. Importantly, there were 13 genes that were identified as 
differentially expressed between the control and enriched cell populations in all of these 
comparisons.  
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Figure 4.1. Venn diagram of differentially expressed genes in putative stem cell side 
population. 
Venn diagram highlighting the number of genes that were identified as exhibiting 
statistically significant changes in expression levels in an RNA-seq analysis between a 
control-sorted cellular population and a population of cells positive for Lin-
/CD24+/CD29+/CD49f+ from 3 different cell lines. 
 
The 13 genes from Figure 4.1 that were differentially expressed in all 3 comparisons between 
the control and enriched cell side populations of Lin-/CD24+/CD29+/CD49f+ cells were 
identified based on their Gene ID from the analysis and the gene name – these genes are 
shown in Table 4.3 with the up or down regulation status for the individual cows sampled 
outlined in Table 4.4.  
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Table 4.3 List of the 13 genes that were identified as statistically significant changes 
between the sorted control and the Lin-/CD24+/CD29+/CD49f+ triple positive side 
populations in all samples that were analysed.  
Gene ID Gene Name 
ACTG2 Actin, Smooth Muscle 
CAMTA2 Calmodulin Binding Transcription Activator 
COL5A3 Collagen alpha-3(V) chain 
GABBR1 Gamma-Aminobutyric Acid (GABA) B Receptor, 1 
IGFBP2 Insulin-Like Growth Factor Binding Protein 2 
KRT14 Keratin 14 
LENG8 Leukocyte Receptor Cluster (LRC) Member 8 
LRRC71 Leucine Rich Repeat Containing 71 
NES Nestin 
PDGFRB Platelet-Derived Growth Factor Receptor, Beta Polypeptide 
SLC25A37 
Solute Carrier Family 25 (Mitochondrial Iron Transporter), Member 
37 
VCAN Versican 
XIST X Inactive Specific Transcript (Non-Protein Coding) 
 
Importantly, while these 13 genes (Figure 4.1 & Table 4.3) were differentially expressed in all 
3 comparisons, 6 genes were identified as up- or down-regulated for all 3 cows (Table 4.4). 
For 7 genes, cows 6441 and 6525 exhibited the same up- and down-regulation patterns (Table 
4.4).  
 
Table 4.4 shows the direction change in the differentially expressed genes analysed for each 
of the three cow samples. Two of genes, IGFBP2 andKRT14, were shown to be up regulated 
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for all three cow samples. Four genes, COL5A3, NES, PDGFRB and VCAN, were down 
regulated in all three cow samples. 
Table 4.4 Directional change in differentially expressed genes identified in all 3 cell line 
comparisons. 
 Gene ID Up Regulated Down Regulated 
ACTG2 6669 6441, 6525 
CAMTA2 6441, 6525 6669 
COL5A3 
 
All Comparisons 
GABBR1 6441, 6525 6669 
IGFBP2 All Comparisons 
 KRT14 All Comparisons 
 LENG8 6441, 6525 6669 
LRRC71 6441, 6525 6669 
NES 
 
All Comparisons 
PDGFRB 
 
All Comparisons 
SLC25A37 6441, 6525 6669 
VCAN 
 
All Comparisons 
XIST 6441, 6525 6669 
 
Gene ontology analysis (DAVID analysis) was performed on the 13 genes to characterise the 
gene function. The analysis represents the proportions of the 13 differentially expressed genes 
that are common to all 3 cell line comparisons (as identified in Figure 4.1 & Table 4.3). Each 
gene may be associated with multiple gene ontologies however only 6 genes were identified 
within the DAVID database as being associated with gene ontologies (Table 4.5). 
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Table 4.5. Description of the 6 genes that were identified by gene ontology analysis as 
differentially expressed in all comparisons.  
Gene Description 
ACTG2 Actin, alpha 2, smooth muscle 
GABBBR1 Gamma-aminobutyric acid B receptor, 1 
IGFBP2 Insulin-like growth factor binding protein 2, 26 kDa 
KRT14 Keratin 14 
PGDFRB Platelet-derived growth factor, beta polypeptide 
VCAN Versican 
 
The genes identified as differentially expressed from each cell line were then subjected to 
pathway analysis using the IPA platform. This method aggregates genes on the associations in 
pathways using statistical models and identifies the gene expression networks that the 
differentially expressed genes may be associated with. Network eligible molecules serve as 
"seeds" for generating networks. Network eligible molecules are combined into networks that 
maximize specific connectivity. The specific connectivity is the interconnectedness each gene 
has relative to all molecules they are connected to in the Ingenuity Knowledge Base. This 
analysis and the number of genes within each network are included in the following tables for 
comparison. Table 4.6 details the pathways associated with selections of the genes found to be 
differentially expressed between cow 6441 enriched cells and the control populations. The 
number of differentially expressed genes that were found to be associated with the listed 
pathways is listed and ranges from 22-1.  
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Table 4.6. Network analysis output from IPA analysis from the Ingenuity platform for cell 
line 6441 enriched vs. control differentially expressed genes.  
ID Focus 
Molecules 
Top Functions 
1 22 Connective Tissue Disorders, Dermatological Diseases and Conditions, Gastrointestinal  
Disease 
2 22 Cellular Assembly and Organization, Cellular Function and Maintenance, Hair and Skin 
Development and Function 
3 22 Cell Cycle, Cell-To-Cell Signaling and Interaction, Cellular Development  
4 21 Cellular Movement, Infectious Disease, Cellular Development 
5 21 Cell Morphology, Cellular Assembly and Organization, Connective Tissue Development 
and Function 
6 19 Cell-To-Cell Signaling and Interaction, Tissue Development, Cellular Assembly and 
Organization 
7 18 Embryonic Development, Tumor Morphology, Developmental Disorder  
8 19 Cardiovascular Disease, Cell-To-Cell Signaling and Interaction, Cellular Assembly and 
Organization 
9 16 Lipid Metabolism, Small Molecule Biochemistry, Cellular Growth and Proliferation  
10 15 Cell Cycle, Cell Morphology, Cell-mediated Immune Response 
11 15 Cellular Development, Connective Tissue Development and Function, Tissue 
Development 
12 14 Cellular Development, Nervous System Development and Function, Cell Morphology  
13 15 Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry  
14 13 Cellular Development, Cellular Growth and Proliferation, Cell Death and Survival  
15 12 Cellular Development, Hematological  System Development and Function,  
Hematopoiesis 
16 12 Cellular Movement, Hematological System Development and Function,  
Hypersensitivity Response 
17 14 Cardiovascular Disease, Hematological Disease, Organismal Injury and Abnormalities  
18 5 Cellular Development, Hematological  System Development and Function,  
Hematopoiesis 
19 1 Cell Signaling, Post-Translational Modification, Protein Synthesis 
20 1 Cancer, Cell Morphology, Cell-To-Cell Signaling and Interaction 
21 1 Developmental Disorder, Hereditary Disorder, Metabolic Disease  
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Table 4.7 details the pathways associated with selections of the genes found to be 
differentially expressed between cow 6525 enriched cells and the control populations of Lin-
/CD24+/CD29+/CD49f+ cells. The number of differentially expressed genes that were found 
to be associated with the listed pathways is shown to range from 23 to only 1 gene.   
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Table 4.7. Network analysis output from IPA analysis from the Ingenuity platform for 
cell line 6525 enriched vs. control differentially expressed genes. 
ID Focus 
Molecules 
Top Functions 
1 23 Cellular Movement, Cell Morphology, Cellular Assembly and O rganization  
2 22 Connective Tissue Disorders, Embryonic Development, Hair and Skin Development 
and Function 
3 20 Cell Morphology, Cellular Compromise, Amino Acid Metabolism  
4 19 Cellular Movement, Cellular Assembly and Organization, Nervous System 
Development  and Function 
5 18 Connective Tissue Disorders, Dermatological Diseases and Conditions, 
Gastrointestinal Disease 
6 20 Cellular Development, Embryonic Development, Organ Development  
7 16 Connective Tissue Disorders, Inflammatory Disease, Skeletal and Muscular Disorders  
8 15 Cellular Movement, Cell-To-Cell Signalling and Interaction, Hematological System 
Development and Function 
9 15 Drug Metabolism, Glutathione Depletion In Liver, Auditory Disease  
10 15 Cellular Assembly and Organization, Cellular Function and Maintenance, Cell Cycle 
11 14 Amino Acid Metabolism, Cell-To-Cell Signalling and Interaction, Molecular Transport 
12 14 Cell Death and Survival, Cardiovascular System Development and Function, Cancer  
13 13 Humoral Immune Response, Protein Synthesis, Cancer  
14 13 Cancer, Endocrine System Disorders, Reproductive System Disease 
15 13 Connective Tissue Disorders, Dermatological Diseases and Conditions, 
Developmental Disorder 
16 12 Cellular Development, Embryonic Development, Cell Death and Survival  
17 10 Drug Metabolism, Molecular Transport, Cell Morphology  
18 10 Cell-To-Cell Signalling and Interaction, Cellular Growth and Proliferation, Renal and  
Urological System Development and Function 
19 8 Lipid Metabolism, Small Molecule Biochemistry, Vitamin and Mineral Metabolism 
20 1 DNA Replication, Recombination, and Repair, Protein Trafficking, Cell Cycle 
21 1 Cell Morphology, Cellular Movement, Nervous System Development and Function  
22 1 Lipid Metabolism, Small Molecule Biochemistry, Cancer  
23 1 Lipid Metabolism, Small Molecule Biochemistry  
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Table 4.8 details the pathways associated with selections of the genes found to be 
differentially expressed between cow 6669 enriched cells and the control populations. The 
number of differentially expressed genes that were found to be associated with the listed 
pathways is listed and ranges from 27-1. 
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Table 4.8. Network analysis output from IPA analysis from the Ingenuity platform for 
cell line 6669 enriched vs. control differentially expressed genes. 
ID Focus 
Molecules 
Top Functions 
1 27 Embryonic Development, Hair and Skin Development and Function, Organ 
Development 
2 24 Cellular Movement, Skeletal and Muscular System Development and Function, Organ 
Morphology 
3 18 Embryonic Development, Organ Development, Organismal Development  
4 18 Cellular Movement, Cell-To-Cell Signalling and Interaction, Tissue Dev elopment 
5 17 Cancer, RNA Post-Transcriptional Modification, Cell Death and Survival  
6 16 Cell Cycle, Cellular Assembly and Organization, DNA Replication,  Recombination, and 
Repair 
7 16 Hereditary Disorder, Cardiovascular System Development and Function, Cell Death 
and Survival 
8 16 Cell Signalling, Vitamin and Mineral Metabolism, Cell Death and Survival  
9 15 Lipid Metabolism, Small Molecule Biochemistry, Molecular Transport  
10 15 Amino Acid Metabolism, Drug Metabolism, Small Molecule Biochemistry  
11 14 RNA Post-Transcriptional Modification, Connective Tissue Disorders, Developmental 
Disorder 
12 15 Tissue Morphology, Cardiovascular Disease,  Nervous System Development and 
Function 
13 15 Lipid Metabolism, Small Molecule Biochemistry, Free Radical Scavenging 
14 10 Developmental Disorder, Embryonic Development, Endocrine System Disorders  
15 10 Cell Death and Survival, Cell-To-Cell Signalling and Interaction, Cell-mediated 
Immune Response 
16 1 Molecular Transport, Renal and Urological System Development and Function, Tissue 
Morphology 
17 1 Cell Morphology, Cellular Movement, Nervous System Development and Function  
 
While there are some differences in the number of networks associated with the differentially 
expressed genes from the different comparisons, there are some themes present in each of the 
tables. Genes of pathways associated with developmental processes (e. g. tissue development, 
cellular assembly and organ development) are common in all 3 tables and repeated within 
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different pathways. There are other important observations of the pathways in this table. Post-
translational modification of RNA plays an important role in cell behaviour modification and 
with 14 focus molecules belonging to this and associated pathways; this may be an avenue for 
further work. A number of metabolic pathways are also presented in this analysis. The 
presence of genes associated with lipid and amino acid metabolism may be associated with 
cell survival or the ability to modulate and influence the environment of the developing cells.   
 
Differential expression of the putative bovine mammary progenitor cell enriched side 
population of Lin-/CD24+/CD29+/CD61+ in comparison to the control sorted cell 
population  
The RNA samples passed all AGRF QC criteria (ideally a 260/280 ratio of 1.8-2.0. On receipt 
at AGRF samples are run through a BioAnalyzer) prior to sequencing of transcripts and 
determination of sequence quality. Table 4.9 highlights the large number of transcripts that 
were sequenced in each RNA sample. These transcripts were analysed to determine the 
differential gene expression between the sorted control and sorted enriched (cell surface 
marker positive) populations.  
 
Similar to Table 4.2, a large amount of data was generated from each RNA-seq analysis of 
Lin-/CD24+/CD29+/CD61+ cell side populations (Table 4.9). Approximately 30-36 million 
individual reads were sequenced for each sample from which the expression of ~ 46,500 gene  
products was estimated. Of these identified gene products, few genes had sufficient data 
(number of transcripts identified, differs for each comparison-for samples isolated from cow 
6441-~22,100 genes, 6669-~18,000 genes, 6525-~17,800 genes) to allow for the fold changes 
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in expression to be determined for each set of paired samples (control vs. enriched side 
populations) for Lin- /CD24+/CD29+/CD61+ cells.  
 
Table 4.9. Summary of number of single reads per sample. 
This data was for the putative progenitor cell side population (Lin-
/CD24+/CD29+/CD61+) and paired sorted control samples. The samples are annotated 
by cow number from which the cells were derived as well as the treatment (C refers to 
the sorted control samples and -Pr refers to the triple positive cell population). 
100bp Single End – Flowcell ID: BC26B2ACXX 
Sample Name Single Reads Data Yield (bp) 
6441C2 31,812,037 3.18 Gb 
6441Pr 36,573,255 3.66 Gb 
6525C2 33,916,721 3.39 Gb 
6252Pr 34,105,649 3.41 Gb 
6669C2 32,085,044 3.21 Gb 
6669Pr 30,967,633 3.10 Gb 
Total 186,583,447 19.95 Gb 
 
Few genes were identified as differentially expressed by the statistical analysis and none were 
common between the differential analyses. Due to this, the genes with greater than a 1.5 fold 
difference in expression levels between control sorted and enriched side populations from the 
Lin-/CD24+/CD29+/CD61+ cells were utilised (Figure 4.2). 
 
From Figure 4.2, a comparison between control-sorted and enriched cell lines for cell line 
from cow 6441 identified there were 1178 genes whose expression changed 1.5 fold between 
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treatments - of these, no genes were identified with a known gene ID. This could be explored 
in future work utilising gene knockdown studies to determine function of the unknown genes. 
Comparisons of cells from cow 6525 identified 768 genes that exhibited > 1.5 fold change 
with 156 genes that had gene identifications. Of the 1344 genes from cow sample 6669, 311 
genes had known gene identifications. When reviewed in more detail, 49 genes exhibited a 
fold change that was common between cellular comparisons from cow sample 6441 and 6525, 
57 genes common between comparison of cells from cow samples 6441 and 6669 and 62 
genes were common between comparisons of cells from cow samples 6525 and 6669. Gene 
ontology analysis of this cohort could not be undertaken as only 5 genes were common 
between all comparisons of the 3 cell lines and only 1 of these had a gene identification 
associated with a known gene (ACSS3, TUBA8 - Acyl-CoA Synthetase Short-Chain Family 
Member 3). 
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Figure 4.2. Venn diagram of differentially expressed genes in putative progenitor cell 
side population in comparison to paired control sorted cells. 
Venn diagram highlighting the number of genes that were identified as exhibiting fold 
changes >1.5 fold in expression levels in an RNA-seq analysis between a control sorted 
cellular population and a population of cells positive for Lin-/CD24+/CD29+/CD61+ 
(putative progenitor cells).  
 
Following the analysis outlined above, very few genes were identified as differentially 
expressed across all three cows paired samples. Comparison of control-sorted vs. enriched 
side populations of Lin-/CD24+/CD29+/CD61+ cells as combined data shows no genes were 
significantly differentially expressed. Individual comparisons of cell lines from the cells of 
cow sample 6441 also showed no genes were significantly differentially expressed. The 
comparisons from cell lines 6525 showed 5 genes significantly differentially expressed (Table 
4.10) with 26 genes identified for comparisons from the cell lines of cow 6669; however - 
several did not have an associated gene ID (Table 4.11). 
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Table 4.10. A list of the 5 genes that were identified as statistically significant changes 
between the sorted control and the Lin- /CD24+/CD29+/CD61+ triple positive side 
populations from the cell line 6525. 
Gene ID Gene name 
CHPF2,MIR671 Chondroitin Polymerizing Factor 2 
CYP26B1 cytochrome P450, family 26, subfamily B, polypeptide 1  
S100A8 S100 calcium binding protein A8  
CYP24A1 cytochrome P450, family 24, subfamily A, polypeptide 1  
AQP3 aquaporin 3 (Gill blood group)  
 
Table 4.11 shows the 26 genes that demonstrated significant changes in expression when the 
control and Lin-/CD24+/CD29+/CD61+ side populations were compared. There are a number 
of genes that might be of relevance to the changes occurring in the populations of cells being 
examined, such as COL6A2, a gene for collagen, and a chondroitin polymerization factor that 
plays a role in the construction of ECM. Another gene of note is a member of the cytochrome 
family (CYP26B1), with roles in molecular processing and detoxification. Changes in 
calcium binding proteins are also seen in the collection of genes that differed between control 
and putative progenitor cell side populations from cow sample 6525.  
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Table 4.11. A list of the 26 genes that were identified as statistically significant changes 
between the sorted control and the Lin-/CD24+/CD29+/CD61+ triple positive side 
populations from the cell line 6669. 
Gene ID Gene name 
COL6A2 collagen, type VI, alpha 2  
SMOC1 SPARC related modular calcium binding 1  
GCNT3 glucosaminyl (N-acetyl) transferase 3, mucin type 
CA8 carbonic anhydrase VIII  
SLCO2B1 solute carrier organic anion transporter family, member 2B1  
CA6 carbonic anhydrase VI  
ZFP3 ZFP3 zinc finger protein  
CLIC5 chloride intracellular channel 5  
CD83 CD83 molecule  
SORBS2 sorbin and SH3 domain containing 2  
CRCT1 cysteine-rich C-terminal 1  
CGN cingulin  
PHGDH phosphoglycerate dehydrogenase  
INHBA inhibin, beta A  
SOX10 SRY (sex determining region Y)-box 10  
CFI complement factor I  
ADAMTS3 ADAM metallopeptidase with thrombospondin type 1 motif, 3  
PSAT1 phosphoserine aminotransferase 1 
POPDC3 popeye domain containing 3 
BOLA,LOC790811 BOLA homolog (e.coli) 
RNF128 ring finger protein 128, E3 ubiquitin protein ligase  
  
Ingenuity Pathway Analysis (Qiagen, Australia) was utilised for the putative stem cell and 
paired control sorted cell comparisons described above. For the analysis of data generated 
from cells isolated from cow sample 6441, genes that were identified as 1.5 fold differentially 
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expressed between the control and enriched mammary progenitor side population did not have 
an associated gene ID; therefore no pathway analysis could be performed.  
 
The data presented in Table 4.12 shows the pathways associated with the genes that 
demonstrated a greater than 1.5 fold change in expression for 6525 enriched cell side 
population (compared to control cells). The Partek pathway analysis identified three genes 
present in the pathway for cocaine addiction out of the list of differentially expressed genes 
from cow sample 6525. This represents approximately 5_% of the genes present in the 
cocaine addiction pathway. Two genes in the list of differentially expressed genes from cow 
sample 6525 were found to be part of the proximal tubule bicarbonate reclamation pathway. 
These two genes represent over 7 % of the proximal tubule bicarbonate reclamation pathway. 
Three of the genes found to be differentially expressed in cow sample 6525 were found to be 
part of the amphetamine addiction pathway. These two genes represent approximately 3.7 % 
of the genes in the amphetamine addiction pathway. Three of the genes found to be 
differentially expressed in cow sample 6525 were found to be part of a pathway associated 
with gap junctions. These three genes represent over 2.5 % of the gap junction associated 
pathway. Two of the genes found to be differentially expressed in the studies of the cells of 
cow sample 6525 were found to be associated with inositol phosphate metabolism pathway. 
These two genes represent almost 3 % of the inositol phosphate metabolism pathway.  
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Table 4.12. Pathway analysis output from the Partek Pathway module for cell line 6525 
enriched vs. control differentially expressed genes (1.5 fold change). 
Function 
Enrichment p-
value 
% genes in 
pathway that 
are present  
# genes in list, 
in pathway 
# genes not in 
list, in pathway 
Cocaine 
Addiction 
0.00408496 5.08475 3 56 
Proximal tubule 
bicarbonate 
reclamation 
0.00885217 7.69231 2 24 
Amphetamine 
addiction 
0.00985735 3.7037 3 78 
Gap junction 0.0267969 2.54237 3 115 
Inositol 
phosphate 
metabolism  
0.0550745 2.89855 2 67 
 
The data presented in Table 4.13 shows the pathways associated with genes from 6669 
enriched cell side population that demonstrated a greater than 1.5 fold change in expression 
when compared to control cells. Four genes that were found to be differentially expressed 
were found to be part of the phototransduction pathway. These four genes account for over 
10.8 % of the genes in the phototransduction pathway. Five genes from the list of 
differentially expressed genes were found to be part of the gastric acid secretion pathway, 
complement and coagulation cascades pathway, Fc gamma mediated phagocytosis pathway 
and pancreatic secretion pathway. While not necessarily the same five genes these genes did 
represent 6.25 %, 5.05 %, 5.72 % and 4.42 %, respectively, of the genes associated with the 
gastric acid secretion pathway, complement and coagulation cascades pathway, Fc gamma 
mediated phagocytosis pathway and pancreatic secretion pathway. The nitrogen metabolism 
pathway was found to contain three of the differentially expressed genes that represent 
11.11_% of this pathway. The propanoate metabolism pathway was found to contain three of 
the differentially expressed genes that represent 7.9 % of this pathway. Three genes were also 
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shown to be part of the ABC transporter pathway, these three genes representing 6.67 %. 
Eight genes representing 3.43 % of the calcium signaling pathway were also found amongst 
those that were differentially expressed. Four genes were also found to be associated with 
arginine and proline metabolism pathways (representing 5.55 %), bacterial invasion of 
epithelial cells (representing 4.44 %) and PPAR signalling pathway (representing 4.44 %). 
Three genes representing 5.88 % of the endocrine and other factor regulated calcium 
reabsorption were also shown to be part of the differentially expressed genes. Two and seven 
genes were found to be part of the glycosaminoglycan biosynthesis – heparin sulphate/heparin 
pathway (representing 8.33 %) and a chemokine signaling pathway (representing just over 
3_% of this pathways genes), respectively.  
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Table 4.13. Pathway analysis output from the Partek Pathway module for cell line 6669 
enriched vs. control differentially expressed genes (1.5 fold change). 
Pathway Name Enrichment 
p-value 
% genes in 
pathway that 
are present  
# genes in list, 
in pathway 
# genes not in 
list, in pathway 
Phototransduction 0.00200602 10.8108 4 33 
Gastric acid secretion  0.00627568 6.25 5 75 
Nitrogen metabolism  0.00697814 11.1111 3 24 
Complement and 
coagulation cascades  
0.0150001 5.05051 5 94 
Propanoate metabolism 0.0179127 7.89474 3 35 
Fc gamma R-mediated 
phagocytosis 
0.0196136 4.71698 5 101 
Calcium signalling 
pathway 
0.0210839 3.43348 8 225 
Arginine and proline 
metabolism  
0.0211259 5.55556 4 68 
Pancreatic secretion 0.0250751 4.42478 5 108 
ABC transporters 0.0279911 6.66667 3 42 
Synaptic vesicle cycle  0.0297247 5 4 76 
Endocrine and other 
factor-regulated calcium 
reabsorption 
0.0385777 5.88235 3 48 
Bacterial invasion of 
epithelial cells  
0.0430124 4.44444 4 86 
PPAR signalling pathway  0.0430124 4.44444 4 86 
Glycosaminoglycan 
biosynthesis – heparin 
sulphate/heparin  
0.0477991 8.33333 2 22 
Chemokine signalling 
pathway 
0.0542119 3.01724 7 225 
 
The data presented in Table 4.14 shows the pathways that were associated with the genes that 
demonstrated a greater than 1.5 fold change in expression when the pooled cell data for the 
enriched cell populations from cow sample 6669 was compared to control cells. Three genes 
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that were found to be differentially expressed were found to be part of the glycine, serine and 
threonine metabolism pathway. These three genes account for over 6.97 % of the genes in the 
glycine, serine and threonine metabolism pathway pathway. Six genes from the list of 
differentially expressed genes were found to be part of the calcium signalling pathway and 
neuroactive ligand-receptor interaction pathway. While not necessarily the same six genes 
these genes did represent 2.58 % and 1.69 % of the genes associated with the calcium 
signalling pathway and neuroactive ligand-receptor interaction pathway. The cocaine 
addiction pathway was found to contain three of the differentially expressed genes that 
represent 5.08 % of this pathway. Three genes were also found to be in the amphetamine 
addiction (3.7 %), melanoma (3.13 %) and morphine addiction (2.91 %) pathways. Two genes 
were found to be associated with pyruvate metabolism, carbohydrate digestion and absorption 
and proteasome pathways. The two genes associated with each pathway represented 4.25 % 
of each of these pathways genes respectively. Glycosaminoglycan biosynthesis was also 
found to have two genes associated with it from the pool of differentially expressed genes, 
representing 8.33 % of the genes in this pathway. Five genes were found to be associated with 
the regulation of actin skeleton and alcoholism pathways. The five genes for each pathway 
represented 2.05 % and 2.02 % of the genes in these two pathways, respectively.   
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Table 4.14. Pathway analysis output from the Partek Pathway module for combined 
data for all cell lines enriched vs. control differentially expressed genes (1.5 fold change). 
Pathway Name Enrichment p-
value 
% genes in 
pathway that 
are present  
# genes in list, 
in pathway 
# genes not in 
list, in 
pathway 
Glycine, serine and 
threonine 
metabolism  
0.00451831 6.97674 3 40 
Calcium signalling 
pathway 
0.00949385 2.57511 6 227 
Cocaine addiction 0.0108934 5.08475 3 56 
Glycosaminoglycan 
biosynthesis – 
heparin 
sulphate/heparin  
0.0149055 8.33333 2 22 
Amphetamine 
addiction 
0.0253302 3.7037 3 78 
Melanoma 0.0390784 3.125 3 93 
Alcoholism  0.0410496 2.05761 5 238 
Regulation of actin 
cytoskeleton 
0.0441702 2.01613 5 243 
Morphine addiction 0.0465599 2.91262 3 100 
Pyruvate 
metabolism  
0.0500974 4.24783 2 44 
Carbohydrate 
digestion and 
absorption 
0.0500974 4.24783 2 44 
Proteasome 0.0520659 4.25532 2 45 
Neuroactive ligand-
receptor 
interaction 
0.057705 1.69492 6 348 
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4.6 Discussion           
RNA-seq was used to characterise the gene expression patterns in the putative stem and 
progenitor cell side populations isolated from bovine mammary epithelial cells. This 
characterisation was used to further understand the gene expression patterns, cell development 
and metabolic pathways, and regulatory mechanisms that differentiate putative stem and 
progenitor cell side populations from the cells comprising the bovine mammary epithelial 
population. The initial analysis of the differential gene expression profiles of the 3 cells lines  
(control vs. putative mammary stem cell side populations expressing Lin-
/CD24+/CD29+/CD49f+, Figure 4.1) showed more similarities between cells derived from 
cow samples 6525 and 6441; cells isolated from cow 6999 differed to the other 2 cow 
samples. It should be noted that the initial biopsy protocol intended for the cows to be 
biopsied at approximately 20 days prior to parturition - this was achieved for cow 6525 with 
cow 6441 close at 16 days prior to parturition. Cow 6669 was biopsied only 6 days prior to 
parturition. The differences could potentially be associated with the days prior to parturition at 
which the cells were collected from each animal. This very late pregnancy state is a period of 
significant change for the bovine mammary gland as it prepares for lactation (Capuco and 
Ellis, 2013) and may account for the gene expression differences of cow sample 6669 to cow 
samples 6525 and 6441. However, without further investigations, such as repeat analysis with 
more cows at different stages of parturition in addition to qRT-PCR or protein analysis, it is 
difficult to determine the cause for these differences.  
 
Gene ontology and pathway analysis was performed for the 13 genes that were identified as 
differentially expressed between all comparisons from the 3 cell lines (control vs. stem cell 
enriched (Lin-/CD24+/CD29+/CD49f+) cell side populations). The limited number of genes 
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available made further pathway analysis unachievable with no pathway matches in the 
DAVID analysis program for the gene set of 13. As a result of this, the differentially 
expressed genes for each cow compared to their control were used for further pathway 
analysis. 
 
4.6.1 The 13 genes identified with statistically significant changes between the 
sorted control and the Lin-/CD24+, CD29+ and CD49f+ triple positive cell 
populations  
Comparisons between the putative bovine mammary stem cells and control cells showed 13 
genes to be differentially expressed (either upregulated or downregulated) in all of the three 
cow samples studied (Table 4.3). The reported roles and potential utility of these individual 
genes are explored below. 
 
4.6.1.1 Actin, Smooth Muscle (ACTG2) 
The ACTG2 gene codes for a component of the contractile sarcomere in smooth muscle (Klar 
et al., 2015). The transcription product from this gene was found to be down regulated in two 
of three (6441 and 6252) cow derived putative stem/progenitor cell side populations tested 
when compared to sorted control cells (Table 4.4). It is possible that these cells are less 
differentiated than the control cells. Given this, there would be an increased amount of gene 
transcription associated with one of the terminal differentiated cell lineages (myoepithelial)  as 
these elements have not been down regulated as the cell moves towards another cell fate. This 
may indicate that the putative stem cell side population being analysed in this study was in a 
less differentiated state. 
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4.6.1.2 Calmodulin Binding Transcription Activator (CAMTA2) 
The transcript of this molecule was shown to be up-regulated in two of the three samples 
(cows 6441 and 6525) of putative stem/progenitor cell side populations. This makes 
biological sense as this molecule is associated with environmental challenges/stress  responses 
(Shen et al., 2015). Of particular note is the involvement of Ca2+ signalling cascades 
downstream of this activator element (Berridge et al., 2003). It is possible that the increased 
up-regulation of this stress pathway in the putative stem/progenitor cells may give the less 
differentiated cells greater chance of surviving stressors. This would allow the resident tissue 
to be repaired if needed. A stress response involving increased calcium movement within cells 
is seen in tumour cells exposed to an acidic environment (Sharma, et al., 2015).  
 
4.6.1.3 Collagen alpha-3(V) chain (COL5A3) 
This gene transcript was down-regulated in all putative stem/progenitor cell side populations 
from the cows sampled. Down-regulation of the COL5A3 gene transcript has been reported in 
fibroblasts when co-cultured with MDA-MB-231 breast tumour cells (Van Rooyen et al., 
2013). This may indicate an interaction within the culture dish to cells that are less 
differentiated/more stem cell- like. However, in the cell culture system presented in this 
chapter, the other cells in the culture have higher levels of this gene product to encourage 
collagen production and tissue creation/stabilisation. 
 
4.6.1.4 Gamma-Aminobutyric Acid (GABA) B Receptor, 1 (GABBR1) 
The transcript of this gene was found to be up-regulated in putative stem/progenitor cell side 
populations from two of three cow samples studied (6441 and 6525). The signalling molecule 
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GABA is an inhibitory neurotransmitter (Hisama et al., 2001) and plays a signalling role in 
the peripheral nervous system in conjunction with steroidal signals (Magnaghi et al., 2006). 
This, in combination with the result for other neuronal associated gene elements, Nestin and 
Versican (outlined below in sections 4.6.1.9 & 4.6.1.12, respectively), may indicate a role of 
these cells interacting with neurotransmitters and/or other signals for development.  
 
4.6.1.5 Insulin-Like Growth Factor Binding Protein 2 (IGFBP2) 
The expression of IGFBP2 transcripts has been shown to be higher in organs with a higher 
metabolic function and cell turnover, for example, the liver expresses higher IGFBP2 
transcripts compared to the heart and muscle (Zhan et al., 2014). The insulin like growth 
factor axis encompasses the IGFBP and insulin like growth factor, and participates in growth 
and regulation of almost all cell types and tissues, including mammary tissue (Beattie et al., 
2015). In addition to influencing tissue development, the family of IGFBP proteins are 
associated with postnatal growth and development, mediating growth hormones anabolic 
functions (Ferry et al., 2000) and enhancing or inhibiting the effects of insulin growth factor 
in the regulation of tissue growth and development (Siwanowicz et al., 2005, Zhan et al., 
2014). The transcript expression of this gene was shown to be up-regulated in putative 
stem/progenitor cells from all three cow samples investigated. Given the role this protein 
plays in growth and development, it makes biological sense for there to be an increased 
expression of this gene product in cells capable of regenerating the cell types and architecture 
of the mammary gland. 
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4.6.1.6 Keratin 14 (KRT14) 
The presence of the keratin 14 molecule has been associated with the expression of the 
ABCG2 membrane transporter, both are considered markers of stem cells (Ma et al., 2015). It 
makes biological sense for this associated molecule to be up-regulated in all three cows 
sampled as this is a known and highly conserved marker of stem cells in other species and 
tissue types (Dontu et al., 2003). For further work, it could be useful to assay or sort based on 
the presence of keratin 14/ABCG2. The ABCG2 gene product participates in dye efflux and 
in bovine mammary tissues is associated with regulation of bovine lactation (Wei et al., 
2012). 
 
4.6.1.7 Leukocyte Receptor Cluster (LRC) Member 8 (LENG8) 
The transcript for the LENG8 gene was found to be up-regulated in two of the three cow 
samples. This gene and associated genes are subunits that make up leukocyte receptors  (White 
et al., 2015) and potentially could play a role in the interaction of the putative stem/progenitor 
cells with the immune-surveillance of the mammary gland across the developmental stages.  
Immune cells participate heavily in the organogenesis in postnatal epithelial tissue 
remodelling, such as the mammary gland (Plaks et al., 2015). It has been suggested that a 
direct association exists between interferon-gamma (IFNγ) producing immune cells, operating 
through a number of immune cell receptors in mammary gland tissue drives luminal cell 
differentiation (Plaks et al., 2015.) 
  
 200 
4.6.1.8 Leucine Rich Repeat Containing 71 (LRRC71) 
The product of this gene was up-regulated in two (6441 and 6525) of the three cow samples 
analysed. However, there is little information about the function of this gene specifically. 
There are associations between other leucine rich repeat regions and G-protein-coupled 
proteins that have been used as a marker for adult stem cells in humans (Barker and Clevers, 
2010). Leucine rich repeat regions associated with kinase receptors have been studied in 
plants as an indication of the multipotency of the cells being studied (Schmidt et al., 1997). It 
may be that this expressed gene is similar in scope/function and may be useful to consider in 
further studies as a marker of adult stem cells in the cultured cells from the bovine mammary 
gland. 
 
4.6.1.9 Nestin (NES) 
The other interesting observation was the inclusion of the gene Nestin in the set of genes 
differentially expressed in this initial global expression profiling contrast (control vs. putative 
mammary stem cell side populations’ positive for Lin-/CD24+/CD29+/CD49f+). As 
previously discussed, this gene has been identified to be expressed  in cells from human milk 
(Cregan et al., 2007) and argued to be a marker for neural stem cells (Zimmerman et al., 
1994). However, this gene exhibited decreased expression in all 3 comparisons in the putative 
stem cell side populations. This is counterintuitive if it is associated with the ‘stem–like’ 
properties from neural stem cells. Again, this is highlighting the challenges of stem cells 
analysis in which the molecular regulatory mechanisms are not fully elucidated. This 
observation is also at odds with our observation of a large number of Nestin positive cells in 
bovine milk (Chapter 5) and would require additional investigations to understand the role of 
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this gene within the regulation of cell function within the bovine mammary gland during the 
lactation cycle. 
 
4.6.1.10 Platelet-Derived Growth Factor Receptor, Beta Polypeptide (PDGFRB) 
In all cows sampled, the RNA transcript from PDGFRB was shown to be down-regulated. A 
high level of PDGFRB, which is associated with the receptor tyrosine kinase family, is 
associated with hematolymphoid neoplasm (Vega et al., 2015). This may indicate a protective 
mechanism against the induction of neoplastic changes in the putative stem/progenitor cell 
population through the downregulation of this gene product in the cells that have the most 
growth potential and pose the greatest risk in the event of neoplastic changes.  
 
4.6.1.11 Solute Carrier Family 25 (Mitochondrial Iron Transporter), Member 37 
(SLC25A37) 
This mitochondrial associated gene (Dolatshad et al., 2014) was found to be differentially 
expressed between control cells and the side populations of putative stem/progenitor cells. 
This gene has been shown to be upregulated in populations of hematopoietic stem cells 
(CD34+) and was shown to have greater levels of expression in aberrant bone marrow cells 
associated with myelodisplastic syndromes (Dolatshad et al., 2014). This gene encodes an 
iron membrane transporter; it is possible that it is differentially expressed in the isolated 
putative stem/progenitor cells due to an increased metabolic demand for the solute of this 
carrier. However, this expression level was not common in all populations with only two of 
the three cows (cows 6441 and 6525) showing upregulation.  
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4.6.1.12 Versican (VCAN) 
Versican is a member of the chondroitin sulphate proteoglycan (CSPG) family of proteins that 
are found in the pericellular space (Bandtlow and Zimmermann, 2000). The CSPG play an 
important role in ECM of tissues (Galtrey and Fawcett, 2007), with Versican playing a 
particular role in the neurons, the CNS and oligodendrocytes (Dyck and Karimi-Abdolrezaee, 
2015). This may indicate that there are signalling changes within the putative stem/progenitor 
cell side populations related to neuronal support and interaction with the mammary gland 
tissue (under normal in vivo conditions). In addition, Versican has been reported to express in 
inflammatory cells, fibroblasts and pericytes associated with diseased CNS tissue (Wright et 
al., 2014). This is more likely to be the reason for the differential gene expression of Versican 
within the isolated putative stem/progenitor cells as all cows sampled demonstrated 
downregulation of an ECM protein when dispersed into culture. This may be a temporary 
measure to preserve energy within the cell as reintroducing cells to culture conditions is 
associated with the secretion of ECM as the monolayer reforms.  
 
4.6.1.13 X Inactive Specific Transcript (Non-Protein Coding) (XIST) 
Although non protein coding, the XIST gene regulatory element interacts with a number of 
proteins and it is hypothesised these protein interactions mediate transcriptional silencing 
(McHugh et al., 2015). It has been shown that the presence of the XIST gene regulatory 
element and subsequent protein associations moves genes to a compartment within the DNA 
associated complexes that exclude the interaction of polymerase enzymes (notably 
polymerase II) (Chaumeil et al., 2006, Engreitz et al., 2013) and may play a role in the stem 
cell functions of the putative stem/progenitor cells. The differential expression of this 
regulatory RNA may play an important role in the establishment of the RNA expression 
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profile of putative bovine mammary stem and progenitor cells. However, only two of the 
three cow samples (6441 and 6525) studied upregulated this molecule in this study (Table 
4.4) indicating the need for further research.  
 
4.6.1.14 Summary for the 13 genes that were identified with statistically significant changes 
between the sorted control and the Lin-/CD24+, CD29+ and CD49f+ triple positive 
side populations 
The comparison of the putative stem cell side population with the control cell population 
transcriptome sought to elucidate what differentiates these two populations on the genetic 
level. As previously outlined, the full transcriptome analysis of the cells from the three cows 
yielded 13 genes that were differentially expressed. The genes that were found to be 
significantly different in all three cows investigated were from a variety of systems and 
pathways within the cells (Table 4.6, Table 4.7, Table 4.8). Genes involved in the interactions 
between the internal cytoskeleton (actin) and the external ECM (collagen and Versican) may 
indicate a role of these cells in directing the external environment of the cell to replicate the 
conditions required for the mammary stem cell niche (Woodward et al., 2005). This 
mammary cell niche maintains tissue specific stem cells in their stem cell- like state 
(Woodward et al., 2005) so for tissue to regenerate this would need to also be regenerated. 
The presence of a growth factor receptor (PDGFRB), insulin receptor (IGFBP2) and 
neurotransmitter receptor (GABBR1) in addition to a leukocyte receptor (LENG8) gives 
further evidence to the notion that this cell population is influenced and responding to the 
external environment in a different way to the control cell population. The presence of keratin 
14 and Nestin, genes associated with stem cells in other studies  (Cregan et al., 2007, Ma et al., 
2015), may indicate a role for these markers in identifying mammary stem cells for other 
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studies. Further study on the roles of these putative stem/progenitor cell markers in mammary 
gland and milk may provide valuable information. In particular the treated control cells may 
also contain copies of the mRNA expressed by the depleted cells and as a result some of the 
less differentially expressed mRNAs may not have been detected so readily. This represents 
an opportunity for further studies where the SC marker enriched population could be directly 
compared to the depleted population instead of a sample of the whole dissociated cell 
population. 
 
Ideally, identifying a single marker to identify and to isolate bovine mammary stem cells 
would prove invaluable to advancing this field of study. The ability to build a better 
understanding of the molecules and signal transduction pathways that drive self-renewal and 
survival of bovine mammary stem cells may allow for improved welfare of dairy animals 
through extended or more persistent lactations.  
 
4.6.1.15 Network analysis output from IPA analysis from the Ingenuity platform  
The IPA analysis seen in Table 4.6 utilises the list of differentially expressed genes found in 
the comparison of the putative stem cell side population expressing Lin-
/CD24+/CD29+/CD49f+ from cow 6441 vs. control cells. This list is compared to the IPA 
database of known biological systems and pathways to generate a listing of genes associated 
with those known pathways. 
 
Of the 220 differentially expressed genes found in the comparison of the putative stem cell 
population from cow sample 6441 vs. control cells, 22 of them had an association with 
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biological pathways that have been identified with connective tissue disorders, dermatological 
disease and gastrointestinal disease (Table 4.6). From the Lin-/CD24+/CD29+/CD49f+ side 
population, an association with connective tissue when it is in a state of inflammation or 
change may resemble what is occurring on a cellular level following the disruption of the 
tissue culture monolayer. The use of trypsin for disaggregation has been shown to sensitise 
cells to cold stress (Mazur et al., 1972) and may do so to other stressors. It is possible that a 
similar cluster of genes involved in the response to connective tissue injury in metabolically 
active systems, such as the gastrointestinal tract and skin, resemble the picture seen in this 
IPA analysis (Table 4.6). Also for cow 6441, another 22 genes were found to be related to 
functional networks associated with cellular assembly and organization, cellular function and 
maintenance, and more broadly hair and skin, in addition to another 22 genes associated with 
molecular domains of cell cycle, cell-to-cell signalling and interaction and cellular 
development (Table 4.6). The expression of genes associated with these domains in cells that 
may, in vivo, contribute to the development of the mammary gland is understandable. The 
mammary gland undergoes a great deal of cell turnover during normal growth and 
physiological function which may require the gene products of these domains. A group of 22 
genes were associated with the molecular domains of cell cycle, cell- to-cell signalling and 
interaction and cellular development. This association is another example of a fairly sensible 
collection of pathways to have expression differences when comparing the putative stem cells 
with controlled cells. Genes associated with the cell cycle domain in addition to cellular 
development have also been seen to be differentially expressed in transcriptional studies of 
mouse embryonic, neural and hematopoietic stem cells when compared to adult cells 
(Ramalho-Santos et al., 2002).  
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Further to this selection of associated pathways, 21 differentially expressed genes were found 
to be associated with cellular movement, infectious disease and cellular development, with a 
different set of 21 genes also having associations with cell morphology, cellular assembly and 
the organisation of connective tissue (Table 4.6). This chapter has investigated the 
transcriptome of a hypothesised stem/progenitor cell population and found that the cells 
isolated using methods and markers validated in other species display a gene expression 
profile with elements of increased metabolic synthesis (for example inositol pathway 
metabolism) and increased signalling molecule responsiveness (for example calcium 
signalling pathway).  
 
A number of other pathways were associated with three clusters of 18-19 genes out of the 
initial differentially expressed 220. Similar to previous analysis, the pathways associated with 
these three clusters are cell-to-cell signalling and interaction, tissue development, cellular 
assembly and organisation, embryonic development. These cell pathways can all be 
associated with the expected developmental and differentiation pathways the cell populations 
of putative stem cells play a role in during the development of the organ during the life of the 
animal. There are a number of pathways associated with these sets that are less than expected 
including tumour morphology, developmental disorders and cardiovascular disease (Table 
4.6). The association with stem cells and tumour morphology is an interesting link and may 
work with the current hypothesis of the stem cell origin of cancers (Rycaj and Tang, 2015). 
Other pathways that were shown to be associated with a number (16 or fewer) of 
differentially expressed genes were those of lip id metabolism, cell mediated immune 
response, tissue development, nervous system development, amino acid metabolism, 
organism injury pathways and protein synthesis. Lipid metabolism and protein metabolism 
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are essential elements of the production of milk in the mammary gland not only important for 
the maintenance of the cell membranes, the production of milk and the quality of the milk for 
commercial or animal husbandry reasons (Rudolph et al., 2007). It is possible that the 
maintenance of these pathways aids in the cell membrane function of lipids during cell 
development and the level of lipid production increases in response to lactation hormones. 
The cell mediated immune response is also essential for combating mastitis and other 
infections of the mammary gland (Sordillo and Streicher, 2002). It has also been shown in 
mice models that the cell mediated response is part of the involution cascade (Stein et al., 
2004). This involution associated gene pathways may need to be a preserved function to 
promptly respond to regenerative involution signals in the mammary gland. The presence of 
tissue development pathways with nervous system development and organism injury 
pathways may indicate a role these cells perform in normal tissue in response to cell dispersal 
and regeneration of damaged tissue. A selection of these pathways was also seen throughout 
the IPA analysis output for the putative stem cells from the two remaining cow samples (6441 
and 6525) studied. This indicates some similarities within the whole population of putative 
stem cells studied although there were a number of conserved genes that were shown to be 
differentially expressed in all of the cow samples studied (Table 4.4). However, the levels of 
this differential expression did not always remain consistent throughout the cell populations. 
There was a consistent difference between cow sample 6669 and the remaining two cow 
samples studied (6441 and 6525). As mentioned previously, the initial cells isolated from cow 
samples 6441 and 6525 were performed 20 days prior to parturition, the cells for cow sample 
6669 were isolated less than 5 days from parturition. The developmental stage difference may 
account for some of the variances between these two cell populations at the time of analysis. 
It should be noted that the conditions and treatment of all cells has been consistent since 
sampling. As the time period between sampling is so discreet (5 vs. 16-20 days to parturition) 
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there is limited literature available concerning the possible differences between these cells. 
However, when viewing Table 4.4 some trends can be seen. Both of the gene elements seen in 
Table 4.4 related to immune function (LENG8 and LRRC71) were downregulated in cow 
sample 6669. This may indicate the development of a mature immune response network in the 
mammary gland prior to parturition had already been completed. The actin associated gene 
(ACTG2) was found to be upregulated in cow sample 6669 perhaps indicating a transition 
point in the growth and development of the mammary gland for lactation. Genes that 
influence solutes and signalling responses were also seen to be downregulated in putative 
stem cells isolated from cow sample 6669 epithelial cells (SLC2537, CAMTA2 and 
GABBR1) which may indicate a transition from pregnancy to lactation energy management 
phases within the cells. The downregulation of XIST in this cell population isolated 5 days 
pre parturition may further support the notion of the cells undergoing a transitional period, 
which may have remained throughout primary cell culture.  
 
4.6.2 The 5 genes that were identified as statistically significant changes between 
the sorted control and the Lin-/CD24+/CD29+/CD61+ triple positive side 
populations 
The comparison between the putative bovine mammary progenitor cell side populations and 
control cells revealed 5 genes were differentially expressed in all of the three cow samples 
studied. The potential implications of these individual genes are explored below.  
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4.6.2.1 Chondroitin Polymerizing Factor 2 (CHPF2, MIR671) 
This enzyme is one of the participants in chondroitin sulfate synthesis (Ogawa et al., 2010). 
Chondroitin sulfate plays a diverse role in cell adhesion, cell morphogenesis, cell formation 
and in the generation of neural networks (Bao et al., 2005, Deepa et al., 2004, Morgenstern et 
al., 2001, Oohira et al., 2000, Perrimon and Bernfield, 2000, Sugahara et al., 2003). It has 
been shown in tumour microenvironments that changes occur to the structure and enzymatic 
processing of chondroitin sulfate (Kalathas et al., 2011). Given the role of chondroitin 
sulphate in cell morphogenesis and formation, higher expression might be due to the culture 
conditions resulting from passaging and trypsin treatment.  
 
4.6.2.2 Cytochrome P450, family 24, subfamily A, polypeptide 1 (CYP24A1) and 
Cytochrome P450, family 26, subfamily B, polypeptide 1 (CYP26B1) 
The enzymes of cytochrome P450, family 26 and family 24 are involved in the degradation of 
retinoic acids (Kasimanickam and Kasimanickam, 2014, Okano et al., 2012). Retinoic acids 
play a vital role in the development of the skin, in particular the dermis and epidermis (Abu-
Abed et al., 2002, Okano et al., 2012). Without the regulatory action of the cytochrome P450, 
family 26, skin development shows an aberrant morphology (Okano et al., 2012) that results 
in an impaired skin barrier and increased skin sloughing (Fallon et al., 2009, Presland, 2009, 
Scharschmidt et al., 2009). The increased expression of this gene in the stem/progenitor cell 
population may indicate a role in regulating tissue development, or an attempt to regulate the 
nutrient environment of the cells in culture. There is also a possibility that, due to the 
relationship of milk production in the mammary gland to photoperiod (Bionaz and Loor, 
2011, Bionaz and Loor, 2008), these enzymes in vitro would regulate the mammary response 
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to the photoperiod signalling of retinoic acid (Bionaz and Loor, 2011, Bionaz and Loor, 
2008). 
 
4.6.2.3 S100 calcium binding protein A8 (S100A8) 
The S100 calcium binding protein A8, also known as the myeloid-related protein 8, is 
commonly expressed in inflammatory states by damaged cells and is designed to activate 
immune cells (such as macrophages, granulocytes and monocytes)  (Foell et al., 2007, Lee et 
al., 2015). The different levels of expression of this gene in stem/progenitor cell side 
populations may be due to the danger posed by aberrant changes in these cells. If these cells 
become damaged, there is a greater chance that these cells may become malignant, thus the 
release of immune system activators may be an attempt to mitigate this risk. It is also possible 
that the damage these cells may be responding to has already stopped gene expression in the 
non-stem/progenitor cells due to stem cells having greater resistance to stressors, as seen in 
mouse hematopoietic, neural and embryonic stem cells (Ramalho-Santos et al., 2002). The 
result of this may have been the different levels of expression between the stem/progenitor 
cells and the control cells under these conditions.  
 
4.6.2.4 Aquaporin 3 (Gill blood group) (AQP3) 
The aquaporin family consists of small membrane proteins that play a role in a number of 
physiological processes (Borgnia et al., 1999). Aquaporin 3 belongs to a subset of the 
aquaporin family that is primarily selective for the passage of water, glycerol and other 
solutes such as urea (Deane et al., 2011). The changes in the expression of this molecule in 
putative stem/progenitor cells may indicate a greater level of control being exerted on the 
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intracellular nutritional environment. There is also the possibility of differences in metabolic 
activity in proliferating vs. differentiated cell populations, as seen in other stem cell 
populations (Rafalski and Brunet, 2011). The significant difference of the expression of this 
gene relative to control cells may indicate a drive towards greater responsiveness to culture 
conditions such as variations in pH, buffering capacity, metabolic waste levels, cell 
confluence, and changes in cofactor availability and trypsin passaging.  
 
4.6.2.5 Summary of the 5 genes that were identified as statistically significant changes 
between the sorted control and the Lin-/CD24+/CD29+/CD61+ triple positive 
populations 
The genes that were found to be significantly different in all three cows investigated when 
compared to the control cells were from a variety of systems and pathways within the cells. A 
number of enzymes (cytochromes) and ECM (Chondroitin polymerising factor) associated 
genes were found to be differentially expressed. This may be a reflection of the culture and 
dispersal conditions, or a reflection of the processes inherent to the putative stem cells being 
studied. In addition, there were a number of genes for receptors found to be differentially 
expressed under these conditions (e.g. Aquaporin and calcium binding receptors). The 
presence of these receptors could also be part of the inherent functioning of the cells being 
studied, or a reflection of the experimental conditions. Further work characterising these 
genes may lead to the identification of a set of genes effective in identifying bovine mammary 
stem/progenitor cells.  
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Due to the small number of genes (5), no results could be obtained from pathway analysis. 
However, pathway analysis was performed on the larger sets of differentially expressed genes 
from each individual of the three cows studied (Table 4.12, Table 4.13, Table 4.14).  
 
4.6.3 The 26 genes that were identified with statistically significant changes between the 
sorted control and the Lin-/CD24+/CD29+/CD61+ triple positive side populations 
from the cell line 6669 
In the comparison between the putative bovine mammary progenitor cells and control cells 
from cow sample 6669, 26 genes were found with statistically significant expression. The 
potential implications of these individual genes are explored below.  
 
4.6.3.1 Collagen, type VI, alpha 2 (COL6A2) 
Collagens are the protein components of connective tissues. Collagen type VI has been found 
to be part of the ECM of the liver and is expressed in small and tightly controlled amounts 
(Freise et al., 2009). The alpha 2 chain has also been identified as the binding of some forms 
of collagenases and stromelysin-1 (Schuppan et al., 1985). It is possible that the expression of 
this gene in the putative stem/progenitor cells is related to the environment of the tissue 
culture. The disruption of the cells from the microenvironment of the culture dish may mimic 
a disruption of the normal resident tissue and the remodelling responses of healing. However, 
it has been shown in studies of tammar wallaby that the phenotype of the mammary epithelial 
cell being cultured influences the nature of the ECM produced by that cell (Wanyonyi et al., 
2013). 
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4.6.3.2 SPARC related modular calcium binding 1 (SMOC1) 
The SPARC related modular calcium binding 1 (SMOC1) protein is a 51-kDa secreted 
glycoprotein that has a number of functional protein domains with serine protease inhibition 
and calcium binding roles (Zhong et al., 2010). The SMOC1 protein shares 37 % amino acid 
homology with SPARC/osteonectin, a protein with known role in adipogenesis (Kos and 
Wilding, 2010). This may indicate a greater level of metabolic activity in this cell population, 
or a greater ability to utilise available nutrients to drive the division required to achieve cell 
culture confluency in vitro and regenerative division in vivo. It has also been shown in studies 
of mouse mammary adipocytes that there is a reversion to adipocytes during the involution 
phase following lactation (Morroni et al., 2004). This may also account for the differential 
expression of this gene. 
 
4.6.3.3 Glucosaminyl (N-acetyl) transferase 3, mucin type (GCNT3) 
Glucosaminyl transferases play an important role in the synthesis of cell adhesion ligands 
(Yen et al., 2003). While the particular cell adhesion molecules produced have been studied in 
immune cells (Yen et al., 2003), there has also been a role elucidated in endothelial cells and 
in the inflammatory cascade (Fukuda, 2002, Lowe, 2002). This may increase the ability of 
inflammatory cells to bind to the putative stem/progenitor cells, perhaps allowing for immune 
response modulation in vivo. 
 
4.6.3.4 Carbonic anhydrase VI (CA6) 
Carbonic anhydrases play a role in many biological processes including the formation of body 
secretions such as saliva, gastric acid and sweat (Adeva-Andany et al., 2015). These enzymes 
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also play a role in calcium homeostasis through a role in bone metabolism (Adeva-Andany et 
al., 2015). The difference in expression of this gene between putative stem/progenitor cell  
side populations and control cells may indicate a greater role of calcium homeostasis and 
pathways of energy release in these biologically active cells. It is also possible that the tissue 
culture conditions increase the demand for carbonic anhydrase expression.  
 
4.6.3.5 Carbonic anhydrase VIII (CA8) 
This carbonic anhydrase (VIII) is an inactive isoform of the enzyme that has been found in 
high concentrations in neuronal tissue and is associated with the development of cancer and 
neurodegeneration (Aspatwar et al., 2015). Apart from studies in neuronal and associated 
tissues, limited work has been done on this gene and its product. The role of the increased 
expression of this molecule in mammary epithelial cell cultures could be the topic of further 
research given the role this gene and its product plays in other biological processes - the 
build-up of this inactive enzyme product may be an indication of aberrant cellular behaviour.  
 
4.6.3.6 Solute carrier organic anion transporter family, member 2B1 (SLCO2B1) 
The presence of the soluble carrier organic anion transporter family proteins is associated 
with drug resistance due to the ability of this family of transmembrane proteins to export 
xenobiotics and hormones (Skazik et al., 2008). In addition to this function, these transporters 
play a role in the transport of nutrients and signalling molecules (Hagenbuch and Stieger, 
2013). The differential expression of this transporter may be due to the metabolic demands of 
the putative stem/progenitor cells. This expression level could also be due to the 
responsiveness of stem/progenitor cells in tissues to biological cues, such as hormone signals 
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or the increased expression of transporters known to be present in stem cells (such as ABCG2 
dye efflux) (Zhou et al., 2001).  
 
4.6.3.7 ZFP3 zinc finger protein (ZFP3) 
Zinc finger proteins play a role in the regulation of gene expression through interactions with 
DNA and posttranscriptional modification of RNA (Yang et al., 2014). The increased 
expression of this protein in putative stem/progenitor cell side populations may indicate 
increasing levels of regulation or the transition from one activated state to another.  
 
4.6.3.8 Chloride intracellular channel 5 (CLIC5) 
The movement of signalling ions, such as chloride, plays a role in a number of biological 
processes including regulating cell volume, regulating membrane potential and regulating 
apoptosis (Kondratskyi et al., 2014, Lang et al., 2005, Razik and Cidlowski, 2002). The 
chloride intracellular channels are associated with the mitochondrial membrane, ER 
membrane and those of the nucleus and cytoplasm (Fernández-Salas et al., 2002). Changes to 
the expression levels of other chloride intracellular channels has been associated with the 
induction of apoptosis and lower expression levels have been shown to confer resistance to 
the influence of TGF-β gene expression regulation (Shukla et al., 2014). Changes to the 
expression of this gene may indicate the cells are recovering from a near apoptotic event by 
upregulating the expression of this transporter. The changes in the expression level may also 
be due to metabolic demands changes of the cell and changes to the osmotic environment the 
cells were in at the time of sampling.  
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4.6.3.9 CD83 molecule (CD83) 
The CD83 molecule is associated with dendritic cell maturation (Borges et al., 2011). The 
presence of cells with antigen presenting characteristics may indicate that a response to tissue 
disruption has resulted in the putative stem/progenitor cells expressing markers to attract and 
activate the immune system responses to injury. This may be a mechanism to allow for the 
damage to be repaired more efficiently when in an in vivo system, or part of a conserved 
maturation mechanism. 
 
4.6.3.10 Sorbin and SH3 domain containing 2 (SORBS2) 
Sorbin and SH3 domain containing 2 has been shown to be released by tissues in response to 
early stage infarction (Kakimoto et al., 2013). These proteins may be useful as a marker of 
early stage tissue damage (Kakimoto et al., 2013). It is possible that the increased expression 
of this protein in the putative stem/progenitor cells is as a result of replacement synthesis. 
This may be due to the increased metabolic capacity of these cells allowing these cells to 
mount a response to the damage done by processing in these experiments.  
 
4.6.3.11 Cysteine-rich C-terminal 1 (CRCT1) 
The cysteine-rich C-terminal 1 is associated with areas of ligaments in the periodontal region 
(Suda, 2008). This gene remains to be fully characterised but there have been associations 
with epidermal differentiation (Marenholz et al., 2001). This might be insight into a genetic 
marker of a possible differentiation pathway that plays a role in the connective deposition 
within the developing mammary gland, or in vitro for monolayer formation. 
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4.6.3.12 Cingulin (CGN) 
Cingulin has been shown to have signalling and structural roles at the cell-to-cell tight 
junctions (Yano et al., 2013). The GTPase regulatory proteins are recruited by cingulin 
indicating a role in the transfer of metabolites through the junctio ns (Aijaz et al., 2005, 
Guillemot et al., 2012). The change in the expression levels of cingulin may be a sign of 
preparation for the reestablishment of cell to cell junctions following the disruption of the 
tissue layers for this experiment.  
 
4.6.3.13 Phosphoglycerate dehydrogenase (PHGDH) 
The increased expression of phosphoglycerate dehydrogenase has been associated with ER 
negative breast cancers (Locasale et al., 2011) leading to the phosphoglycerate dehydrogenase 
gene being proposed as a candidate oncogene (Mullarky et al., 2011). High levels of 
phosphoglycerate dehydrogenase expression found in normal mammary epithelial cells of the 
basal phenotype (Haughian et al., 2012) indicate a wide range of expression values depending 
on the experimental conditions. This may be a reflection of the expression levels seen in the 
putative stem/progenitor cells or an indication of a developmental/proliferative state resulting 
from the monolayer disruption. 
 
4.6.3.14 Inhibin, beta A (INHBA) 
The inhibin beta A signalling molecule has been shown to be induced in response to PDGF-D 
(Hye Kim et al., 2015) and has been shown to have an important role in the gonadotrophin 
negative feedback during development (Muttukrishna et al., 1997). It is possible that this gene 
was upregulated as a driver for cell division in the cells studied and within the culture system. 
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4.6.3.15 SRY (sex determining region Y)-box 10 (SOX10) 
The sex determining region Y has been shown to be involved in chondrogenic differentiation 
(Gao et al., 2014) and to upregulate in response to treatment with melatonin (Gao et al., 
2014). It is possible that the expression of this marker has a role in the beginning of selection 
towards other differentiation pathways such as those cells involved in the production of ECM 
in the developing and cycling mammary gland.  
 
4.6.3.16 Complement factor I (CFI) 
This gene is a regulatory element for the expression of the immunomodulation element 
complement (Kavanagh et al., 2008). Complement is involved in antibody mediated immunity 
(Walport, 2001) particularly in response to bacterial infection. Although the differential 
expression of this gene may be due to responses to contamination in the tissue culture realm, 
there may also be another role for complement in the mammary tissue response to damage or 
disruption (Paape et al., 2002). 
 
4.6.3.17 ADAM metallopeptidase with thrombospondin type 1 motif, 3 (ADAMTS3) 
The ADAMTS3 belongs to the ADAMTS family of proteins that function in the processing of 
collagen to allow correct assembly (Kesteloot et al., 2007). This function provides connective 
tissues with structure and mechanical strength (Fernandes et al., 2001). The expression of this 
gene may indicate that the cells are responding to the disruption in the culture monolayer and 
preparing to process and produce ECM and other connective tissues.  
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4.6.3.18 Phosphoserine aminotransferase 1 (PSAT1) 
Phosphoserine aminotransferase 1 is involved in the serine biosynthesis pathway (Pollari et 
al., 2011). The change in expression seen in the putative stem/progenitor cell side populations 
may be due to the increased metabolic demands of the underlying cell state or the increased 
demands of cells preparing for cell division. 
 
4.6.3.19 Popeye domain containing 3 (POPDC3) 
The Popeye domain containing genes encode for membrane proteins that have been 
extensively studied in muscle cells (Brand, 2005) and are also found in smooth muscle cells 
(Froese and Brand, 2008). This family of proteins has a known, but little understood 
association with cAMP-binding domains (Froese et al., 2012). It is possible that the 
expression profile of this gene seen in the putative stem/progenitor cell side populations 
shows the beginnings of an interaction or transformation with cells more closely resembling 
those of the myoepithelial lineage.  
 
4.6.3.20 BOLA homolog (e.coli) (BOLA,LOC790811) 
Although the BOLA homolog gene has been studied in bacteria, the function of this gene has 
been hypothesised to infer resistance to acid stress (Guinote and Freire, 2012) and has shown 
in studies of bacteria to play a role in survival under other challenging culture conditions  
(Guinote and Freire, 2012) and exposure to penicillin (Batista and Freire, 2011). It is possible 
that the presence of penicillin or the building acidic environment of tissue culture has resulted 
in the differential expression of this gene in the putative progenitor cell populations. This may 
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mean that these cells have a greater resistance and/or survivability in challenging culture 
conditions.  
 
4.6.3.21 Ring finger protein 128, E3 ubiquitin protein ligase (RNF128) 
The ring finger proteins are a collection of protein domains with an unknown biological 
function (Gray et al., 2000). This protein domain is a cysteine rich zinc binding region (Huang 
et al., 2004). It has been hypothesised that the zinc finger domains play a role in the regulation 
of signal transduction (Huang et al., 2004). It is possible that the expression levels of this gene 
product seen in the putative stem/progenitor cells are due to the increased metabolism and 
proliferation required by these cells following other tissue culture passages.  
 
4.6.3.22 Summary for the 26 genes that were identified as statistically significant changes 
between the sorted control and the Lin-/CD24+/CD29+/CD61+ triple positive 
populations from the cell line 6669 
In order to understand what makes the progenitor cell population different from the control 
mammary epithelial cell population, transcriptome analysis of these two populations was 
performed. The genes that were found to be significantly different in all three cows 
investigated were from a variety of systems and pathways within the cells. Regulatory 
elements, such as a ring finger protein, were shown to be differentially expressed. These 
proteins are thought to regulate signal transduction within a cell (Huang et al., 2004) and may 
be responsible for modulating external signals in order to maintain the progenitor state of the 
putative mammary progenitor cells. The differential expression of matrix metalloproteases 
may indicate that this progenitor cell population has a role of regulating or modifying the 
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ECM environment. The particular metalloprotease found to be differentially expressed plays a 
role in the strengthening of the ECM (Kesteloot et al., 2007). This may also be part of the 
establishment of the stem cell niche in developing tissues (Woodward et al., 2005). 
Complement factor expression is also another indication that the progenitor cell population 
can interact with the external environment as this particular element is a regulatory factor for 
complement activation (Kavanagh et al., 2008). Differential cingulin expression may indicate 
further that this cell population is attempting to rebuild the tissue architecture, as this 
molecule is an integral part of cell junctions and cell to cell signalling (Yano et al., 2013). 
There were a number of transporter and enzyme molecules found to be differentially 
expressed in the putative bovine mammary progenitor cell population (such as phosphoserine 
aminotransferase and phosphoglycerate dehydrogenase). This indicates that the cell is not 
only modulating the external environment, but also the internal cell milieu.  
 
4.6.4 Pathway analysis output from the Partek Pathway module for cell line 6525 
enriched vs. control differentially expressed genes (1.5 fold change). 
Utilising the Partek pathway module, 5 % of the genes that were differentially expressed 
when comparing putative progenitor cells from cow sample 6525 and control cells were 
associated with cocaine addiction. The neurobiology of cocaine and other addictions is driven 
by the neurochemical dopamine (Nestler, 2005) which also plays a role in lactation in dairy 
cows (Lacasse et al., 2012). The use of a dopamine antagonist has been shown to inhibit milk 
production in dairy cows (Lacasse et al., 2012) further inferring the role of dopamine in 
lactation with dopamine acting directly on the cells of the mammary gland (Hennighausen et 
al., 2005). This may also explain the association between 3.7 % of the genes differentially 
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expressed and elements of the amphetamine addiction pathway. Given the low numbers this 
relationship would require further work to fully elucidate.  
 
Two of the associated pathways outlined by Partek pathway analysis were related to 
metabolism, in particular inositol phosphate metabolism (2.9 % of genes investigated) and 
bicarbonate reclamation in the proximal tubule (7.7 % of genes investigated). This fits with 
the overall picture of the putative progenitor cells  driving elements of expansion and growth 
as a part of a biologically active organ. However, as this is based on tissue culture 
experiments drawing this conclusion is of limited value. This limitation is compounded 
through the low numbers of significantly differing genes and further work would be required 
before this relationship is fully understood.  
 
Perhaps the most relevant pathway found to be associated with differentially expressed genes 
(2.54 %) through this analysis is the gap junction pathway (Table 4.12). Given the disruption 
of the cell monolayer in the experimental protocol it is reasonable that the cells are beginning 
to respond and attempt to rebuild the cell to cell connections. The putative progenitor cells 
may be the most robust of the cells in the culture system and this pathway association may be 
an early indication of the response of the cultured calls as a whole, given time and the right 
conditions.  
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4.6.5 Pathway analysis output from the Partek Pathway module for cow 6669 
enriched vs. control cell side populations differentially expressed genes (1.5 
fold change) 
A number of metabolic pathways were shown to have associated genes amongst those 
differentially expressed between putative progenitor cells of cow sample 6669 and control 
cells (Table 4.11). These included nitrogen metabolism (11.11 % of pathway present), 
propanoate metabolism (7.89 % of pathway present), arginine and proline metabolism 
(5.56_% of pathway present) and glycosaminoglycan biosynthesis (8.33 % of pathway 
present). The presence of increased metabolic demands of the putative progenitor cells, 
relative to differentiated cells,  or the increased responsiveness of these cells to changing 
conditions may account for the presence of differentially expressed genes of metabolism.  
 
A number of genes associated with signalling pathways were also reported (Table 4.13) with 
genes from the phototransduction pathway (10.81 % of the pathway present), calcium 
signalling pathway (3.4 % of pathway present), PPAR signalling pathway (4.44 % of pathway 
present) and the chemokine signalling pathway (3.01 % of pathway present). It is possible that 
these cells have an increased responsiveness to signals when in vivo and retain this behaviour 
in the tissue culture. This may enable the stem cell function of asymmetric division (Capuco, 
2007) to reseed the epithelial cell culture monolayer if needed in both a laboratory and 
biological context. 
  
Genes related to reabsorption and secretion was also shown to be differentially expressed. 
Genes from gastric acid secretion (6.25 % of pathway present), pancreatic secretion (4.42 % 
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of pathway present), ABC transporters (6.67 % of pathway present), synaptic vesicle cycle 
(5_% of pathway present) in addition to endocrine and other factor regulated calcium 
reabsorption (5.88 % of pathway present) were also reported. This provides further evidence 
that the putative progenitor cells studied are responding to external changes and, with the acid 
and other secretion pathways, are metabolising waste and modifying the external milieu of the 
cell suspension.  
 
Also seen was a set of pathways related to immune function and phagocytosis  - namely genes 
related to the complement and coagulation cascades (5.05 % of pathway) and Fc gamma R 
mediated phagocytosis (4.72 % of pathway present). This may reflect the normal function of 
these cells in response to tissue injury to signal for immune mediated clean-up of dead or 
dying cells. Curiously there were genes associated with the specific pathway of bacterial 
invasion of epithelial cells (4.44 % of pathway present) perhaps indicating some bacterial 
contamination in the culture. This pathway may also relate to immune function/response to 
tissue injury as well.  
 
When contrasting the analysis from the putative stem and progenitor cell enrichment 
experiments, there are some noted differences. Importantly the second analysis (control vs. 
cells enriched from Lin-/CD24+/CD29+/CD61+ cells or putative mammary progenitor cells) 
was sequenced as 100 bp reads instead of 50 bp reads. There were many more genes 
identified in the second analysis than that for the putative stem cell differential expression 
analysis and may be a result of the longer read length. Paradoxically, although more unique 
genes were identified, fewer of these genes were well annotated and similarly very few were 
identified as differentially expressed utilising normal parameters for analysis. When relating 
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this determination of differential expression to a threshold value of 1.5 fold change, more 
genes were identified as differentially expressed between the control and mammary 
progenitor cell enriched cell populations. From this modified analysis, few genes were 
identified as differentially expressed in all datasets and only 1 had a gene identity annotated 
which made ontology and pathway analysis difficult on this subset of differentially expressed 
genes.  
 
Despite the challenges of interpreting the global expression analysis, this data identified a 
number of genes associated with putative bovine mammary stem and progenitor cell function 
of cultured cells. Direct analysis of primary tissue samples could be used to further the 
understanding of the regulatory mechanisms of stem and progenitor cells; this may also 
represent a more biologically accurate analysis than cultured cells. Similar to the 
experimentation in this thesis, stem and progenitor cell populations from primary tissues 
could be isolated using FACS and further analysed using transcriptome profiling. This would 
further the understanding of the genes involved in stem and progenitor cell function in 
primary tissues as well as identifying similarities/differences to the genetic profiles of 
cultured cells. 
 
Through the course of the project, alternative analysis based on NextGen sequencing became 
cost comparable with microarray analysis but provided a significant advantage over the 
microarray platform. The RNA-seq approach has reported advantages of potentially being 
more sensitive to less abundant transcripts and has a greater dynamic range of detection 
compared to microarray analysis. As RNA-seq is also sequencing data it can be further 
examined for alternative splicing or single nucleotide polymorphisms (SNP) expression 
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analysis, although these analysis are less relevant to the initial analysis conducted in this 
project. Further, de-novo sequencing of transcripts occurs even if the genome annotation is 
incomplete, unlike microarray analysis where specific probes need to be designed and some 
transcripts could not be detected if previously not known or annotated.  
 
There are a number of experimental challenges that might impact on this analysis including 
the limited annotation of the bovine genome in comparison to the genomes of other species, 
such as human and mouse, which are more detailed. This is likely a factor in the observations 
for the progenitor cells expression analysis. Another issue may be that the isolation of cells by 
cell surface markers could be further refined similar to other studies where the level of 
expression of cell surface markers (e.g. CD29mid or high) were selected through the gating 
strategy (Choudhary, 2014). The ‘between animal’ variability is also potentially an issue 
impacting on the expression profiling analysis. A final consideration that has not been defined 
previously is that the cells being grown in culture (on plastic) may display altered expression 
patterns overtime due to the difference environment (or niche) (Liaw and Schwartz, 1993). 
This may lead to the less defined contrasts in global expression profiling observed in the 
analysis described above. As mentioned earlier, ideally primary tissue dissociation would be 
used for the isolation of these cell populations for study from a series of comparable animals  
in addition to sample collections from cows earlier in the same lactation and at multiple time 
points throughout the lactation (Perruchot et al., 2016). 
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4.7 Conclusion           
This chapter aimed to analyse the transcriptome of putative bovine mammary stem and 
progenitor cells vs. control cell populations to identify potential key expression markers of 
multipotency/pluripotency and any potential key regulatory mechanisms. RNA-seq analysis 
of the putative stem (Lin-/CD24+/CD29+/CD49f+) cell population revealed statistically 
significant different expression (either up-or down-regulated) of pathways associated with 
ECM proteins, internal structural proteins, receptors and growth modulation factors for all 
three cows studies. This result further supports the potential structural and interacting roles 
these putative stem cells may play in the bovine mammary gland. The RNA-seq analysis of 
the putative progenitor cell side population (Lin-/CD24+/CD29+/CD61+) from all three cow 
samples did not produce consistent up- or down-regulated genes in comparison to the control.  
On an individual cow level, the differentially expressed genes were seen to vary between 5-26 
genes for two cow samples (6525 and 6669) with a greater than 1.5 fold change. This 
experimental system will require refinement in order to be robust enough to detect true gene 
expression markers for stem and progenitor cells from bovine mammary tissue.  
 
The number of significantly expressed genes was determined through comparisons of sorted 
populations of putative bovine mammary stem and progenitor cells. A number of 
differentially expressed genes, including Nestin and genes for collagen processing enzymes 
were seen through this comparison. It was comforting to see a known stem cell marker 
differentially expressed, even if the profile was not what was expected. The populations of 
differentially expressed genes were further investigated through pathway analysis and links 
between the differentially expressed genes and a number of biological pathways were 
revealed. These pathways included a number of cell survival, metabolic and receptor 
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pathways. Continued investigation of these genes may provide insight into the regulatory 
processes of putative bovine mammary stem or progenitor cells that might be further 
investigated as means of in vivo manipulation.  
 
Given the complexity of acquiring putative mammary stem/progenitor cells for study it was 
thought that another more readily accessible source of bovine cells may be investigated as 
part of this project. The next chapter of this thesis investigates bovine milk as a potential 
source of stem/progenitor and other cells.   
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Chapter 5  
Cytological Analysis of the Cellular Fraction of 
Bovine Milk Samples 
 
5.1 Introduction           
Breast milk has been known to contain cells since the 17th & 18th century (Hassiotou and 
Hartmann, 2014). Subsequent investigations resulted in the classification of cells found in 
milk into the broad categories of epithelial cells and immune cells (Hassiotou and Hartmann, 
2014). From this historical perspective, advances in analysis and characterisation systems 
have allowed a more specific categorisation of these cells. Research has shown the 
populations of cells in milk to be dynamic relative to many factors such as the health of the 
mother and neonate, frequency of infant feeding and the stage of lactation (Hassiotou and 
Geddes, 2013, Hassiotou et al., 2013a). For example, an abundance of immune cells 
(estimated 70 % of cells in milk) have been found in the colostrum but decrease to around 
2_% of the cells found in milk samples from later (day 8) in lactation unless there is an active 
infection of the mammary gland (Hassiotou et al., 2013a). The remaining cells have been 
shown to be a combination of cells from the mammary epithelium, luminal epithelial cells and 
their derivative cells that synthesise milk proteins (lactocytes) (Hassiotou et al., 2013a) in 
addition to a mixture of myoepithalial and mesenchymal cell types (Cregan et al., 2007, Fan 
et al., 2010, Hassiotou and Geddes, 2013, Hassiotou et al., 2013a, Hassiotou et al., 2013b). As 
mentioned, this mixture of 2 % immune cells and 98 % luminal and myoepithelial occur in 
milk of animals that are not impacted by disease (Twigger et al., 2013). The presence of 
progenitor cells have also been shown in the populations isolated from human milk (Villadsen 
et al., 2007).   
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Putative stem and progenitor cells in the tissue of the mammary gland have been the focus of 
a great deal of research including the previous chapters of this thesis. This research has shown 
that these types of cells are present in milk (Brooker, 1980, Polanowski et al., 1976, Stoker et 
al., 1982). However, these cells are potentially not limited to the tissues of the mammary 
gland with milk cells positive for the neural stem cell marker Nestin also reported (Cregan et 
al., 2007, Fan et al., 2010). Other markers of mammary gland stem/progenitor cells such as 
CD49f and p63 have been found (Twigger et al., 2015, Twigger et al., 2013) with these cells 
reportedly demonstrating multipotent behaviour in vitro that are characteristic of two 
mammary gland lineages (CK18+ luminal and CK14+ myoepithelial) (Twigger et al., 2013). 
Other subpopulations of milk cells have been shown to be hematopoietic stem cells (CD34+) 
which have been found in colostrum and milk samples (Fan et al., 2010, Indumathi et al., 
2013). The presence of these cells may indicate communication between the bloodstream and 
milk secretions (Hassiotou and Hartmann, 2014).  
 
The purpose of hematopoietic and bipotent progenitor cells in milk secretions remains to be 
fully elucidated. These cells appear to play a role in the remodelling that occurs throughout a 
lactation cycle by influencing the tissues of the resting mammary gland and during epithelial 
expansion (Hassiotou et al., 2012, Roy et al., 2013). It has been suggested that these cells are 
ingested in large numbers by the neonate and developing infant and may have a role in infant 
development (Hassiotou et al., 2013b). A primate model has shown that cells from milk can 
remain unharmed through the digestive tract of the infant and can cross the intestinal mucosa 
subsequently providing active immunity (Goldman and Goldblum, 1997, Schnorr and 
Pearson, 1984, Weiler et al., 1983, Zhou et al., 2000b) as well as integrating into various 
tissues including the liver (Hassiotou et al., 2014). This maternal cell transfer to the infant via 
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milk continues what was already taking place via the placenta during gestation (Barinaga, 
2002). It has been shown that these microchimerism cells can survive for severa l years in the 
infant (Barinaga, 2002). Reports of microchimerism (cells from the mother implanting in 
neonatal tissues) have been shown in animals (Jain et al., 1989) as well as humans (Maloney 
et al., 1999). To date, no similar investigations of the cellular fraction of bovine milk have 
been studied. However, a study has reported the detection of cells labelled with fluorescent 
markers in the blood of lambs several hours after milk consumption (Schnorr and Pearson, 
1984). This transfer was also found to occur when lymphocytes from unrelated ewes were 
added to milk, indicating this is not a solely maternal–foetal relationship (Schnorr and 
Pearson, 1984). Research into the role and uses of the cellular component of milk is a 
developing field and while a majority of the research has been conducted in humans, the 
implications for calf health in the bovine warrants further investigation.  
 
In this chapter, FACS analysis of stem cell surface markers (CD24, CD29, CD34, CD44, 
CD49f, CD61, Sca-1, Ki67 and Nestin) from cells isolated from bovine milk samples was 
investigated.  
 
5.2 Aims            
To immunophenotype of the cells found in bovine milk using a suite of antibody markers 
(CD24, CD29, CD34, CD44, CD49f, CD61, Sca-1, Ki67 and Nestin) and to correlate the 
levels of positive cells with days in lactation and number of lactations.  
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5.3 Objectives           
 Develop a method to stain internal and external antigens to immunophenotype the 
cells isolated from bovine milk. 
 Develop a method for the characterisation of CD24, CD29, CD34, CD44, CD49f, 
CD61, Sca-1, Ki67 and Nestin positive cellular fractions from bovine milk. 
 Develop a method to determine the viability of the cells isolated from bovine milk.  
 Use data generated to investigate the temporal nature of the expression of 
immunophenotype antigens across a lactation cycle.  
 Use data generated to investigate the relationship of antigen expression and lactation 
number.  
 
5.4 Materials & Methods         
5.4.1 Animals used to obtain milk samples 
Twelve milk samples were collected from different cows (Table 5.1) representing a spread 
across the lactation stages (from 39-398 days in milk). These animals also represented 
different parities (from parity 1-8). The cows used in this study were Holstein-Friesians from 
the herds managed on a twice daily milking schedule at the Camden Campus farms of the 
University of Sydney, Australia. The cows are on pasture when not milking and are supported 
with supplementary feed while in the milking stalls.  
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Table 5.1 The details of the Cows samples for milk cell analysis. The days in lactation 
and the number of lactations at sampling were recorded.  
Cow number Days in Lactation at  
Sampling 
Number of Lactations at 
Sampling 
1085 108 3 
1101 333 3 
1104 125 4 
1128 327 3 
1218 141 3 
1296 152 2 
1319 76 2 
1478 327 1 
6690 398 8 
7011 156 5 
7028 76 5 
7046 39 5 
 
5.4.2 Methods for isolation and flow cytometry of the cellular fraction of Bovine 
milk 
5.4.2.1 Isolation of cells from bovine milk. 
The initial 50 mL of milk collected from each mammary gland quarter by manual milking 
contained the most significant concentration of cells. The collection of additional milk from 
each quarter did not significantly increase cell number. For all experiments, samples of 
approximately 50 mL were taken from each quarter of each quarter of each cow’s mammary 
gland during the afternoon milking and pooled for subsequent isolation and washing 
procedures.   
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For each cow, the first 50 mL from each of four quarters were sampled by hand stripping, 
each into a separate 50 mL tube. These samples were stored at room temperature for less than 
30 min prior to further processing. Milk samples were centrifuged at 500 xg (5810, 
Eppendorf, Australia) for 15 min. The supernatant was removed leaving 3-4 mL of milk 
covering the cell pellet, ensuring the pellet was not disturbed. Following this 45 mL of 
warmed PBS was added to the tube and the pellet resuspended by inversion. The samples 
were then centrifuged at 400 xg for 15 min. Following this the supernatant was removed 
leaving 3-4 mL liquid covering the cell pellet. The cell pellet was resuspended and the 4 
samples from each individual cow were pooled into a single 50 mL tube. A volume of 
warmed PBS was added to bring the volume of suspension in the pooled sample tube up to 
45_mL. The samples were then centrifuged at 400 xg for 15 min and the supernatant removed 
ensuring not to disturb the pellet. A fresh 5 mL volume of stain buffer (FBS) (554656, BD 
Pharmingen, Australia) was added to the tube and the pellet resuspended. Following this the 
total cell number and viability was determined using Trypan Blue counting method (outlined 
in Chapter 3, section 3.2.5). This cell suspension was separated into 1.5 mL Eppendorf tubes 
in 1 mL aliquots of 1 x 106 cells. 
 
5.4.2.2 Bovine milk cell apoptosis analysis 
The number of apoptotic cells was determined using the commercial kit CaspACE™ FITC-
VAD-FMK In Situ Marker (9PIG746, Promega, Australia) and FACS. An aliquot of milk 
cells resuspended in stain buffer (containing foetal bovine serum - FBS) was taken and placed 
into a fresh 1.5 mL Eppendorf tube. The cells were centrifuged at 300 xg for 5 min and the 
supernatant removed. The cells were then resuspended in PBS to the equivalent of 1.5 x 106 
cells mL-1. The marker was added to a final concentration of 10 µM and the solution vortexed 
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to mix. This solution was protected from light and incubated at 37 °C for 20 min. The cells 
were then centrifuged at 300 xg for 5 min, the supernatant was removed and the cells 
resuspended in 1 mL of PBS. The cell suspension was centrifuged a second time at 300 xg for 
5 min and the supernatant removed and the cells resuspended in 900 µL of PBS. To this, 
100_µL of 37 % neutral buffered formalin was added for a final concentration of 3.7 %. This 
was incubated for 30 min at room temperature, protected from light. This was followed by 3 
washes consisting of centrifugation at 300 xg for 5 min and the removal of the supernatant 
and the addition of 1 mL of PBS. After the final wash the cells were resuspended in 1 mL of 
stain buffer (FBS) and stored at 4 °C until FACS.  
 
5.4.2.3  Milk cell viability 
A sample of 1 x 106 cells milk cells was also used for further viability analysis of the milk cell 
population. This was performed using the LIVE/DEAD® Fixable Dead Cell Stain Kit (L-
34971, Invitrogen, Australia). The cells were added to a 1.5 mL Eppendorf tube and 
centrifuged at 300 xg for 5 min. The supernatant was removed and the cells resuspended in 
1_mL of PBS. To this solution 1 µL of the reconstituted fluorescent reactive dye was added 
and the solution vortexed to mix. This solution was incubated for 30 min at room temperature 
and wrapped in foil to protect from light. Following incubation the cell suspension was 
centrifuged for 5 min at 300 xg and the supernatant removed. The cells were resuspended in 
1_mL of PBS and centrifuged for 5 min at 300 xg and the supernatant removed. The cells 
were then resuspended in 900 µL of PBS and 100 µL of 37 % formaldehyde, for a final 
concentration of 3.7 % formaldehyde. This solution was vortexed and incubated at room 
temperature for 15 min protected from light. The cells were then centrifuged for 5 min at 
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300_xg and the supernatant removed. The cells were resuspended in 1 mL of stain buffer 
(FBS) and stored at 4 °C until flow cytometry analysis. 
 
5.4.2.4 Milk cell surface markers and internal antigen flow cytometric analysis 
The surface markers CD24, CD29, CD44, CD49f, CD61, Sca-1, the internal antigens Ki67 
and Nestin, and an apoptosis marker (commercial kit, CaspACE™ FITC-VAD-FMK In Situ 
Marker) were investigated (Table 5.2). Approximately 1 x 106 cells were individually 
aliquoted for each analysis. These milk cells were already suspended in stain buffer (FBS). 
The antibodies were added to this cell suspension applied at the concentrations listed below 
(Table 5.3) and incubated for 30 min at 37 °C, protected from light. Following this the cell 
suspensions were centrifuged at 300 xg for 5 min. The supernatant was removed and the cells 
were resuspended in 1 mL of stain buffer (FBS). This was wash step was repeated and the 
cells were then resuspended in 900 µL of PBS with 100 µL of 37 % formaldehyde added for a 
final concentration of 3.7 %. This solution was vortexed and incubated at room temperature 
for 15 min protected from light. The cells were then centrifuged for 5 min at 300 xg and the 
supernatant removed. The cells were resuspended in 1 mL of stain buffer (FBS) and stored at 
4 °C until FACS. 
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Table 5.2. Markers used for assessment of the milk cellular fraction. 
CD24: Mammary stem cell marker (Heat stable antigen – Cell adhesion mol ecule)  
CD29: Mammary stem cell marker (integrin beta-1).  
CD44: Breast and prostate cancer stem cells marker (hyaluronic acid receptor).  
CD49f: Mammary stem cell marker (alpha-6 integrin).  
CD61: Marker of  (integrin beta-3) 
Sca-1: Marker for hematopoietic stem cells and progenitor cells of other lineages (Ly6A/E or Ly6D). 
Ki67:  Marker of proliferating cells (MK167 gene product).  
Nestin: Marker for intermediate filament protein that is expressed in stem cells of the central nervous  
system (CNS) but not in mature CNS cells. 
Apoptosis: marker of programmed cell detail – methodology detailed in section 5.4.2.2.  
  
Table 5.3. Surface Antibodies used for the investigation of milk cells. 
Antibody Final 
Concentration 
Clone Target  Cat. No. Supplier Label 
CD24 1 in 100 ML5 Heat stable antigen 
– Cell adhesion 
molecule 
311104 BioLegend Fluorescein 
Isothiocyanate 
CD29 1 in 100 TS2/16 integrin beta-1 303016 BioLegend Alexa Fluor 488 
CD34 1 in 100 HM34 Hematopoietic 
Progenitor Cell 
Antigen 
128609 BioLegend Phycoerythrin 
CD44 1 in 100 IM7 Cell Surface 
Glycoprotein 
103015 BioLegend Alexa Fluor 488 
CD49f 1 in 100 GoH3 alpha-6 integrin 313612 BioLegend Phycoerythrin 
CD61 1 in 100 VI-PL2 Integrin beta-3 336406 BioLegend Phycoerythrin 
Sca-1 1 in 100 D7 glycosyl 
phosphatidylinosit
ol-anchored cell 
surface protein 
MCA2782
F 
AbD Serotec  Fluorescein 
Isothiocyanate 
 
A slightly modified methodology was used for antibodies with internal markers (Nestin and 
Ki67). Approximately 1 x 106 cells were individually aliquoted for each analysis. These milk 
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cells were already suspended in stain buffer (FBS). The cell suspensions were centrifuged at 
300 xg for 5 min and the supernatant removed. The cells were resuspended in a 70 % ethanol 
solution and incubated for 5 min at room temperature. This solution was centrifuged at 300 xg 
for 5 min and the supernatant removed. The cells were resuspended in 1 mL of stain buffer 
(FBS) with antibodies added at the concentrations listed below (Table 5.4) and incubated for 
30 min at 37 °C, protected from light. Following this, the cell suspensions were centrifuged at 
300 xg for 5 min. The supernatant was removed and the cells were resuspended in 1 mL of 
stain buffer (FBS). For the Ki67 antibody treatment the cells were stored at 4 °C until FACS. 
For the cells with Nestin antibody treatment the secondary antibody was added to the solution 
at the concentration listed below (Table 5.4) and incubated for 30 min at 37 °C, protected 
from light. The cell suspension was then centrifuged for 5 min at 300 xg and the supernatant 
removed. The cells were resuspended in 1 mL of stain buffer (FBS) and stored at 4 °C until 
FACS. 
 
Table 5.4. Internal Antibodies used for the investigation of milk cells. 
Antibody Final 
Concentration 
Clone Target  Cat. No. Supplier Label 
Ki67 1 in 100 MIB-1 MK167 gene 
product 
F726801 DAKO Fluorescein 
Isothiocyanate 
Nestin 
(primary) 
1 in 100 - Protein 
Marker for 
Neural Stem 
Cells 
NBP1-
02419 
Novus 
Biologicals 
N/A 
Secondary 
to Nestin 
1 in 100 2A9 Secondary to 
Nestin 
primary 
ab99704 
 
Abcam Phycoerythrin 
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5.4.2.5 Flow cytometry analysis for assessment of apoptosis, viability and antigen 
detection of bovine milk cells 
Flow cytometry was conducted on a BD FACScanto II using the following voltages set for 
each analysis: 405 nm at 100 mW (Pacific Blue), 488 nm at 200 mW (FITC), 561 nm at 150 
mW (PE). Data was collected and analysed using BD FACSDiva Software Version 6.1.3 
(build 2009 05 13 13 29). Specific gates were used to eliminate counting cellular debris, to 
calculate cells positively labelled for each antigen as well as estimates of live, dead and 
apoptotic cells.   
 
Each antigen, live/dead and apoptosis analysis was measured in triplicate from a separate 
aliquot of cells pooled from the 4 quarters of each animal. Approximately 50,000 events were 
collected for each analysis. The flow cytometry was set up to gate out counting events that 
were not cells of normal size and shape using a 1:1 ratio of forward to side scatter to eliminate 
counting larger and smaller cellular debris which may have bound antibodies. Subsequently 
control samples were run to a standard set of gates for detection of cells that exhibited 
antibody binding higher than the background. Each antibody was measured against an 
appropriate isotype control at the same concentration and blank control (Table 5.5). An 
example of this is shown below (Figure 5.1). Each sample was sampled 3 times for a set of 
technical replicates. 
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Table 5.5. List of the isotype control antibodies utilised for experimental protocols. All 
antibodies were treated at identical concentration and conditions.  
Antibody Isotype Antibody  Clone Cat. No. Supplier 
CD24 FITC Mouse IgG2a, κ Isotype Ctrl 
Antibody 
MOPC-
173 
400208 BioLegend 
CD29 Alexa Fluor® 488 Mouse IgG1, κ 
Isotype Ctrl (FC) Antibody  
MOPC-21 400129 BioLegend 
CD34 PE Armenian Hamster IgG Isotype Ctrl 
Antibody 
HTK888 400908 BioLegend 
CD44 Alexa Fluor® 488 Rat IgG2b, κ Isotype 
Ctrl Antibody  
RTK4530 400625 BioLegend 
CD49f PE Rat IgG2a, κ Isotype Ctrl Antibody  RTK2758 400508 BioLegend 
CD61 PE Mouse IgG1, κ Isotype Ctrl (FC) 
Antibody 
MOPC-21 400114 BioLegend 
Sca-1 Rat IgG2a Negative Control Antibody N/A MCA1212F AbD Serotec  
Ki67 Mouse IgG1/FITC DAK-G01 X0927 DAKO 
Nestin 
(primary) 
Rabbit IgG isotype control Polyclonal AB-105-C Novus 
Biologicals 
Secondary 
to Nestin 
Rabbit IgG  Isotype Control, PE 
Conjugate 
N/A PA5-23093 ThermoFischer 
 
Similar plots were constructed for each of the (i) labelled antibodies or (ii) for the analysis of 
cells that were live or dead or (iii) positive for staining for apoptosis. These were all 
expressed as a percentage of a defined number of cell counting events of 50,000 per sample. 
Gates were adjusted against the negative control samples to ensure that background 
fluorescence or non-specific binding was not counted. Once the gates were established for 
each antibody, the same gating parameters were utilised for each sample analysed (for eac h 
individual animal) so that different gating would not result in variation.  
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A)                                                                                        B) 
Figure 5.1. Flow cytometry gated for milk cell analysis. 
An Example of flow cytometry dot blots with A) control unlabelled cells with gates to 
detect PE labelled CD29 antibody exhibiting very few cells within the PE positive gate 
and B) labelled cells from milk with cells positive for the CD29 antibody within the PE 
positive gate and visualised and purple data points on the dot plot. 
 
5.4.3 Statistical Analysis 
The standard error of the mean of the pooled data was performed using the analysis toolpak 
add-in of Microsoft Excel 2010 (Ver 14.0.7116.5000, Microsoft, U.S.A). 
 
5.5 Results            
Figure 5.2. The mean (± SD) percentage of milk cells identified as CD24 positive plotted 
against the days in lactation (n= 12 milk samples analysed in triplicate). At 39 days there 
was a mean of 5.03 % (± 0.15 %) of counted milk cells positive for CD24. Two cows sampled 
at 76 days showed 1.07 % (± 0.31 %) and 0.8 % (± 0.0 %) of CD24 positive cells. At 108, 
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125, 141, 152 and 156 days of lactation, the following percentages of CD24 positive cells 
were observed: 3.6 % (± 0.26 %), 0.93 % (± 0.21 %), 0.87 % (± 0.23 %), 0.3% (± 0.0 %) and 
3.03 % (± 0.06 %), respectively. Two cows sampled at 327 days of lac tation demonstrated 
3.43 % (± 0.15 %) and 1.73 % (± 0.15 %) of cells positive for CD24, respectively. Cow’s 
sampled at 333 and 398 days in lactation showed 1.57 % (± 0.32 %) and 0.13 % (± 0.06 %) 
cells positive for CD24.  
 
 
Figure 5.2. The mean (± SD) percentage of milk cells identified as CD24 positive plotted 
against the days in lactation (n= 12 milk samples analysed in triplicate). 
 
The percentage of CD29 positive cells counted from milk across lactation is shown in Figure 
5.3. At 39 days there was a mean of 16.03 % (± 0.23 %) of CD29 positive milk cells. Two 
cows sampled at 76 days demonstrated CD29 positive cell numbers of 9.13 % (± 2.15 %) and 
7.8 % (± 1.33 %). At 108, 125, 141, 152 and 156 days of lactation, the CD29 positive cells 
were 17.76 % (± 0.25 %), 6.53 % (± 0.74 %), 4.30 % (± 0.91 %), 2.0% (± 0.10 %) and 
21.90_% (± 0.60 %), respectively. The two cows sampled at 327 days of lactation showed 
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8.87 % (± 0.64 %) and 9.03 % (± 0.31 %) of cells positive for CD29. The cows sampled at 
333 and 398 days in lactation showed 5.80 % (± 0.79 %) and 0.73 % (± 0.06 %) of cells 
positive for CD29, respectively. From this preliminary analysis in Figure 5.3, a decline in 
CD29 positive cells over the course of lactation was observed a lthough this trend is not 
pronounced and subject to individual cow variability.  
 
 
Figure 5.3. Mean percentage (± SD) of cells identified as CD29 positive from cow’s milk 
sampled at different days in lactation (n= 12 milk samples analysed in triplicate). 
 
The mean percentage of CD34 positive cells counted in the milk of a cow at 39 days lactation 
was 3.00 % (± 0.52 %), as shown in Figure 5.4. The CD34 positive cells for 2 cows sampled 
at 76 days were 0.90 % (± 1.21 %) and 0.07 % (± 0.06 %). Milk from cows at 108, 125, 141, 
152 and 156 days of lactation, the following percentages of positive CD34 cells were 
observed: 0.47 % (± 0.12 %), 0.27 % (± 0.12 %), 0.77 % (± 0.15 %), 0.33% (± 0.06 %) and 
0.20 % (± 0.33-16 %), respectively. Two cows sampled at 327 days of lactation showed 0.00 % 
(± 0.17-16 %) and 0.10 % (± 0.00 %) of cells positive for CD34. Cow’s sampled at 333 and 
0
5
10
15
20
25
0 50 100 150 200 250 300 350 400
P
e
rc
e
n
ta
ge
 o
f 
M
ilk
 C
e
lls
 C
D
2
9
 P
o
si
ti
ve
 
Days in Lactation at Sampling
CD29 Positive Cells in Milk Sampled at Different Stages of Lactation
 244 
398 days in lactation showed 0.0 % (± 0.0 %) and 0.00 % (± 0.00 %) cells positive for CD34, 
respectively. Although the number of cells positive for CD34 was initially low, there was still 
a decline observed over the course of the lactation sampled.  
 
 
Figure 5.4. Mean percentage of cells (± SD) identified as CD34 positive from cow’s milk 
sampled at different days in lactation (n= 12 milk samples analysed in triplicate). 
 
Figure 5.5 shows the mean percentage of CD44 positive cells counted in milk plotted against 
the day of lactation the cow was at when sampled. The mean o f 25.03 % (± 0.59 %) was 
observed for CD44 positive cells isolated from the milk of a cow at 39 days lactation. Two 
cows sampled at 76 days showed 17.90 % (± 5.66 %) and 29.13 % (± 0.72 %) of CD44 
positive cells. A percentage of 14.80 % (± 0.61 %), 33.50 % (± 5.05 %), 14.97 % (± 1.46 %), 
3.17% (± 0.06 %) and 63.27 % (± 0.12 %) was observed for cows whom milk had been 
sampled at 108, 125, 141, 152 days and 156 days of lactation, respectively. At 327 days of 
lactation, two cows sampled showed 17.33 % (± 0.20 %) and 63.20 % (± 1.32 %) of cells 
positive for CD44. The cows sampled at 333 and 398 days in lactation showed 45.03 % 
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(±_0.71 %) and 37.30 % (± 0.53 %) of cells positive for CD44. There was an upward trend in 
the number of cells positive for CD44 relative to the number of days the sampled animal had 
been lactating.  
 
 
Figure 5.5. Mean percentage of cells (± SD) identified as CD44 positive from cow’s milk 
sampled at different days in lactation (n= 12 milk samples analysed in triplicate). 
 
Figure 5.6 shows the mean percentage of CD49f positive cells counted in milk plotted against 
the day of lactation. At 39 days there was an observed mean of 10.80 % (± 0.75 %) of isolated 
milk cells positive for CD49f. The two cows sampled at 76 days of lactation showed 0.63 % 
(± 0.35 %) and 0.20 % (± 0.10 %) of CD49f positive cells. At 108, 125, 141, 152 and 156 
days of lactation, the cows sampled showed 4.80 % (± 0.20 %), 0.80 % (± 0.26 %), 1.13 % 
(±_0.21 %), 0.63 % (± 0.06 %) and 4.70 % (± 0.15 %) cells positive for CD49f, respectively. 
A further two cows sampled at 327 days of lactation showed 0.37 % (± 0.34-16 %) and 0.20 % 
(± 0.06 %) of cells positive for CD49f. The cows at 333 and 398 days in lactation showed 
0.70 % (± 0.10 %) 0.10 % (± 0.17-16 %) of cells positive for CD49f. There was an observed 
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decline in the overall trend for the number of cells positive for CD49f relative to the number 
of days the cows had been lactating.  
 
 
Figure 5.6. Mean percentage of cells (± SD) identified as CD49f positive from cow’s milk 
sampled at different days in lactation (n= 12 milk samples analysed in triplicate). 
 
The mean percentage of CD61 positive cells counted in milk at various days of lactation is 
shown in Figure 5.8. Only the samples at day 39 and 156 showed CD61 positive cells with 
both at 0.1 % positive (± 0.17%).  
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Figure 5.7. Mean percentage of cells (± SD) identified as CD34 positive from cow’s milk 
sampled at different days in lactation (n= 12 milk samples analysed in triplicate). 
 
Figure 5.8 shows the mean percentage of Sca-1 positive cells counted in milk relative to the 
lactation day of the cow when sampled. The mean percentage of positive Sca-1 cells at 39 
days was 1.80 % (± 0.10 %). Two cows sampled at 76 days showed 0.35 % (± 0.07 %) and 
0.23 % (± 0.06 %) of Sca-1 positive cells. At 108, 125, 141, 152 and 156 days of lactation, the 
mean percentage of Sca-1 positive cells were observed: 0.47 % (± 0.06 %), 0.17 % (± 
0.06_%), 0.20 % (± 0.34-16 %), 0.10 % (± 0.17-16 %) and 0.57 % (± 0.06 %). Two cows 
sampled at 327 days of lactation showed 0.60 % (± 0.00 %) and 0.30 % (± 0.00 %) of cells 
positive for Sca-1. A mean percentage of 0.50 % (± 0.00 %) and 0.07 % (± 0.06 %) were 
observed for Sca-1 positive cells sampled from cows at 333 and 398 days in lactation. 
Overall, when measured against days in lactation, Sca-1 showed a decreasing trend across the 
course of lactation. 
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Figure 5.8. Mean percentage of cells (± SD) identified as Sca-1 positive from cow’s milk 
sampled at different days in lactation (n= 12 milk samples analysed in triplicate). 
 
The mean percentage of Ki-67 positive cells is shown in Figure 5.10. At 39 days there was a 
mean of 0.30 % (± 0.0 %) for positive Ki-67i cells. The two cows sampled at 76 days showed 
0.20 % (± 0.34-16 %) and 0.10 % (± 0.17-16 %) of Ki-67 positive cells. The cows sampled at 
108, 125, 141, 152 and 156 days had a mean percentage of 0.10 % (±0.17-16 %), 0.50 % 
(±_0.14 %), 0.37 % (± 0.06 %), 0.10 % (± 0.17-16 %) and 0.63 % (± 0.06 %) for Ki-67 
positive cells, respectively. The two cows sampled at 327 days of lactation showed 0.33 % 
(±_0.06 %) and 0.67 % (± 0.06 %) of cells positive for Ki-67. The cows sampled at 333 and 
398 days in lactation showed 0.33 % (± 0.06 %) and 0.10 % (± 0.17-16 %) Ki-67 cells positive. 
Overall there was a slight upward trend in the number of milk cells positive for the Ki-67 
antigen relative to the number of lactation days.  
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Figure 5.9. Mean percentage of cells (± SD) identified as Ki67 positive from cow’s milk 
sampled at different days in lactation (n= 12 milk samples analysed in triplicate). 
 
The surface marker Nestin was also evaluated across numerous days of lactation (Figure 
5.11). The cow sampled at 39 days produced a mean of 2.83 % (± 0.25 %) for Nestin positive 
cells with the two cows sampled at 76 days showing 49.15 % (± 0.21 %) and 27.30 % (± 
0.10_%). The cows sampled at 108, 125, 141, 152 and 156 days of lactation showed 1.77 % 
(± 0.15 %), 45.90 % (± 1.13 %), 36.80 % (± 0.28 %), 36.27 % (± 0.15 %) and 39.80 % 
(±_1.45 %) positive Nestin cells. For the two cows sampled at 327 days of lactation, the 
positive Nestin cell percentage was 1.17 % (± 0.20 %) and 23.4 % (± 0.06 %). The cows 
sampled at 333 and 398 days in lactation showed 26.03 % (± 0.45 %) and 0.37 % (± 0.06 %) 
cells positive for Nestin. There was an observed decline in the number of cells positive for the 
Nestin antigen when measured against days in lactation.  
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Figure 5.10. Mean percentage of cells (± SD) identified as Nestin positive from cow’s 
milk sampled at different days in lactation (n= 12 milk samples analysed in triplicate). 
 
The mean percentage of apoptotic positive cells counted in milk from numerous days of 
lactation is shown in Figure 5.12. The 39 day sample showed a mean of 62.25 % (± 0.07 %) 
of positive cells. The two cows sampled at 76 days showed 59.00 % (± 0.57 %) and 36.85 % 
(± 6.51 %) apoptotic positive cells. A mean percentage of 58.55 % (± 0.35 %), 50.70 % 
(±_0.28 %), 62.45 % (± 0.32 %), 0.85 % (± 0.06 %) and 8.30 % (± 0.12 %) apoptotic positive 
cells were observed for cows sampled at 108, 125, 141, 152 and 156 days. Two cows sampled 
at 327 days of lactation showed an apoptotic positive percentage of 17.90 % (± 0.06 %) and 
16.35 % (± 0.20 %). The cows sampled at 333 and 398 days in lactation showed 42.90 % 
(±_0.20 %) and 1.50_% (± 0.06 %) cells positive for apoptosis. There was a sharp decline in 
the number of cells that were positive for apoptosis when measured against the lactation days.  
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Figure 5.11. Mean percentage of cells (± SD) identified as apoptosis positive from cow’s 
milk sampled at different days in lactation (n= 12 milk samples analysed in triplicate). 
 
5.5.1 Measurements of milk cell viability using the LIVE/DEAD® Fixable 
Dead Cell Stain Kit 
The mean percentage of viable cells (determined by LIVE/DEAD® Fixable Dead Cell Stain 
Kit) counted in milk relative to the lactation day is shown in Figure 5.13. Unfortunately the 
number of milk cells was limited for the cows at day 39 and 108 and as a result there are no 
viability measures for these cows. Two cows sampled at 76 days showed 18.20 % (± 0.79 %) 
and 61.33 % (± 1.27 %) viable cells. The cows sampled at 125, 141, 152 and 156 days in 
lactation demonstrated 48.23 % (± 0.23 %), 24.67 % (± 0.21 %), 15.13 % (± 0.42 %) and 
56.23 % (± 1.46 %) of positive viable cells, respectively. The two cows sampled at 327 days 
of lactation showed 51.30 % (± 0.15 %) and 72.13 % (± 0.30 %) of viable cells. For the cows 
sampled at 333 and 398 days in lactation, the mean percentage of viable cells produced was 
49.07 % (± 0.12 %) and 90.80 % (± 0.78 %). There was a sharp increase in the number of 
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cells that were viable when measured against days in lactation. This is the opposite of the 
trend observed for the apoptotic cells (Figure 5.11).  
 
 
Figure 5.12. Mean percentage of cells (± SD) identified as viable positive from cow’s 
milk sampled at different days in lactation (n= 12 milk samples analysed in triplicate). 
 
Figure 5.13 shows the mean percentage of non-viable cells measured by LIVE/DEAD® 
Fixable Dead Cell Stain Kit isolated from milk samples at various days of lactation. For the 
two cows sampled at 76 days, a mean non-viable percentage of 76.57 % (± 1.80 %) and 
36.83_% (± 1.16 %) were observed. The cows at 125, 141, 152 and 156 days in lactation 
demonstrated 50.57 % (± 0.23 %), 73.70 % (± 0.17 %), 5.70 % (± 0.10 %) and 40.30 % 
(±_0.92 %) non-viable cells. Two cows sampled at 327 days of lactation showed 22.83 % 
(±_0.12 %) and 25.23 % (± 0.15 %) of non-viable cells. The cows sampled at 333 and 398 
days in lactation showed 49.57 % (± 0.32 %) and 8.30 % (± 0.70 %) of non-viable cells. 
There was a sharp decline in the number of non-viable cells relative to days in lactation. This 
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result is similar for the apoptotic positive cells (Figure 5.11) and opposite for Ki-67 positive 
cells (Figure 5.1) and viable cells (Figure 5.12). 
 
 
Figure 5.13. Mean percentage of cells (± SD) identified as non-viable positive from 
cow’s milk sampled at different days in lactation (n= 12 milk samples analysed in 
triplicate). 
 
5.5.2 Cellular immunophenotype percentage of mammary cells isolated from milk 
correlated with lactation number  
Figure 5.14 shows the mean percentage of viable cells relative to the number of lactations the 
cows have experienced. This analysis was performed to determine if there was a relationship 
between the number of lactations a cow had been through and the numbers of cells positive 
for the suite of markers used in this chapter. For the samples from animals in their first 
lactation, the mean viability was 72.13 % (± 0.15 %). The mean values recorded for cows at 
their second lactation were 18.20% (± 0.42 %) and 15.13 % (± 0.79 %) of viable cells. The 
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mean percentages from animals in their third lactation at sampling were 24.67 % (± 0.21 %), 
51.30 % (± 0.12 %) and 49.07 % (± 0.3 %). For samples from animals in their fourth lactation 
the mean viable cells were 48.23 % (± 0.23). Animals in their fifth lactation had measured 
viable cell percentages of 61.33 % (± 1.46 %) and 56.23 % (± 1.27 %). For animals sampled 
in their eighth lactation there was a mean percentage viable of 90.80 % (± 0.78 %). There was 
an observed increase in the number of viable cells found in milk with the higher number of 
previous lactations a cow had experienced.  
 
 
Figure 5.14. Mean percentage of cells (± SD) identified as viable positive from cow’s 
milk against number of lactations (n= 12 milk samples analysed in triplicate). 
 
Figure 5.15 shows the mean number of cells that were measured as non-viable graphed 
against the lactation the cow sampled was in at sampling. For first lactation animals the mean 
non-viable cell percentage was 25.23 % (± 0.12 %). In second lactation animals the mean 
values recorded for non-viable cells was 79.56% (± 0.10 %) and 5.70 % (± 1.80 %). Mean 
percentages in third lactation animals at sampling were 73.70 % (± 0.17 %), 22.83 % 
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(±_0.32_%) and 49.57 % (± 0.15 %). Fourth lactation animals exhibited mean non-viable cell 
percentages of 50.57 % (± 0.23). Animals in their fifth lactation had measured non-viable cell 
percentages of 36.83 % (± 0.92 %) and 40.30 % (± 1.16 %). For animals sampled in their 
eighth lactation there was a mean percentage non-viable of 8.30 % (± 0.70 %). This data is an 
opposite trend to the viable cell counts (Figure 5.14) as it shows a lower number of non-viable 
cells with increasing numbers of lactations experienced by the sampled animal.  
 
 
Figure 5.15. Mean percentage of cells (± SD) identified as non-viable positive from 
cow’s milk against number of lactations (n= 12 milk samples analysed in triplicate). 
 
The mean number of cells that were measured as apoptosis positive graphed against the 
lactation the cow sampled was in at sampling is shown in Figure 5.16. For animals in their 
first lactation the mean apoptosis positive cell percentage was 16.35 % (± 0.06 %).  Mean 
values recorded for apoptosis positive cells for animals in their second lactation were 59.00% 
(± 0.06 %) and 0.85 % (± 0.57 %). The mean percentages from animals in their third lactation 
at sampling were 58.55 % (± 0.35 %), 62.45 % (± 0.32 %), 17.90 % (± 0.20 %) and 42.90 % 
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(± 0.20 %). Animals in their fourth lactation demonstrated a mean apoptosis positive cell 
percentages of 50.70 % (± 0.28). Apoptosis positive cell percentages for animal in their fifth 
lactation were shown to be 62.25 % (± 0.07 %), 36.85 % (± 0.12 %) and 8.30 % (± 6.51 %). 
The mean percentage of cells apoptosis positive for animals in their eighth lactation was 
1.50_% (± 0.06 %). The number of apoptotic cells was lower with greater lactation cycles 
previously experienced by the sample animal. This follows the data seen for cells measured as 
non-viable (Figure 5.15). 
 
 
Figure 5.16. Mean percentage of cells (± SD) identified as apoptotic positive from cow’s 
milk against number of lactations (n= 12 milk samples analysed in triplicate). 
 
Figure 5.17 shows the mean percentages of cells positive for each marker. This data was 
constructed from pooled data (n = 12 milk samples analysed in triplicate). The mean 
percentage of cells positive for CD24, CD29, CD34, CD44, CD49f, CD61, Sca-1, Ki-67 and 
Nestin was shown to be 1.88 % (± 0.03 %), 9.16 (± 0.17 %), 0.51 % (± 0.10 %), 30.39 % 
(±_0.55 %), 2.09 % (± 0.06 %), 0.02 % (± 0.19 %),  0.45 % (± 0.01 %),  0.31 % (± 0.01 %) 
and 24.23 % (± 0.13 %), respectively. For the most part there were very low levels numbers 
0
10
20
30
40
50
60
70
0 2 4 6 8 10P
e
rc
e
n
ta
ge
 o
f 
M
ilk
 C
e
lls
 M
e
as
u
re
d
 
as
 V
ia
b
le
Number of Lactations
Apoptotic cells in Milk Sampled from Animals in 
Different Lactations
 257 
of cells found to be positive for the markers utilised in this work .Nestin, CD29 and CD44 
showed higher levels of positive cells.  
 
 
Figure 5.17. Mean numbers of positive cells for all markers (±SD). 
Diversity in abundance of the percentage of cells that were identified as positive for each 
of the antibodies. These included the highly abundant CD44, which was observed in 
approximately 30.4% of cells, and the scarce CD61, which was only detected in 0.01 % of 
cells in milk.  
 
As shown in Figure 5.18, the mean number of cells that were shown to be positive for 
apoptosis from pooled data (n = 36) was 34.80 % (± 0.53). There was also demonstrated mean 
percentages of viable or non-viable cells of 48.71 % (± 0.15 %) and 39.26 % (± 0.18 %) 
respectively. The measure of cells that are apoptotic or dead (Figure 5.18) is not cumulative 
as both methodologies are measured by membrane permeability. The dead cells were 
identified by dye inclusion but the apoptosis assay measures cells that are expressing caspase 
enzymes involved in apoptosis. The concordance between these two measures potentially 
indicates that the majority of cells identified as dead were apoptotic.  
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Figure 5.18. Mean (n = 36) percentage of cells counted in milk that were apoptosis 
marker positive or measured viable or non-viable using the LIVE/DEAD® Fixable Dead 
Cell Stain Kit. 
 
5.6 Discussion            
The stage of lactation, feeding times and the health of the mother and child has been shown to 
influence the population of cells in human milk (Hassiotou et al., 2013b). A long held view is 
that cells present in milk may play a part in the normal cellular turnover in the mammary 
gland (Hassiotou and Hartmann, 2014). Previous work on human milk classified these cells as 
mesenchymal or immune cells (Czerny, 1890, Gruber, 1924, Hassiotou and Hartmann, 2014, 
Holmquist and Papanicolaou, 1956, Papanicolaou et al., 1956). More advanced techniques 
that allow single cell analysis has revealed this population of cells to be more heterogeneous 
than previously thought (Hassiotou and Hartmann, 2014) with immune cells constituting 
around 2% of the total cells (Hassiotou et al., 2013a). The remainder has been shown to 
comprise a selection of cells that are present in the ductal and alveolar lumen of the human 
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mammary gland including luminal epithelial cells (CK18+) and the cells that synthesise 
human milk proteins (β-casein positive cells) (Hassiotou et al., 2013a). These β-casein 
positive cells have been shown to constitute 32-86 % of isolated cells (Hassiotou et al., 
2013a). The relevant cell population to this study are the myoepithelial cells (CK14/SMA-
positive) found in other studies of milk cells (Cregan et al., 2007, Fan et al., 2010, Hassiotou 
and Geddes, 2013, Hassiotou et al., 2013a, Hassiotou et al., 2013b). The presence of this 
population has been suggested to contain putative progenitor cells (Villadsen et al., 2007). 
Although the presence of myoepithelial cells in milk may suggests that whole or part lobules 
are being lost and exfoliated into the milk, or perhaps myoepithelial cells are located within 
rather than outside the alveolus. Given the FACS screening procedure used is designed to 
analyse only single cell droplets it is unlikely that if this is occurring, this is the population 
being studied. 
 
While somatic cell count in bovine milk has been the subject of a significant amount of 
research, much of the detailed characterisation of the bovine milk cellular fraction has focused 
on the leukocyte or other inflammatory cell populations and the role in the mammary gland 
with respect to clinical conditions like mastitis (Barkema et al., 1998, Bradley, 2002, Kehrli Jr 
and Shuster, 1994). Researchers recently extracted the cellular fraction of milk and perform 
global transcript profiling by RNA-seq analysis to identify the bovine milk transcriptome 
(Wickramasinghe et al., 2012). This research characterised the transcriptome at discreet stages 
of lactation (transition lactation, peak lactation and late lactation) finding lactose synthesis 
enzymes were upregulated in early lactation and fat metabolism enzymes were seen 
predominantly seen throughout transition and peak lactation (Wickramasinghe et al., 2012).  
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The data in Figure 5.17 represents the investigation for the presence of the  cells that exhibit 
the cell markers CD24, CD29, CD34, CD44, CD49f, CD61, Sca-1, Ki67 and Nestin in the 
cellular fraction of bovine milk utilising immunophenotying by flow cytometry.  
 
5.6.1 Viability studies 
The LIVE/DEAD® Fixable Dead Cell Stain Kit uses a novel method to evaluate the viability 
of mammalian cells by employing two fluorescent nucleic acid stains. Live cells are identified 
by the fluorescence profile of SYTO-9, this stain is capable of permeating an intact cell 
membrane. When the cell membrane integrity fails (cells become non-viable), the nucleic 
acids are bound by the propidium iodide (PI) reactive dye that subsequently quenches the 
fluorescence of SYTO-9 (Stocks, 2004). The greater the fluorescent signal of PI, the lower the 
membrane integrity of the target cells. This kit was utilised in the flow cytometric analysis of 
milk cells isolated from bovine milk from cows at different stages of lactation. When cells are 
analysed by this methodology and initially assessed for those that have a 1:1 ratio of forward 
and side scatter by flow cytometry analysis which removes the smaller irregular cellular 
debris particles and larger droplets containing more than one cell. The protocols for this kit 
were also used to subsequently stain for cell surface or internal antigens associated with 
cellular lineage or stem cell markers (as described below). Significant methodological 
development was involved in adapting these protocols to analyse the cells in milk, which 
contains a complex mixture including fat and protein components that can impact on the flow 
cytometry analysis. Semi-purification by centrifugation and washing cellular fractions from 
milk using warmed PBS was performed as additional purification steps.  
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5.6.2 Analysis of immunophenotype of cellular fraction of bovine milk  
There was a general decline in the number of CD24 positive cells when measured across the 
lactation cycle for the numerous cows sampled. This data may represent the first investigation 
of the temporal nature of CD24 expression on cells isolated from milk samples. Other studies 
in human milk have investigated CD24 levels in milk samples in conjunction with other 
markers to identify particular cell types, such as putative mammary stem cells 
(CD49fhigh/CD29+/CD24low/Sca-1+) (Hassiotou et al., 2015, Twigger et al., 2013). Although 
the CD49f, CD29, CD24 and Sca-1 markers were not investigated together, the CD24 levels 
reported in Figure 5.2 do demonstrate low levels that could correlate with the levels found in 
these studies. This reduction in the levels of CD24 may indicate that the CD24 positive cells 
are cycled in the early stages of lactation or are retained to a greater degree as a lactation 
progresses. To fully understand this phenomenon further studies are warranted.  
 
The CD29 positive cells were observed to decline when measured across a lactation cycle. 
Other studies in human milk have investigated CD29 levels in milk samples in conjunction 
with other markers to identify particular cell types, such as putative mammary stem cells 
(CD49fhigh/CD29+/CD24low/Sca-1+) (Hassiotou et al., 2015, Twigger et al., 2013). The CD29 
levels seen in these studies differed to the CD29 levels found in Figure 5.3 with this chapter 
presenting higher levels compared to the combination of markers in side populations in 
(Hassiotou et al., 2015, Twigger et al., 2013). This could be due to the differences in 
expression between species, or the stage of lactation or the presence of suckling young in the 
human studies. All these measures may influence the levels of marker expression in milk cells  
(Hassiotou and Hartmann, 2014). It is also important to consider variations in technique and 
sampling strategies may also have played a role in the differences between the results 
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presented in this chapter and the current literature. Other studies have found CD29 positive 
cells in human breast milk at levels approaching 10-15 % (Patki et al., 2010) and this level 
was shown to increase to 96.8 % of the cells after culturing for two to six passages in DMEM. 
Overall, even the limited expression of one of the markers used for the isolation of mammary 
stem cells is an interesting outcome and should be investigated in future work.  
 
When measured across a lactation cycle, the number of CD34 positive cells was shown to 
decline (Figure 5.4). Other studies have investigated CD34 levels in human milk and 
hypothesised that the cells positive for CD34 originated from the maternal bloodstream 
(Hassiotou et al., 2014) at levels (0.7±0.2 %) comparable to those presented in this chapter 
(overall mean 0.51 % - Figure 5.17). Another study found CD34 levels at 13.07 ± 2.0 % of 
cells isolated from human breast milk samples from day 3-7 post-partum and were washed in 
a solution with DMEM (Indumathi et al., 2013), which may have affected the survival and 
expression of the CD34 antigen.  
 
There was an observed increase in CD44 positive cells when measured across a lactation 
cycle. Studies have investigated CD44 levels in cells isolated from milk samples in 
conjunction with other markers to identify particular cell types, such as putative mesenchymal 
stem cells (CD29+/Sca-1+) (Patki et al., 2010). It should be noted that these markers were 
investigated in cells isolated from milk at days 0-5 after parturition and then cultured for two 
to six passages prior to immune-staining (Patki et al., 2010). The subsequent investigations 
showed 97.6 % of cells positive for CD44 (Patki et al., 2010) which is contrasting to what was 
seen in the milk cells in this study (30.39 % (± 0.55 %), Figure 5.5). It is possible that the 
influence of culturing the cells greatly increases the number of cells CD44 positive (Patki et 
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al., 2010). It is also worth considering that the earliest day in lactation sampled in this chapter 
was 39 days compared to the 0-5 used in the investigations by Patki et al. (2010); it may be 
that CD44 levels are higher in the initial days of lactation compared to day 39 and above. 
Another study determined CD44 positive cells at a level of 5.9 ± 2.4 % on cells isolated from 
human milk samples from 1-12 months following parturition (Fan et al., 2010). These 
samples were washed and separated using culture medium (RPMI) which may have played a 
role in preserving a greater portion of the cells from the milk samples accounting for the 
differences in numbers between our study and that of Fan and colleagues (2010). The 
differences in expression between species, or the stage of lactation or the presence of suckling 
young in the human studies may also influence the levels of CD44 expression in milk cells 
(Hassiotou and Hartmann, 2014). There was a decreasing trend observed in the number of 
CD49f positive cells when correlated to days in lactation. The levels of CD49f in milk 
samples have been investigated in conjunction with other markers to identify particular cell 
types, such as putative mammary stem cells (CD49fhigh/CD29+/CD24low/Sca-1+) (Hassiotou et 
al., 2015, Twigger et al., 2013). In this chapter, the CD49f levels were lower (2.09 % (± 0.06 
%), Figure 5.6) than previous studies (Hassiotou et al., 2015, Twigger et al., 2013). This could 
be due to the differences in expression between species, the stage of lactation or the presence 
of suckling young in the human studies. All these measures may influence the levels of 
marker expression in milk cells (Hassiotou and Hartmann, 2014). Other studies have found 
CD49f positive cells in human breast milk at levels approaching 11.4 % (Patki et al., 2010). 
The levels of CD49f after culturing for two to six passages in DMEM were not given, but it 
was mentioned that there were still colonies staining positive for this marker (Patki et al., 
2010). 
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A trend toward decreasing numbers of cells positive for CD61 were observed in the studies 
correlated with days in lactation. Other studies of CD61 levels in milk samples and associated 
CD61 detection with a structurally similar excreted oligosaccharide that mediated cell 
adhesion (Klein et al., 2002). This may account for the very low levels of CD61 expression 
(0.02 % (± 0.19 %) detected in the bovine milk cell populations studied (Figure 5.17).  
 
The number of cells isolated from milk shown to be positive for Sca-1 decreased across a 
lactation cycle (Figure 5.8), although these numbers were on average very low (0.45 % (± 
0.01) (Figure 5.17). Human milk cells have been investigated for the presence of cells 
positive for Sca-1 (Hassiotou et al., 2015, Patki et al., 2010, Twigger et al., 2013). The Sca-1 
levels seen in Patki et al. (2010) at 10-15 % at isolation was shown to increase to 49.4 % by 
passage four. This could be due to the differences in expression between species, or the stage 
of lactation or the presence of suckling young in the human studies. All these measures may 
influence the levels of marker expression in milk cells (Hassiotou and Hartmann, 2014). The 
presence of Sca-1 positive cells, even at low levels may be applied to further studies to utilise 
stem cells isolated from milk samples.  
 
The Ki-67 positive cells were shown to increase in number across a lactation cycle (Figure 
5.9). Overall the mean numbers for Ki-67 expression in the milk cell population was very low 
at 0.31 % (± 0.01 %) (Figure 5.17). Cells isolated from human breast milk were assayed for 
the proliferation marker, Ki-67. The work in Kourtis et al. (2007) demonstrated levels of Ki67 
expression at 2.6 % (range 0.8 % - 10.2 %) in breast milk CD4+ T cells and 5.1 % (range 1.4 
% - 15.1 %) in CD8+ T cells (Kourtis et al., 2007). This differed from the mean Ki67 positive 
cells in this study (0.3 % - Figure 5.17), however it is worth noting that the values extracted 
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from the T cell study were based on the proliferation of a small subset of the population of 
milk cells compared to the whole milk cell population assayed in this chapter. This work 
demonstrates that a relatively low number of the cells found in milk, unde r these conditions 
were viable.  
 
Nestin positive cells isolated from milk samples were shown to have a tendency to decrease 
when related with days in lactation (Figure 5.10). The average numbers of Nestin positive 
cells was relatively high at 24.23 % (± 0.13 %) compared to other markers used in this 
Chapter (Figure 5.17). Nestin levels in cells isolated from milk samples have suggested 
Nestin is an ectodermal progenitor cell marker (Cregan et al., 2007, Hassiotou et al., 2013a). 
Nestin has also been shown to be induced under culture conditions for neurological 
differentiation (Hassiotou et al., 2012). Investigations into the expression levels of Nestin in a 
population of human milk cells found that breastmilk cells, relative to fibroblasts OCT4 
transfected breast cells and human mammary epithelial cells, have a higher expression of 
Nestin (Twigger et al., 2015). The presence of Nestin positive cells at relatively high levels 
may be useful in the future experiments to study stem cells.   
 
5.6.3 Apoptosis 
The flow cytometry apoptosis detection kit utilises the pan-caspase inhibitor carbobenzoxy-
valyl-alanyl-aspartyl-[O-methyl]-fluoromethylketone, also known as Z-VAD-FMK, which 
has been modified to include a fluorescein isothiocyanate (FITC) fluorescent molecule. This 
modified pan-caspase inhibitor binds irreversibly to activated caspase molecules and is not 
able to penetrate healthy cell membranes thus limiting the number of binding sites and the 
fluorescent signal from live cells. However, when the cell begins to lose viability the cell wall 
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becomes permeable to the molecule and the modified pan caspase inhibitor can bind to many 
more activated caspases. This increased access to binding sites increases the fluorescent 
signal from cells that are undergoing apoptosis resulting in an increased fluorescence level for 
the apoptotic population.  
 
The number of cells counted in milk exhibiting signs of apoptosis was shown to have a 
decreasing trend across a lactation cycle (Figure 5.11). The mean of apoptosis positive cells 
was 34.80 % (± 0.53) (Figure 5.18) among the cells isolated from bovine milk. While there is 
a great deal of research addressing the anti-  or pro-apoptotic properties of proteins found in 
the milk of various species, to our knowledge a study of the apoptotic state of the cells that 
are isolated from milk samples has not been published. However, there have been studies on 
the viability of the cells isolated from bovine milk samples. Using manual milking techniques 
(by hand) it was shown that the viability of the cells isolated from milk was lowest in early 
lactation (9 ± 3 days), at around 40 %, increasing in mid lactation (127 ± 10 days) to close to 
60 % and was the highest in late lactation (271 ± 12 days) at close to 62 % viability 
(Vangroenweghe et al., 2001). The results outlined in this chapter resemble the data presented 
by Vangroenweghe et al. (2001). However it should be noted that Vangroenweghe and 
colleagues (2001) stated that the data collected was highly variable as a repeated study found 
an increase from early to mid- lactation in terms of cell viability, but a decrease in cell 
viability from mid to late lactation (Vangroenweghe et al., 2001). An animal having to wait to 
be milked, sometimes hours longer than normal could account for variations in the number of 
viable and apoptotic cells found in the population of milk cells as it has been shown that milk 
accumulation can trigger mammary epithelial cell apoptosis (Marti et al., 1997). This may be 
another consideration for the unexpected decrease in the number of apoptotic cells as lactation 
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progresses. This may be due to a reduced number of tissue dwelling adult stem cells resulting 
in a more efficient or fastidious lineage of cells. This may account for the gradual decline in 
milk production in later lactations and also the reduced number of apoptotic cells seen in this 
study. 
 
Overall this work viewed in conjunction with the conventional understanding of the cellular 
fraction components of milk would suggest that the cells found in milk are either leukocytes 
or other cells associated with immune function in the mammary gland or are mammary tissue 
cells that have been eliminated into milk as part of normal cellular turn over (Buehring, 
1990). Cell viability was assessed over the course of lactation and between lactations with 
some interesting but potentially confounding patterns emerged. When looking at Figure 5.11 
and Figure 5.13 together, there appears to be a marked decline in number of viable cells with 
increasing days in lactation. This would appear to be contrary that which has been observed in 
previous chapters studying the cellular cytodynamics in bovine mammary tissue. The cells 
present in milk may have been sloughed off as part of the natural cycling of the mammary 
gland which may account for the lower viability (Dulin et al., 1983). This is somewhat at odds 
with what was observed at a histological level with the percentage of apoptotic cells 
increasing as the lactation progresses (Figure 5.11). This observation corresponds with the 
current understanding of cellular cytodynamics in the bovine mammary gland that apoptotic 
cell number increased the further into lactation mammary tissue is sampled (Wilde et al., 
1997a). It is important, however, to note that the behaviour of the milk cellular fraction may 
not directly mirror the gland cytodynamics as milk may be a mechanism to remove unwanted 
cells. Similarly, the observations made when the data is expressed against parity or number of 
lactations (Figure 5.12 and Figure 5.13) is also interesting in that there may be an association 
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with a trend towards a decrease in non-viable, and an increase in viable cells, is seen. It is 
important to note however that the samples were not matched for the stage of lactation and 
therefore this factor may influence the results as the numbers of samples from any individual 
time point in a lactation is small. The relatively low number of samples analysed also limit the 
conclusions that can be drawn from this analysis. Importantly from Figure 5.17 and Figure 
5.18, it is evident that in this cohort of samples, there does not seem to be an association 
between stage of lactation and total cell number but there does seem to be an association 
between number of cells isolated from milk and the number of lactations a cow has 
experienced as shown in Figure 5.13 and Figure 5.14. An explanation for this could be given 
by the gradual decline in the integrity of tight junctions between bovine mammary epithelial 
cells with increasing days in lactation. As lactation progresses toward involution, the 
deterioration in the tight junctions is demonstrated by increases in the relative concentrations 
of blood constituents like albumins (which are also synthesised by mammary gland cells) in 
milk and the identification of milk protein in serum of cows (Politis et al., 1989, Sheldrake et 
al., 1983). This phenomenon may also account for the increases seen in total cell numbers in 
cow milk as lactation number increases.  
 
The total cell number in the milk samples do not appear to be influenced by the number of 
days in lactation under these conditions and it would seem that many of the markers decline 
over the course of lactation. This was observed as a basic trend for cells exhibiting the 
markers CD24, CD29 and CD49f. These were the markers for putative mammary stem cells 
(Stingl et al., 2006) and when enumerated in the histological sections showed a comparable 
trend (Figure 2.30). However it is not strictly analogous, as the histological analysis was 
conducted on sections from late pregnant and involuting mammary gland samples which are 
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not in a physiological state of lactation (See Chapter 2). Other markers, such as Sca-1 (Figure 
5.8) showed a similar trend but a very low level of detection. Although it is hard to draw 
conclusions from this low level of expression detection in this initial work. Further 
investigations may allow for a greater understanding of Sca-1 and other low detected 
molecules. The marker CD61 (marker for mammary progenitor cells) was also detected at 
lows levels, making conclusions difficult, but suggesting that fewer proliferating cells or that 
cells exhibiting stem or progenitor cell markers may decline in frequency with lactation stage. 
This is aligned with the generally accepted view of mammary gland cytodynamics over 
lactation (Asselin-Labat et al., 2007).  
 
The observation of the marker Nestin (Figure 5.10) was also surprising in that the anticipated 
result was that this antibody would be expressed at low levels in bovine milk cells as it is a 
marker for neural stem cells (Zimmerman et al., 1994). Similarly, the observation of increased 
evidence of CD44 (Figure 5.5) in the cellular fraction of milk across lactation was also not 
expected as it is a known marker for neoplastic cells in mammary tissue (Nishi et al., 2014). It 
is difficult to suggest what these results might mean without further investigation. It could 
simply indicate binding to a similar antigen or it could mean that within the cellular fraction 
these markers have significantly different functional roles.  
 
The current investigations should be viewed within the context that these were preliminary 
studies and that future investigations of the cellular fraction of milk will require additional 
development in order to consider specific and defined analysis. There are a number of the 
issues that limit the interpretation of the results presented in this chapter. This includes the 
relatively low number of samples for each day of lactation and for each of the distinct days in 
 270 
lactation. The influence of disease status may also play a role in the number and viability of 
cells found, as infection would logically result in an increase in the number of immune cells 
located in the luminal compartment and therefore found in milk. This is of course the basis of 
the use of somatic cell count as an index of milk quality and animal health (Riollet et al., 
2001). This aspect was not investigated in the present study with samples that indicated 
contamination (e.g. blood within the sample) being discarded and not included in the analysis. 
None of the animals sampled showed any signs of mastitis. The final constraint to the pilot 
study was that the samples were collected from different animals rather than successive 
sampling from the same animals over the course of lactation or between successive lactations. 
Such an approach would better estimate the changes that may occur in the milk cellular 
fraction within this physiological context. The timing of sample collection could also be 
further considered with sampling in early lactation, immediately post parturition, being a time 
when the potential for microchimerism in the neonate is a possibility.  
 
5.7 Conclusion            
The aim of this chapter was to characterise (immunophenotype) the cells found in bovine milk 
using a suite of antibody markers (CD24, CD29, CD34, CD44, CD49f, CD61, Sca-1, Ki67 
and Nestin) and to correlate the levels of positive cells with days in lactation and number of 
lactations. A method to isolate cells from bovine milk samples and to stain internal and 
external antigens of cells isolated from bovine milk was successfully developed. Low levels 
of CD34, CD61, Sca-1 and Ki-67 were found in the cells isolated from bovine milk samples. 
However, higher levels of CD24 and CD49f were observed. The antibodies with the highest 
levels of expression were CD44 and Nestin. This data presents an interesting insight into the 
cell population of bovine milk. The presence of CD44 (a known marker of mammary cancer) 
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in a number of the cells found may indicate that cells transitioning to a cancero us state are 
disposed of through the milk. The presence of high levels of Nestin positive cells may open 
an interesting avenue to isolate neuronal stem cells (Nestin positive) for study. In 
consideration of the primary use of milk (providing nutrition for calves), the identification of 
these putative stem and progenitor cells in milk indicates an interactive environment between 
the mammary gland and milk.  
 
The viability of the cells found in the bovine milk samples was also investigated. On average 
almost 50 % of the cells isolated from bovine milk samples were found to be viable. 
However, around 35 % of the cells were found to be positive for markers of apoptosis as well. 
Although the cells isolated from the bovine milk samples were unable to be cultured, the data 
indicated that close to 50 % of the cells in this population are viable and may make this worth 
investigating in future work. With successful culturing, these cells could be characterised 
further through techniques such as FACS and immunostaining and genetic profiling.  
 
The temporal nature of antigen expression across lactations was also investigated in this 
chapter. A number of antigens declined across a lactation (CD24, CD34, CD49f. CD61, Sca-1 
and Nestin). This may indicate a reduction of the cells in the mammary tissue that are positive 
for these markers, leaving fewer to move into the milk. The markers CD44 and Ki-67 were 
found to increase across a lactation. This may indicate the increased incidence of CD44 
precancerous cells as the lactation continues and for the increase in Ki-67 this may be due to 
changes in the cell numbers of the mammary gland as the lactation persists. This data is 
interesting when coupled with the investigation of the relationship of cell viability and 
lactation number. The number of apoptotic cells was found to decrease the more lactations a 
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cow has experienced. This was also seen with the numbers of non-viable cells found in the 
bovine milk samples. The more lactations a cow had experienced meant a higher level of 
viable cells found in the milk specimens.  
 
Overall the data presented in this chapter is a first investigation into the cells found in bovine 
milk samples when characterised with a suite of stem cell markers. These stem cell markers 
also showed patterns of expression based on the day in lactation an animal was at and the 
number of previous lactations an animal had undertaken. This pattern of cells in the milk cell 
population may have implications for the growth and development of the neonate given the 
relationship between early feeds and maternal cell microchimerism. Further work will be 
needed to fully understand and elucidate these trends in antigen expression in bovine milk 
samples. Similar to other experimentation within this thesis and despite the challenges of 
interpreting the global expression analysis, cell populations from milk samples could be 
isolated using FACS and further analysed using transcriptome profiling. This direct analysis 
of the cells isolated form milk samples could be used to further the understanding the role and 
identities of these cells.  
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Chapter 6  
General Discussion 
 
This thesis investigated potential bovine mammary stem and progenitor cell markers in 
histological sections and milk at three stages of lactation (late pregnancy, peak lactation and 
involution) using cell surface markers. Previous research has investigated markers of 
mammary stem and progenitor cells in prepubertal heifers that were studied at only one time 
point (Capuco, 2007). The findings presented in this thesis show the quantification of putative 
stem and progenitor cell markers in bovine mammary tissue at three distinct time points 
across a lactation cycle. This not only demonstrated that the antibodies chosen may be 
appropriate for use in bovine tissues; it also provided insight into the cytodynamics of 
lactation and some of the underlying tissue biology.  The histological location of cells positive 
for the markers used in this thesis supported what was already present in the literature 
(Capuco et al., 2001, Rauner and Barash, 2012, Visvader and Smith, 2011, Visvader and 
Stingl, 2014) and expands this knowledge to include other time points in the lactation cycle of 
the mammary gland. This study is a starting point to more extensive studies. The appearance 
of expected markers, such as Nestin, reduces the probability that the gene changes observed 
were due to chance and may speak to the usefulness of the experimental protocols developed.     
 
Histological investigation of bovine mammary tissue samples 
To ensure that the binding of experimental markers was valid, the tissue integrity of biopsy 
samples was first determined using H&E staining. This showed the tissue biopsies to be intact 
with late pregnancy and peak lactation tissue alveolar subunits surrounded by limited stromal 
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tissue, and involuting tissue with little to no identifiable alveolar structure and increased 
stromal tissue. This histological arrangement was similar to previous reports in cows (Long et 
al., 2001). The alveoli are the milk-producing subunits of the mammary gland and therefore 
structural arrangements would be necessary prior to parturition in preparation for milk 
availability for the new born calf. In involution, alveoli is no longer required and the bovine 
mammary gland increases stromal and adipose tissue during this period of regeneration 
(Choudhary, 2014). It should be noted that some of the lactating tissues used in these 
experiments may appear to have been sampled post milking, i.e. alveoli relatively empty with 
wide stromal areas. This may also be an artefact of the freezing process where alveolar 
contents may have escaped due to freeze fracturing of the tissue prior to mounting it on the 
slide. This could also be a result of a biopsy procedure where narrow biopsies are taken and 
the majority of ducts are cut, allowing alveolar contents to escape. Alternatively it could 
reflect variation in the lactational state of the tissue at the site of the biopsy. To remedy this 
future work could involve the immediate formalin fixation of biopsied samples for 
comparison to the frozen tissues.  
 
Proliferation vs. apoptosis in tissue sections and milk 
The number and location of proliferating (Ki-67) and apoptotic cells in tissue sections from 
the three stages of lactation (late pregnancy, peak lactation and involution) was performed 
using colourimetric visualisation (Chapter 2). This ratio was also investigated in milk cells 
using flow cytometry (Chapter 5). The histological results showed increased levels of 
apoptotic cells as the lactation progressed relative to decreased numbers of proliferating cells 
and corresponded to the stage of lactation. The opposite observation was found for the milk 
samples. The Ki-67 (proliferating) positive cells in the tissue and milk samples had low 
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percentages relative to the apoptotic cells. This may be due to the mammary gland retaining 
its healthy and proliferating cells. It should also be considered that these Ki-67 cells could be 
from a different tissue (e.g. immunological) and would require further characterisation to fully 
elucidate the origin. However, the apoptotic percentage for the milk samples produced the 
highest percentage comparatively to the histology tissue. This observation is potentially due 
to the mammary gland removing the dying or dead cells by concentrating and eliminating this 
cell fraction in the milk.  
 
The ratio of proliferating vs. apoptotic cells is important for milk production. It has been 
reported that milk production is a function of cell output as opposed to the number of cells 
(Capuco et al., 2001). From a biological perspective, the cow is able to produce sufficient 
milk for the calf while also maintaining the energy balance required by the cow itself (Capuco 
et al., 2001). Should this trend of decreasing proliferation vs. increasing numbers of apoptotic 
cells over a lactation be disrupted, the cow would experience a greater NEB and result in 
impaired fertility, decreased infection resistance and reduced future milk production (Pryce et 
al., 2004). Such an occurrence would result in large financial losses for the farmer. Further 
research to identify the optimal ratio of proliferating vs. apoptotic cells in bovine mammary 
glands with easily accessible methods of measuring this ratio could assist with high milk 
yield, maintaining fertility and prolonged lactation. The ability to control and influence the 
ratio of proliferating and apoptotic cells could potentially minimise the financial burden for 
farmers.  
 
Putative bovine mammary stem and progenitor cells identified by CD24, CD29, CD49f and 
CD61 
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For this thesis, the combination of cell-surface markers CD24/CD29/CD49f was used to 
identify putative bovine mammary stem cells with putative bovine progenitor cells identified 
by the CD24/CD29/CD61 combination. The CD markers were analysed individually in the 
tissue histology (Chapter 2) and milk samples (Chapter 5). The anti-CD marker antibodies for 
CD29, CD49f and CD61 had previously been used in humans and mice studies in various 
combinations (Visvader, 2009) and have known reactivity with bovine cells. The exception 
for this thesis is CD24 that was custom made specifically for bovine reactivity (deta ils in 
Chapter 2). Individual application of these CD markers for the histologically section 
identified (Chapter 2) that low levels of CD24 and CD61 were found in the stromal regions 
during late pregnancy and peak lactation (identified by colourimetric analysis). It is possible 
that these locations indicate a stem and progenitor cell niche within the mammary gland to 
assist with repopulation of cells within the stroma and alveolar subunits. Comparatively, 
much higher levels of CD29 and CD49f were observed throughout the lactation states; this 
higher level is potentially due to the imaging technique (fluorescence) however previous 
research has identified high CD29 and CD49f levels comparatively to CD24 (Rauner and 
Barash, 2012).  
 
The CD29 positive cells were consistently seen lining the basal cells of the alveoli in both late 
pregnancy and peak lactation whereas the CD49f cells were lining the alveoli subunits. Both 
of these cell surface markers are integrins and have a role in the structure of tissues giving  
shape through cell-to-cell interactions as well as self-renewing capabilities (Ying et al., 2008). 
The importance of the role for CD29 in tissue structure was demonstrated by Li et al. (2005) 
using CD29 knock-out mice; impaired alveolar unit formation and architecture and the 
inability to repopulate cleared fat pads in these deficient mice was demonstrated in this study. 
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Although this study was performed in mice, it shows the importance of CD29 in alveoli 
architecture within the mammary gland and that the stem cells features including self- renewal 
are necessary for this structural maintenance. Similarly, CD49f has reported activities in 
maintaining alveolar architecture (Yu et al., 2012) and consists of stem cell properties i.e. 
self-renewal potential and multipotency (Yu et al., 2012). The percentage of CD29 in the 
tissue and milk samples produced the highest percentage of the markers for putative bovine 
mammary stem and putative progenitor cells. The CD49f percentage was also high in the 
tissue sections but low in the milk samples. A possible explanation may be due to the 
anchorage role of CD49f in maintaining tissue structure and that potentially these cells may 
eventually no longer express high levels of CD49f and are therefore able to move into the 
milk; this could also be of benefit to calf growth and development. The observation of CD49f 
lining the alveolar subunits in the late pregnancy and peak lactation tissue implies that these 
cells are important to the functioning and structure of the milk producing units.  
 
The transition from late pregnancy to involution showed consistent decreases in CD marker 
results for CD24, CD29, CD49f and CD61 in both tissue and milk samples. However, CD49f 
showed the largest decrease with 30 % in the tissue sample. This result is potentially due to 
the role CD49f plays during late pregnancy and peak lactation in terms of milk production 
and tissue structure and during involution where this role shifts mainly to maintaining tissue 
structure during the dry period until the next pregnancy. Further support is provided by the 
histological investigations which showed the distribution of these CD markers throughout the 
stromal tissue. During the involution period in bovine, it is known as a regenerative period 
that involves the maintaining of tissue in preparation for a concurrent pregnancy due to 
hormonal signals and does not resemble involution in other species e.g. rats that have a 
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complete tissue reversion similar to pre-pregnancy (Chepko and Dickson, 2003). This may 
also explain the presence of CD24, CD29, CD49f and CD61 in the involuting bovine tissue 
samples. The stem cell population in cows may potentially be manipulated during the 
involuting period to increase the milk-producing potential of subsequent lactations.  
 
Fluorescence activated cell sorting of bovine mammary epithelial cells in tissue samples 
from late pregnant animals 
The putative bovine mammary stem and progenitor cell populations from cultured primary 
bovine epithelial cells were initially depleted of linage committed cells (Lin+) using magnetic 
bead separation. The putative bovine mammary stem cell side populations were isolated by 
FACS based on the expression of Lin- /CD24+/CD29+/CD49f+ cells. This combination of 
markers has previously been used in mice and humans to identify putative mammary stem 
cells (dos Santos, et al., 2012). The combination of Lin-/CD24+/CD29+/CD61+ has been 
reported to identify putative mammary progenitor cells in humans and mice (dos Santos, et 
al., 2012). The isolated populations demonstrated a higher percentage of triple positive cells 
than the work in humans and mice (dos Santos, et al., 2012). This higher percentage is 
potentially due to the lineage depletion step that allowed the identification of a higher 
proportion of triple positive cells. In this thesis, these populations of putative stem and 
progenitor cell side populations isolated from bovine mammary epithelial cells by FACS were 
further analysed using functional assays (mammosphere formation) and RNA-seq 
(transcriptomic analysis).  
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Functional analysis of putative bovine mammary stem and progenitor cells determined by 
proliferative analysis and mammosphere formation 
The proliferative ability of isolated Lin-/CD24+/CD29+/CD49f+ and Lin-
/CD24+/CD29+/CD61+ cells were investigated as a part of the functional analysis of these 
triple positive populations. Statistically significantly higher levels (compared to the control) 
for proliferation rates was observed for these two populations following seven days of 
culturing (Chapter 4). This observation is potentially due to the highly concentrated 
population of putative stem and progenitor cells that influenced the environment creating 
conditions favourable for proliferation. The RNA-seq results for the putative stem cell 
population showed differentially expressed genes for the production of extracellular matrix 
proteins (Versican), internal structural proteins (Keratin 14 and alpha 2 Actin), receptors 
(Gamma-aminobutyric acid B receptor, 1) and growth modulation factors (Insulin- like growth 
factor binding protein 2 and platelet-derived growth factor, beta polypeptide). These gene 
results provides support for the increased proliferative results for the putative stem cell 
populations with the foundation of ECM and internal structure genes for individual and cell-
to-cell stability and growth modulation factors that potentially encourage proliferation. The 
putative progenitor cell population was also found to differentially express a number of genes 
for ECM proteins (Chondroitin Polymerizing Factor 2), metabolic and signalling pathway 
proteins (cytochrome P450, family 24, subfamily A, polypeptide 1, cytochrome P450, family 
26, subfamily B, polypeptide 1, S100 calcium binding protein A8) and membrane transporters 
(aquaporin 3). The differential expression of these gene elements supports the finding of 
increased proliferative potential seen in the population of putative bovine mammary 
progenitor cells. In particular, the ECM protein for tissue monolayer stability, the metabolic 
and signalling pathway for growth and development and the membrane transporter for greater 
uptake of substrate for growth. However, it is unlikely this limited number of genes solely 
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account for the increased proliferative potential of these cell populations. In order to fully 
understand the influence of these genes and their products on the proliferative capacity of 
bovine mammary epithelial cells further investigations are needed.  
 
The putative bovine mammary stem/progenitor cell side populations were cultured under 
mammosphere formation conditions, on Matrigel. Neither population was observed to have 
increased mammosphere formation potential relative to control cells. In addition, the size of 
the mammospheres formed under these conditions did not statistically differ between putative 
bovine mammary stem/progenitor cells and control cells. This could be due to the Matrigel 
ECM being of murine origin, and may lack suitable components for bovine stem/progenitor 
cells. A bovine ECM or the use of ultra- low attachment conditions may show a significant 
difference between stem/progenitor cell mammosphere formation and control cells. However, 
a trend was observed for the putative stem and progenitor cell populations with lower 
mammosphere numbers and mammosphere surface area than the control populations. This 
could indicate the need to isolate a further subpopulation of the putative stem and progenitor 
cells in addition to investigating other ultra- low attachment conditions to facilitate 
mammosphere formation. Also, the mammosphere formation of primary tissue cells samples, 
isolated using the same suite of markers outlined in this thesis could be compared with the 
mammosphere formation efficiency of a population of cells depleted of putative 
stem/progenitor cells. Mammosphere investigations on Matrigel have focused on primary 
mammary cells from humans (Dontu et al., 2003) and mice (Dong et al., 2013). These studies 
used markers of lineage commitment in addition to markers for stem and progenitor cells 
(Dontu et al., 2003; Dong et al., 2013). Nonetheless, this work demonstrated techniques for 
the isolation and initial functional investigations of the putative bovine mammary stem and 
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progenitor cell populations. The demonstration of increased proliferation capacity in these 
populations was a promising sign of stem and progenitor cell activity. There have been other 
studies utilising sorted bovine mammary cells to form mammospheres (Rauner and Barash, 
2012). These studies looked at mammosphere formation potential over a number of 
generations of dispersal and reformation to observe differences between control and target 
cell populations (Rauner and Barash, 2012). The gold standard for the evaluation of 
mammary stem cells in other species has been the use of a xenograft mammary repopulation 
study (Eirew et al., 2008). The protocol for the isolation of putative bovine mammary stem 
and progenitor cells presented in this thesis could be quite useful in studies with this 
functional assessment endpoint.   
 
Expression of CD34, CD44, Sca-1 and Nestin in milk samples.  
The presence of cells positive for CD34 and CD44 and Sca-1 in milk samples was determined 
through flow cytometry. The identification of cells positive for these markers was to 
determine if other populations of putative stem cells were present in the cell fraction of milk 
samples. Low levels of CD34 and Sca-1 were identified (<1 %) with both exhibiting a 
decrease in number with increasing days in lactation. Being associated with a hematopoietic 
stem cell marker (CD34) and an antigen that has been put forward as a marker of stem cells 
(Sca-1), the positive result is favourable for other potential stem cells to be isolated from the 
cellular fraction in milk. The higher levels of CD44 (>30 %) was observed. This CD marker 
has been associated with human breast cancer cells and is often used in studies of breast 
cancer stem cells isolated from human tissues (Perrone et al., 2012). However, CD44 in dogs 
is utilised as a marker of mammary side population cells with mammosphere formation 
potential with Sox2 and Oct4 expression (Ferletta et al., 2011). The presence of CD44 in 
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bovine milk may not necessarily indicate a cancer cell type. Nestin positive cells were also 
found in the cell population of bovine milk and showed a mean of 24 %. The Nestin gene was 
downregulated in all three populations of putative stem cells analysed by transcriptomics 
(Chapter 4). The Nestin gene codes for an intermediate filament protein that drives radial 
growth of the cell (Michalczyk and Ziman, 2005). The presence of Nestin gene 
downregulation in the putative stem cell population may indicate that the structural 
cytoskeleton remains intact in these cells to a greater extent than the control cell population. 
The cells that contain the Nestin molecule within the cell population of milk may also  be 
retaining more of the cytoskeletal components than the remaining cells in the milk cell 
fraction. The Nestin gene was also found to be downregulated in the expression analysis 
(chapter 4) of the Lin- /CD24+/CD29+/CD49f+ cell population (putative stem cells). This 
seems counterintuitive to the notion of Nestin as a marker of stem cells as it would be 
expected to see an upregulation to be observed in a population of putative stem cells, not a 
downregulation as seen in this study. When viewed in conjunction with the decreasing trend 
in Nestin positive milk cells (chapter 5) throughout a lactation it may be that as the mammary 
gland has a decreased numbers of stem cells as a lactation progresses. This inconsistency 
highlights the need for further investigations into the expression of Nestin in bovine 
mammary tissues as additional information about these populations in milk and the mammary 
gland tissues may open avenues for the increasing lactation volume and persistence. There 
were also a number of transporter and enzyme molecules found to be differentially expressed 
in the putative bovine mammary progenitor cell population (such as phosphoserine 
aminotransferase and phosphoglycerate dehydrogenase). This indicates that the cell is not 
only modulating the external environment, but also the internal cell milieu and would be 
another avenue for relevant for future work concerning the changes that occur when there is a 
loss of pluripotency and further lineage commitment.  
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Conclusions 
Cell surface markers specific for other species have been used to isolate putative mammary 
stem cell side populations. This investigation has shown that populations of cells express a 
number of these markers, as identified by antibodies to cell surface markers that are cross-
reactive for bovine cells. This demonstrates that some functional and transcriptional 
characteristics of the bovine mammary gland tissue and cells may also be characteristic of 
stem or progenitor cells. The histological investigations exhibited binding of the cell surface 
markers (CD24, CD29, CD49f and CD61) that have been identified as putative stem and 
progenitor cells in other species. The location of these markers indicated an active role of 
these markers in the structure and activities of the stroma and alveolar of the bovine 
mammary gland. Fluorescence analysis of CD29 and CD49f also revealed co- localisation of 
these markers throughout the stroma further supporting the structural and active role of these 
markers during lactation. Some of the markers found to be differentially expressed in the 
isolation studies were found in the cells of milk. This strongly indicates a potential movement 
of these and other cells between the mammary gland tissue and milk. Ultimately milk is 
required to provide a nutritional source to the cow’s offspring (calf). This movement of cells 
into the milk suggests that the cells of the milk (including putative stem and progenitor cells) 
play a major role in the growth and development of the calf. In consideration that cells of milk 
(including immunological cells) can cross the intestinal epithelial layer of the gut in 
newborns, it is possible that cells with stem- and progenitor- like characteristics are present in 
milk. The results presented in Chapter 4 showed an increase in the proliferation of the 
putative stem (Lin- /CD24+/CD29+/CD49f+) and progenitor (Lin-/CD24+/CD29+/CD61+) 
cell populations isolated from late pregnancy epithelial cells. The highly proliferate state of 
these populations provides further support for the active role of these cells in the mammary 
gland and therefore potentially also contribute to the nutrition of the milk. Further 
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investigations into the cell types, mechanisms and roles in milk would lead to increased 
understanding and potentially influence the production of milk with decreased NEB rates in 
cows, increased rates of fertility, improved nutritional value of milk and associated reduced 
costs for farmers. To remain competitive on the international level, farmers will need to 
consider alternatives to the current production systems in place. Further understanding of the 
bovine mammary gland cellular activities could be the answer. This data and experimental 
development is an initial step in the investigation and full characterization of mammary stem 
and progenitor cells from bovine tissues and would be useful in forming the basis of further 
investigations into bovine mammary stem and progenitor cells in the future.  
 
Future Work 
Further research is needed to fully investigate the influence of bovine mammary stem and 
progenitor cells on lactation. Detailed analysis is required to investigate whether manipulation 
of these cell populations is able to prolong lactation at economically viable levels. The ability 
to isolate and culture putative bovine mammary stem and progenitor cells (Chapter 3) will 
form an important basis for further functional and genetic analysis of these cell populations. 
This work would ideally culminate in the use of a xenograft mammary repopulation model 
(Eirew et al., 2008) that may further demonstrate the potential of these cell populations.  
Combining different fluorescent proteins with genetic elements unique to each of the main 
lineages of the mammary gland could give a xenografted mammary gland that develops with 
specific lineages in individual colours. This would give insight into the working of the cells 
within the tissue of the mammary gland and could be very useful in the study of mammary 
gland development, regulation and dysregulation. A greater understanding may also be gained 
from the study of cells from bovine milk that were positive for stem cell markers (such as 
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Nestin – Chapter 5) now that a method of isolation has been developed. Testing of a greater 
number of cows with a more focused selection strategy may provide insight into the cell 
content associated with peak lactation, colostrum-milk transition or add another element to 
the investigation of what makes cows with the greatest breeding values different. Further 
work into the cell content of milk may also lead to assays of milk cells that give insight into 
the health and welfare of the cows sampled. An important step in the longitudinal study of 
this milk cell population would be the establishment of culture conditions that a llowed for the 
growth and further characterisation of these cell populations.  
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